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ABSTRACT OF DISSERTATION 
 
METHODS DEVELOPMENT IN QUALITATIVE AND QUANTITATIVE 
PROTEOMICS  
Proteomics based on liquid chromatography coupled to mass spectrometry has 
developed rapidly in the last decade and become a powerful tool for protein mixtures 
analysis. LC-MS based proteomics involves four steps, sample preparation, liquid 
chromatography, mass spectrometry and bioinformatics.  Improvements in each step have 
extended its applications to new biological research areas. This dissertation mainly 
focuses on method developments in both qualitative and quantitative proteomics.   
The first part of this dissertation focuses on qualitative analysis of T. gondii 
Parasitophorous Vacuole Membrane (PVM) proteins, which is very important for T. 
gondii’s survival.  The hypothesis of this study is that proteomic approaches coupled with 
immunoprecipitation using polyclonal antisera as affinity reagents can successfully 
characterize the proteome of the T. gondii PVM. The “Three-layer Sandwich Gel 
Electrophoresis” (TSGE) protocol, was developed to contend with efficient salt removal 
and protein concentration from challenging samples. Furthermore, the TSGE coupled to 
2D-LC-MS/MS was proven to be effective with the proteomic analysis of complex 
protein mixtures like T. gondii whole cell lysate, allowing for high-throughput protein 
analysis from complex samples. By using the TSGE-2D-LC-MS/MS methodology, we 
successfully identified 61 proteins from the PVM samples and constructed the PVM 
proteome.  
The second part of this dissertation describes a novel method for selecting an 
appropriate isocyanate reagent for potential quantitative proteomics application. Our 
hypothesis is alteration of isocyanate structure will change fragmentation pattern and ESI 
property of isocyanate modified peptides. The CID property of N-terminal modified 
peptides by phenyl isocyanate (PIC), phenethyl isocyanate (PEIC) and pyridine-3-
isocyanate (PyIC) was systematically studied using LC-ESI-MS/MS.  We observed that 
adjustment of isocyanate structure changed both ESI and fragmentation characteristic of 
modified peptides.  We rationalized the decrease of protonation of PIC and PEIC 
modified peptides results from the neutral property of the both reagents.  The electron-
 withdrawing feature of PyIC leads to significant reduction of fragments during CID. 
Therefore, we designed a new isocyanate reagent, 3-(isocyanatomethyl) pyridine 
(PyMIC). The results revealed that PyMIC modified peptides had more suitable ESI 
properties and generated more sequence-useful fragments compared to PIC, PyIC and 
even unmodified peptides. PyMIC is a more appropriate labeling reagent for quantitative 
proteomics applications. 
 
KEYWORDS:   Mass Spectrometry, Toxoplasma gondii Parasitophorous 
Vacuole Membrane (PVM), Three-layer Sandwich Gel 
Electrophoresis, Isocyanate, ESI and Fragmentation 
Characteristics. 
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CHAPTER ONE 
INTRODUCTION 
Proteomics Background 
Bottom-Up Proteomics  
Proteomics is defined as the analysis of complete complements of proteins, 
including not only the identification and quantification of proteins, but also the 
determination of their localizations, modifications, interactions and functions.  There are 
four components to a proteomic approach: sample preparation, chromatography, mass 
spectrometry and proteomic informatics.  In the most commonly used bottom-up 
approaches, purified proteins or complex protein mixtures are generally subjected to 
proteolytic cleavage prior to mass spectrometric analysis. Bottom-up proteomics can be 
carried out in two basic schemes (Figure 1.1).  One scheme is called as peptide 
fingerprinting1, 2.  Protein mixtures are first resolved by two-dimensional polyacrylamide 
gel electrophoresis (2D-PAGE)3, 4, in which proteins are separated by isoelectric focusing 
(IEF) in the first dimension based on their isoelectric point (pI) difference and followed 
by SDS-PAGE separation in the second dimension based on their size difference.  Then 
the two-dimensional electrophoresis gels are visualized and analyzed by gel image 
analysis softwares so that proteins of interest can be localized on the gel. Selected 
proteins are cut from the gel for further enzymatic digestion. Then the resultant peptides 
are extracted from the gel pieces and introduced into a mass spectrometer for MS 
analysis.  Proteins are identified by searching the experimental peptide masses against 
calculated peptide masses generated by in silico cleavage of the protein using the same 
enzyme employed in the experiment.  One disadvantage of peptide mass fingerprinting is 
the requirement for pure proteins or simple protein mixtures.  Protein separation and 
purification steps therefore are crucial and limit the efficiency of the peptide mass 
fingerprinting approach.  Also, multiple peptides are required for unique identification of 
a protein. 
The other scheme used for bottom-up proteomics is via peptide fragmentation5.  
In this scheme, protein mixtures are initially enzymatically digested to the peptide level.  
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The resulting digests are separated by on-line chromatography coupled to electrospray 
mass spectrometry (ESI–MS).  Since the digest may contain thousands of peptides, two 
chromatographic dimensions have been used for efficient separation before MS analysis.  
After MS analysis is performed for each isolated peptide, the instrument automatically 
swiches to MS/MS analysis to obtain product ion fragments. The amino acid sequence of 
each analyzed peptide can be deduced from the masses of the fragment ions via de novo 
peptide sequencing6 (peptide sequencing performed without prior knowledge of the 
amino acid sequence).  Alternatively, tandem MS data can be correlated to computer-
predicted MS/MS spectra to obtain the peptide sequences and further identify proteins. 
One of the most common mass spectrometers used for tandem MS analysis is the 
quadrupole ion trap. It is the earliest developed instrument for multiple stage 
fragmentation and has the ability to generate high-quality MS2 and MSn spectra (n≤12)7.   
Compared to the peptide fingerprinting scheme, the peptide fragmentation is capable of 
analyzing complex protein mixtures, especially when coupled to high-resolution 
chromatographic techniques such as 2D-HPLC8, 9, 10.  Also, peptide fragmentation has the 
ability to identify an intact protein based on elucidation of one unique peptide amino acid 
sequence. Furthermore, strategies like stable isotope affinity tags11, 12 have been 
developed and added to the peptide fragmentation scheme, making it capable to 
determine up- and down-regulated proteins in expression proteomics. 
In the remaining part of the introduction, components of bottom-up proteomics 
will be described in detail.  
Gel Electrophoresis 
Electrophoresis can be used to separate biomolecules in an electric field. By 
applying an electric potential, the biomolecules trapped in a matrix will move through the 
matrix at different rates based on their size. When the molecules have positive charge, 
they will be drawn toward the negative anode.  If they are negatively charged, they will 
be repelled by the anode and move toward the positive cathode.    
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Figure 1. 1: two basic schemes for performing bottom-up proteomics: A: peptide 
fragmentation scheme. B: peptide fingerprinting scheme.  
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Electrophoresis Theory 
Electrophoretic separations are based upon the fact that a charged particle in an 
electric field (E) experiences an electric force (F) that is  proportional to the particle’s 
charge (q)13, (Eqn.1.1):   
qEF =                                                                                                   (Eqn. 1.1). 
The velocity (v) of a charged molecule in an electric field is dependant on both electric 
force (F) and the frictional force: 
f
qE
=ν                                                                                                    (Eqn. 1.2) 
where f represents frictional coefficient. The frictional coefficient relates to both size and 
shape of the particle. 
The electrophoretic mobility of a molecule (µ) is defined as the migration of the 
charged particle in the electric field.  It is expressed as the velocity per unit field strength 
as follows (Eqn. 1.3) 
 f
q
E ==
νµ                                                                                    (Eqn. 1.3) 
where v is the velocity of the charged particle and f is the frictional coefficient. Since the 
frictional coefficient is proportional to both viscosity of the medium and size of the 
molecule, from Equation 1.3, it can be seen that electrophoretic mobility decreases for 
larger particles and increases with higher charge. 
Factors that affect gel electrophoresis 
Matrix 
Depending on the targeted biomolecules to be separated, different matrices are 
chosen for gel electrophoresis. The most commonly used matrix for protein separation is 
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polyacrylamide gel.  Agarose is another common matrix for gel electrophoresis. It usually 
is used for larger biomolecule separation. 
Polyacrylamide gel14 is prepared by adding free radical initiators to an aqueous 
solution of the monomer mixture, which typically includes acrylamide monomer and 
crosslinking agent N,N’-methylene bisacrylamide (bis).   The most common free radical 
initiator system used is ammonium persulfate and N,N,N’N’-tetramethylethylenediamine  
(TEMED). The structures of all reagents employed in the polymerization reation and the 
polyacryamide product are shown in Figure 1.2.  Compounds that may act as a free 
radical trap will inhibit polymerization. As one of the inhibitors, oxygen is usually 
removed from gel solution via degassing process prior to the addition of free radical 
initiator to the monomer solution.  
The effective pore size of polyacrylamide gels is an inverse function of “the total 
acrylamide concentration” (T %), which is defined as the sum of the concentrations of 
acrylamide and Bis in the polymerization mixture15.   The proportion of crosslinker Bis 
also affects the pore size of gel. The effective pore size decreases as crosslinker Bis 
concentration increases and reaches a minimum at a concentration of Bis of 5%. With 
higher concentration of Bis, the polymer chain becomes crosslinked into large bundles. 
The spaces between these bundles become larger, which directly leads to the increase of 
effective pore size. Pore size reproducibility depends on the accuracy and purity of 
monomer stock solution. The polymer formed will not be reproducible unless the 
polymerization yield reaches over 95%.  
Agarose is obtained from the agar-bearing seaweeds from the class Rhodophyta, 
or red algae. Agarose is an alternating 1,3 linked beta-D-galactopyranose and 1,4-linked 
3,6-anhydro alpha-L-galactopyranose. Agarose gel has the characteristic of large pore 
size, which allows it to separate larger complex or molecules like DNA, RNA and 
nucleoproteins.  
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Buffer Systems 
Buffer systems are classified as continuous and discontinuous buffer systems. If 
the same buffer ions are present throughout the sample, gel and electrode reservoirs at 
constant pH, it is referred as continuous buffer systems. In contrast, if different buffer 
ions are used in the gel compared to those in the electrode reservoirs, it is called as 
discontinuous buffer systems. Both buffer composition and pH factors are applied in 
most discontinuous buffer systems. The major advantage of discontinuous buffer systems 
is that good resolution of sample components can be obtained even for large volumes of 
dilute protein samples. The most commonly used SDS-Discontinuous system described 
by Laemmli16 consists of Tris-glycine buffer pH 8.3 in both upper and bottom electrode 
reservoir, Tris-HCl buffer pH 6.7 in stacking gel and Tris-HCl buffer pH 8.8 in resolving 
gel.  An anionic detergent, sodium dodecyl sulphate (SDS), which is the most common 
dissociating agent, is present in the entire buffer system.  SDS can bind to hydrophobic 
portions of a protein (one SDS anion to two amino acids) in a constant weight ratio (1.4g 
SDS per gram of polypeptides). The natural charges of the polypeptide are insignificant 
compared to the negative charges provided by the SDS, so the SDS bonded polypeptides 
have identical charge densities and migrate in gels according to polypeptide size. 
Polyacrylamide gel electrophoresis (PAGE) can be carried out at a pH anywhere between 
2.5 and 1115. In SDS-PAGE, the SDS-polypeptides are negatively charged over a wide 
range so the pH of the buffer systems is not critical. 
Two-dimensional Gel Electrophoresis (2D-SDS-PAGE)  
Traditionally, two-dimensional gel electrophoresis (2D-SDS-PAGE) coupled with 
MS is used for differential protein expression studies3. As described previously, 2D-SDS-
PAGE is involved in resolving proteins by isoelectric focusing (IEF) using immobilized 
pH gradient (IPG) strips in the first dimension followed by further protein separation 
using SDS polyacrylamide gel17 in the second dimension.  For comparative proteomic 
studies, practically two protein samples from control and tested samples are dissolved in 
loading buffer and loaded onto two IPG strips, respectively.  The proteins are absorbed 
into the IEF strips with the aid of low voltage and further resolved by increasing the  
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Figure 1. 2: Mechanism of acrylamide polymerization 14. Polyacrylamide gel is 
prepared by adding free radical initiators like ammonium persulfate and N,N,N’N’-
tetramethylethylenediamine  (TEMED) to an aqueous solution of the monomer mixture, 
which typically includes acrylamide monomer and crosslinking agent N,N’-methylene 
bisacrylamide (bis).    
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voltage.  Once the first dimension separation is finished, the IPG strips are transferred to 
the top of 1D-SDS-PAGEs and gel electrophoresis is carried out under voltage.  The 
resolved proteins are visualized by conventional staining techniques, such as Coomassie 
Blue18, SYPRO Ruby19 or silver staining20.  Among these staining techniques, the 
sensitivity of SYPRO Ruby and silver staining can reach 1ng, which are more sensitive 
than Coomassie Blue. SYPRO Ruby has better linear dynamic range (1-1000ng) 
compared to silver staining (1-100ng).  Relative quantities of each pair of interested 
proteins can be obtained by comparing the densities of stained spots from control sample 
with the tested sample via gel image analysis softwares like PDQuest21 22. 
High-Performance Liquid Chromatography (HPLC) 
Since HPLC was developed in 1970’s23, it has been extensively applied to 
separate a variety of mixtures including biological, environmental and industrial samples.  
The HPLC instrument consists of reservoirs of mobile phase, a pump, an injector, a 
separation column and a detector23.  The separation is performed by pumping mobile 
phase at high pressure through the column followed by introduction of the sample to be 
analyzed onto the column.  The sample is then forced to flow through the column by 
continuously running mobile phase and eventually detected by the detector while eluting 
from the column.  HPLC comprises all liquid chromatographic techniques that require the 
use of high pressure to force the liquid through a packed bed of the stationary phase.  
Among these liquid chromatographic techniques, reversed-phase chromatography and ion 
exchange chromatography are typically used for peptide separation prior to MS analysis 
in proteomics and therefore will be discussed in detail. 
Reversed-Phase Chromatography 
Reversed-phase chromatography (RP-HPLC) is a very popular HPLC tecnique 
and accounts for about 90% of small molecule separations HPLC 24.  RP-HPLC is 
characterized as comprising a non-polar stationary phase and a polar mobile phase.  The 
hydrophobic stationary phases for RP-HPLC are to a large extent based on long-chain 
hydrocarbons attached to supports.  For peptide separation, Silica-based C18 packing 
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materials have been commonly used.  This type of packing materials is prepared by 
treating silica support with RMe2SiCl, where R is a straight chain alkyl group: C18H3725.  
A typical mobile phase for RP-HPLC contains mixtures of water with polar organic 
solvents like methanol or acetonitrile.  RP-HPLC operates on the principle of 
hydrophobic interactions between the analytes and nonpolar stationary phases.  Many 
models have been developed to explain retention in reversed-phase chromatography26-29. 
According to the liquid-crystalline hydrocarbon partition model developed by Martire 
and Boehm30, the properties of the stationary phases, which directly influence the 
retention behavior in RPC, will change dramatically with mobile phase conditions. The 
bonded hydrocarbon chains on the surface of the silica support are extended and oriented 
at organic-rich mobile phase. The brush-like configuration allows complete penetration 
of solvent and solute molecules.  However, as mobile phase increases aqueous 
composition, the alkyl chains behaves as a quasi-liquid layer that allows solute 
penetration but not solvent. Martire and Boehm concluded that the retention process in 
RPC approaches the classic liquid-liquid partitioning model. As known in partitioning 
model, the equilibrium generated during analytes partition between the stationary phase 
and the mobile phase23 can be described as Eqn. 1.4. 
stationarymobile AA ↔                                                                     Eqn. 1.4 
The equilibrium constant (K) is defined as the ratio of the molar concentration of analyte 
in the stationary phase and the molar concentration of the analyte in the mobile phase 
(Eqn.1.5): 
K =
m
s
C
C
                                                                                                       Eqn. 1.5 
Hydrophobic peptides have higher equilibrium constants (K) and stay on the 
stationary phase longer than relatively hydrophilic peptides.  When mobile phase passes 
through the column, peptides move in and out of the stationary phase and migrate toward 
the direction of the column outlet.  When enhancing the hydrophobicity of the mobile 
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phase, the partition equilibrium can be shifted toward the mobile phase.  Theoretically, 
the most polar component elutes first, and the most nonpolar component elutes last25. 
Column Efficiency  
A fundamental disadvantage of HPLC is the broadening of the sample component 
band during migration through the separation system, which seriously affects column 
efficiency of the chromatographic separation.  The column efficiency is usually measured 
by plate count (N), which is related to the length of the separation column and the 
theoretical plate height (H), as shown in Eqn.1.6:  
N = 
H
L                                                                              Eqn. 1.6  
L:    length of the separation column;  
H:    theoretical plate height 
The theoretical plate height is used as a measure of relative peak dispersion in distillation 
technology.  The relationship of the theoretical plate height with linear velocity can be 
described by the Van Deemter equation31 (Eqn. 1.7): 
                  H = A + 
u
B + Cu                                                                                   Eqn. 1.7  
                            Where      u = the linear velocity of the mobile phase 
          A= the eddy diffusion 
          B= the longitudinal diffusion coefficient 
          C= Resistance to mass transfer in the stationary (Cs) and 
mobile (Cm) phases 
The eddy diffusion term (A) relates to the various pathways, by which a component finds 
its way through the column.  It is independent of the flow velocity but dependent on the 
size of the packing particles, the distribution of the inter-particle channels and other non-
uniformities in the packed bed.  The longitudinal diffusion term, B/u, describes the 
molecular diffusion in the axial direction. It is inversely related to the mobile phase 
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velocity.  Cu represents all terms related to mass transfer between mobile and stationary 
phase. It is associated with the time needed for establishing dynamic equilibrium of an 
analyte between the mobile and stationary phases and directly proportional to the linear 
velocity.  At high mobile flow rates there is less time for this equilibrium to take place, 
therefore a higher Cu value is observed.  
A plot of plate height versus linear velocity is shown in Figure 1.3, which 
indicates the optimum flow rate of a given column.  As shown in Figure 1.3, at mobile 
phase velocities below the optimum, the overall column efficiency is mainly affected by 
eddy diffusion term A.  At the optimum velocity, the longitudinal diffusion term (B/u) 
plays an important role on increase of the theoretical plate height.  When velocities 
become higher than the optimum, the resistance to mass transfer term (Cu) contributes 
more for the decrease of column efficiency.  Column efficiency takes into account only 
peak dispersion.  The higher values of theoretical plate height, are the lower column 
efficiencies obtained, which implies broad chromatographic peaks are observed.  In order 
to obtain high column efficiency for peptide separation, RP-HPLC running condition 
needs to be optimized. 
Challenges in LC-MS/MS-Based Bottom-up Proteomics 
The proteomes of mammalian cells, tissues and biologic fluids are complex and 
consist of thousands proteins.  For peptide fragmentation, protein mixtures are subjected 
to tryptic digestion prior to LC-MS/MS analysis, which makes the sample more 
complicated.  Therefore, it is very important to evaluate the peak capacity of the 
chromatographic column to see if it can overcome the sample complexity for 
comprehensive analysis.  Peak capacity (nc) represents the number of peaks that can be 
separated from one another by a specific chromatographic column, which is defined by 
the equation31 (Eqn. 1.8): 
s
c R
Ln
σ4
=                                                                             Eqn. 1.8  
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Figure 1. 3: The van Deemter plot 31. H is the plate height, A is the Eddy diffusion term, 
B is the longitudinal diffusion term, C is the resistance to mass transfer term and u is the 
mobile phase velocity. 
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where L is the column length, σ is the standard deviation and Rs is the resolution of 
separated peaks.  The equation is based on the assumption that all the peaks are separated 
from one another by four standard deviations of the Gaussian peak profile, which is far 
beyond actual situation.  Therefore, the peak capacity ideally reflects the maximum 
number of resolved peaks that can fit within the column length.  For best-case scenario, 
considering that a reversed-phase chromatography column has a peak capacity of 250 32 
and no more than 10-20 peptides can be analyzed simultaneously in electrospray 
ionization mass spectrometers, theoretically, the peptides that can be separated and 
analyzed using LC-MS might reach103 at most, which is still orders of magnitude lower 
than the peptide number generated in a proteome (for example, about 4000 predicted 
proteins from E. coli genome)33.  Therefore, additional fractionation steps are needed to 
deal with a sample’s complexity.  Furthermore, the abundance differences from protein to 
protein in most proteomes, which are far beyond the dynamic range of most mass 
spectrometers, seriously challenges the LC-MS/MS analysis.  The coelution of high and 
low abundance peptides due to the limited peak capacity of RP-HPLC columns 
compounds this problem.  The ionization of low abundance peptides can be suppressed 
and their spectra are masked by high abundance species, making it very difficult to 
analyze all species.   
In order to analyze low abundance proteins or as many proteins as possible in a 
proteome, further sample purification steps such as removal of high abundance proteins 
from samples or sample simplification via affinity selection methods34 35 are widely 
employed. Another effective way is the application of multidimensional HPLC 
separations36-38 to increase HPLC peak capacity, therefore reducing the number of 
coeluting peptides. The most commonly used two-dimensional HPLC system involves 
the combination of strong cation exchange (SCX) chromatography with reversed-phase 
HPLC chromatography. 
Strong Cation Exchange Chromatography 
Strong cation exchange chromatography (SCX)39 is based on the electrostatic 
attraction between opposite charges on the stationary-phase and the molecules.  The 
typical strong cation exchange column has sulfonic acid groups on the surface of the  
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Figure 1. 4: Schematic representation of a surface-sulfonated cation exchange material. 
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stationary phase. Since the sulfonic acid functional group can be ionized at all pH values 
and has negative charges, it has wide applications23.  Figure 1.4 schematically depicts a 
representative cation exchange material.  Typically, the SCX column is equilibrated using 
low ionic strength buffers (e.g. 0.1% formic acid, 95% aquious solution, 5% acetonitrile). 
Under these conditions, all sulfonate groups in the stationary phase are associated with 
protons.  Then, the sample is applied to the stationary phase.  Only species carrying 
positive charges will be retained by the negative charged stationary phase.  Species 
having negative charge or no charge will simply flow through without binding.  The ion 
exchange matrix is washed with additional low ionic strength buffer to completely 
remove any remaining unbound species from the SCX column.  The exchange reaction of 
a cation M+ with a cation exchanger on the stationary phase can be expressed as 
follows39: 
Resin-SO3-H+ + M+A- ↔ Resin-SO3-M+ + H+A- 
The separation of cations is determined by their different affinities towards the stationary 
phase.  The bound peptides are eluted by increasing the salt concentration of the mobile 
phase.  As the ionic strength of the mobile phase increases, salt cations compete with the 
peptides for binding to the charges on the ion exchange matrix.  Peptides with weaker ion 
interactions will be released at lower salt concentrations.  Peptides with higher charge 
will have a higher affinity towards the stationary phase and will stay on the column 
longer.  The effectiveness of displacement for cations39 commonly used in mobile phase 
is: Ca2+ > Mg2+ > Na+ > K+ >NH4+.  Ammonium acetate is usually employed for peptide 
separation in proteomics. The elution is expressed as follows: 
Resin-SO3-M+ + NH4+AC- ↔ Resin-SO3-NH4+ + M+AC- 
Electrospray Ionization-Ion Trap Mass Spectrometry 
Electrospray Ionization 
One challenge for LC-MS is the introduction of species eluted from a HPLC 
column to a mass spectrometer.  The difficulty is to transform a solute in solution into a 
 16
gas-phase ion.  Currently electrospray is the most popular technique for ion introduction 
approach.  John Fenn demonstrated the use of ESI for the ionization of high mass 
biological compound 40, 41, over 20 years ago and won the 2002 Nobel Prize in chemistry 
for his contribution to the development of electrospray ionization 42.  
Electrospray ionization takes place at atmospheric pressure. It is considered to be 
a soft ionization method since little or no fragmentation takes place during this process.  
The full MS spectrum provides mainly molecular weight information of analytes.  
Practically, the HPLC effluent is directly connected to the electrospray probe, which is 
shown in Figure 1.5.   A typical voltage between 500 V to 4.5 kV is applied to the ESI 
probe tip.  When the HPLC effluent passes through the electrospray needle, the high 
voltage leads to charged droplets spraying out of the probe tip. Those droplets have the 
surface charge identical to the electrospray needle.  Thus the droplets are repelled from 
the needle and fly toward the counter electrode on the atmospheric pressure ionization 
(API) sources.  The droplets generated from this process contain both solute and solvent 
molecules. Solvent evaporation starts to take place as soon as the droplets form and fly 
towards to the API stack.  Then the droplets are drawn into a heated capillary located in 
the API stack from atmospheric pressure region to vacuum region by a decreasing 
pressure gradient. The high temperature of the heated capillary assists solvent 
evaporation process of the charged droplets.  Ultimately, all solvent molecules evaporate 
and gas-phase ions are formed.   
ESI can be operated in either positive mode (positive potential is applied to the 
electrospray needle) or negative mode (negative potential is applied to the electrospray 
needle)43.  The produced ions are dependent on the species present in eluent buffers.  In 
positive mode, typical ions produced by ESI include [M+H] +, [M+Na] +, [M+K] + and 
[M+CH3CN+H] +, etc.  In negative mode, ions like [M-H] - and [M+HCOO -] - are easily 
generated.  Considering properties of peptides, the positive mode is usually used during 
the ESI for bottom-up proteomics.  The typical buffer used for peptide elution from 
HPLC is 0.1% formic acid in water or 0.1 % formic acid in water-acetonitrile solvent 
which has an approximate pH of 3.  Under this condition, multiple positive charged 
peptide ions can be easily formed.
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Figure 1. 5: A schematics of electrospray probe. The HPLC effluent is directly 
connected to the electrospray probe.   A typical voltage between 500 V to 4.5 kV is 
applied to the ESI probe tip.  When the HPLC effluent passes through the electrospray 
needle, the high voltage leads to charged droplets spraying out of the probe tip. 
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 Mechanisms of Electrospray Ionnization  
The first step of ESI is production a stream of charged droplets at the capillary 
needle tip.  The high potential applied at the electrospray capillary needle leads to a 
partial separation of positive ions from negative ions in the solution.  In the positive 
mode, positive ions are forced to move to the surface of the liquid at the capillary needle 
tip while negative ions are forced to move back forward the inside of the capillary needle.  
The repulsion of the positive ions at the surface overcomes the surface tension of the 
liquid, causing the formation of a Taylor cone at the the capillary needle tip (Figure 1.6).  
The tip of the Taylor cone breaks up into individual charged droplets.  The occurrence of 
the whole process requires at least 10-5 molar electrolytes present in the liquid.  Since ESI 
is a continuous process, series of droplets form and move toward the counter electrode, 
which forms the total droplet current (TDC) between the electrospray capillary needle 
and the negative counter electrode.  An electrochemical oxidation reaction, which 
removes negative ions, occurs at the metal capillary44.  Correspondingly, an 
electrochemical reduction reaction, which removes positive ions, occurs at the negative 
counter electrode (Figure 1.6).  
Once the droplets form, solvent evaporation starts and eventually gas-phase ions 
are formed.  This process can be explained by two mechanisms.  One is called the 
charged residue model (CRM), originally proposed by Dole 45, 46, and the other one is the 
ion evaporation model (IEM), which is proposed by Iribarne and Thomson47-50 .  
According to charged residue model, as solvent evaporation occurs, the droplet keeps 
shrinking until the Rayleigh limit is reached. This implies the surface tension can not 
hold the charges in the droplet any longer.  A "Coulombic explosion" occurs to break up 
the droplet into smaller droplets. The whole process repeats until the droplets are so small 
that only one analyte molecule is present.  Then the gas-phase ions will be produced by 
evaporating all solvent in the droplets.  The ion evaporation model (IEM) proposes a 
different scheme. In brief, the initial droplet shrinkage is via solvent evaporation and 
Coulomb droplet fissions.  However, when the process has reduced the size of the 
charged droplets to a certain point, direct emission of ions to the gas phase begins to 
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Figure 1. 6:  A schematic of the mechanism of ion formation in ESI. *: Adapted from 
http://www.chm.bris.ac.uk/ms/theory/esi-ionisation.html   
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occur.  Since the charge density on the droplet required for this ion-emission is lower 
than that required for the Coulomb fission, ion emission replaces Coulomb fission until a 
naked charged ion is formed. 
Electrospray ionization has several features.  First of all, it is characterized as a 
soft ionization technology since very little residual energy is retained by the analyte.  
Therefore, ESI does not damage non-covalent interactions during the process of 
transferring the analytes into gas phase, which is crucial for biological studies involved in 
protein-protein interactions.  Second, it is well-known that ESI is able of producing 
singly or multiply charged ions depending on the chemical structure of the analyte.  For 
peptide analysis, since both N-terminal amino groups and basic side-chains of peptides 
can be protonated at low pH value, multiple positively charged ions are easily formed 
during the ESI process, which is critical for analyzing high molecular weight peptides 
using mass spectrometers with limited mass range detection such as quadrapole ion trap 
mass spectrometers.  Also, since very little fragmentation is produced during the ESI 
process, tandem mass spectrometry is needed to fragment analytes for structural 
elucidation studies. 
Quadrupole Ion Trap Mass Spectrometry 
In the early 1950s, Wolfgang Paul and co-workers invented both the quadrupole 
mass analyzer and the quadrupole ion trap mass spectrometer (QIT-MS)51.  For the 
invention of the ion trap, Dr. Paul won the 1989 Nobel Prize in Physics.  His work builds 
the foundation of the present-day quadrupole ion trap instruments.  However, because of 
limited performance of the ion trap at that time, it was primarily restricted to the physics 
community.   In 1983, breakthroughs in ion trap design were fulfilled by George Stafford 
and co-workers at Finnigan MAT52 which significantly simplified the operation of the ion 
trap and simultaneously improved the mass resolution of the instrument.  All these 
improvements led to the successful development of a commercial ion trap mass 
spectrometer.  Today, the QIT-MS has been widely applied to chemical, biochemical and 
forensics areas and has become one of the most common instruments in various 
laboratories. A schematic of the basic setup of a quadrupole ion trap is shown in Figure 
1.7.  The core of quadrupole ion trap consists of three hyperbolic electrodes: a ring and 
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two end-caps.  These electrodes form a small trapping volume with a dimension of r0 and 
z0 as shown in Figure 1.7.  A gating lens located in front of the entrance end-cap 
electrode pulses positive or negative voltages to repel or inject ions into the ion trap.  The 
gating lens open time is optimized so that maximum signal and minimum space-charge in 
the ion trap can be obtained.  Ions injected into the ion trap collide with helium gas 
molecules present in the trap (1 mtorr).  The collisions dampen the kinetic energy of the 
ions and make these ions move toward the center of the ion trap53, 54.  The fundamental rf 
(1.1 MHz), which creates a saddle-shaped quadrupole field in the ion trap, is applied onto 
the ring electrode for further focusing the ions toward the center of the trap7. The 
oscillation of the fundamental rf causes a periodic inversion of the quadrupole field, 
which leads to the ion staying at the center of the trap.  The potential values at any point 
of the quadrupole field can be described by the following equation55, 56 (Eqn. 1.9): 
2
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where,  U = dc potential applied to ring electrodes 
            V = rf amplitude applied to ring electrode (fundamental rf) 
           =Ω oscillating frequency of rf (V), typically 1.1 MHz 
           r0 = distance between the center of QIT and the ring electrode 
           r = closest distance between the ion and the ring electrode 
          z = closest distance between the ion and the end-cap electrode 
The solutions to the equation can be expressed in the form of a second order differential 
equation, the Mathieu equation7.  Two dimensionless Mathieu parameters az and qz, 
derived from the Mathieu equation (Eqn. 1.10 and Eqn.1.11), are used to describe ion’s 
stable motion in the trap: 
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Figure 1. 7:  A schematic of quadrupole ion trap. The core of quadrupole ion 
trap consists of three hyperbolic electrodes: a ring and two end-caps.  These electrodes 
form a small trapping volume with a dimension of r0 and z0.  A gating lens located in 
front of the entrance end-cap electrode pulses positive or negative voltages to repel or 
inject ions into the ion trap.  Ions injected into the ion trap collide with helium gas 
molecules present in the trap (1 mtorr) and get trapped in the trap, or move out of the trap 
by adjusting amplitude of RF on the ring electrode.  
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where,     e = electronic charge  
                                                               m = the mass of the ion 
 Mathieu Stability Diagram 
A plot of az vs qz is called  Mathieu stability diagram,7 and represents radial and 
axial stability overlap.  Depending on the values of the dc potential (U) and rf amplitude 
(V) placed on the ring electrode, an ion of a given m/z will have an az and a qz value. If 
the values fall within the boundaries of the stability diagram, the ion will be trapped.  If 
the values fall outside of the boundaries of the stability diagram, the ion will hit the 
electrodes and be lost.  By changing both dc potential (U) and rf amplitude (V) on the 
ring electrode, we can control the movement of an ion with a given mass-to-charge ratio 
in the ion trap so that the ion of interest can either stay within the boundaries of the 
stability diagram and be trapped in the trap, or move out of the boundaries and be 
expelled from the trap.  
Mass Selective Instability Scan 
Mass spectra are normally recorded by means of the “mass selective instability 
scan” mode 52.  In this mode of operation, the dc potential (U) on the ring electrode is not 
employed and the ion motion is constrained to the az = 0 axis. The rf potential (V) applied 
to the ring electrode is raised to “move” ions along the qz axis. When qz values approach 
0.908, ions reach the boundary of the stability diagram, become unstable, and eventually 
are ejected from the ion trap (shown in Figure 1.8).   A well-defined low-mass cutoff is 
created for a given value of the fundamental rf (V).  Theoretically, ions with mass larger 
than mmin will be trapped in the trap.  But ions with large m/z values ions have low 
trapping efficiency compared to ions with small m/z values.  As amplitude of the 
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fundamental rf potential (V) is raised, ions of increasing m/z are sequentially ejected 
from the ion trap through the holes in the end-cap electrode and detected by an external 
electron multiplier detector.  Therefore, a mass spectrum is produced.  
Resonance Ion Excitation and Ejection 
The other way to eject ions from ion trap is resonance ejection57.  Ions oscillate 
with a frequency, the secular frequency (fz), when they are trapped in the QIT.  The 
secular frequency (fz) is lower than angular frequency (Ω ) of the fundamental rf and 
decreases with increasing mass.  It is determined by the values for az, qz andΩ .  When a 
supplemental potential which has frequency that matches the secular frequency fz of an 
ion is applied on the end-cap electrode of the ion trap, the ion’s kinetic energy is 
increased and its axial trajectory is exaggerated until the ion is ejected from the trap.  So 
resonance ejection can expel ions from the trap at a qz value below normal value (0.908).  
For example, qz values as low as 0.01 instead of 0.908 can be used to eject ions in this ion 
ejection method, therefore, extending the mass to charge ratio range that can be scaned in 
normal scan mode.     
MS/MS Experiments 
Tandem mass spectrometry in an ion trap can be carried out in three steps: the 
isolation of the ions of interest, the fragmentation of ions via collision-induced 
dissociation (CID) and the scan of resultant product ions out of the trap.  Resonance 
ejection57 as described above can be employed to isolate an ion with particular m/z, while 
ejecting all others.  Another approach to ion isolation is reverse-then-forward scanning55. 
A supplemental rf is applied to the endcap electrodes to create an ejection hole at low qz. 
Ions bigger than the ion of interest are first moved to the ejection hole and are ejected out 
of the trap by scanning the findermental rf amplitude (V) on the ring electrode in the 
reverse direction. Then the ions smaller than the interest ion are ejected by changing the 
supplemental rf to form an ejection hole at high qz. The rf amplitude on the ring electrode 
(V) is then scanned forward, thus ejecting all ions of lower m/z 7.  Once 
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Figure 1. 8:  Mathieu stability diagram for a 3D quadrupole ion trap. The az 
parameter is proportional to dc and the qz parameter is proportional to rf. In “mass 
selective instability scan” mode, the dc potential (U) on the ring electrode is not 
employed and the ion motion is constrained to the az = 0 axis. The rf potential (V) applied 
to the ring electrode is raised to “move” ions along the qz axis. When qz values approach 
0.908, ions reach the boundary of the stability diagram, become unstable, and eventually 
are ejected from the ion trap.  
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the ions of interest are isolated, the low-energy collision-induced dissociation (CID) 
fragmentation is performed by the application of a supplemental potential (ac) with a 
low-amplitude to the endcap electrodes, which causes excitation of the ion and the 
increase of the ion kinetic energy. The amplitude of the applied supplemental potential is 
controlled to a reasonable level so that the ion will not be ejected from the trap.  The 
excited ions in the trap collide with the damping gas helium and fragment to from 
product ions.  The last step of the MS/MS experiment is to sequentially eject product ions 
from low m/z to high m/z by a gradual change in the fundermental rf amplitudes (V).  
Ions are ejected through holes in the endcap electrode and detected using an electron 
multiplier.  
Quadrupole ion trap mass spectrometers have become one of the most popular 
instruments and have been widely used in bottom-up proteomic studies due to their 
unique features.  First of all, QIT is very amenable to soft ionization techniques like ESI 
ionization, making it suitable for biological molecule analysis.  Also the QIT instruments 
have the ability to perform MSn experiments58.  The QIT has been used to perform up to 
12 stages of tandem mass spectrometry (MS12), greatly increasing the amount of 
structural information obtainable for a given molecule.  These characteristics make the 
ion trap extensively applied to bottom-up proteomics.   
In order to meet the needs of full automation and high through-put analysis of a 
numbers of proteins in bottom-up proteomics, QIT mass spectrometers are usually 
coupled with HPLC via electrospray ionization techniques.  Data-dependent algorithms 
have been used to obtain both MS and MS/MS data during the course of a single LC/MS 
run.  In the data-dependent mode, the instrument first acquires full scan mass spectra, 
then the most intensive precursor ions from previous full scan spectra are automatically 
chosen for following MS/MS experiments.  The switch from MS mode to MS/MS mode 
takes place once a signal threshold is exceeded.  With dynamic exclusion enabled, once 
one ion is analyzed by MS/MS, it is put on an exclusion list. The ion is not analyzed 
further for a pre-selected time window.  Then the instrument proceeds with the analysis 
of other ions present in the full scan. 
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Proteomic Bioinformatics 
Peptide CID fragmentation is usually carried out by cleaving amide bonds along 
the peptide backbone, producing six possible types of fragments: a,b,c ions (when the 
charge is retained on the N-terminal fragment), and x, y, z ions (if the charge is retained 
on the C-terminus)59.  Under low-energy collision-induced dissociation conditions, 
peptides typically form b, y, and occasionally a ions (structure showed in Figure 1.9).  
Peptide sequences can be elucidated by using database searches or de novo sequencing6.  
The database-searching approach is convenient and important for high through-put 
protein identification technology such as 2D-LC-MS/MS.  However, when the 
corresponding sequences are not included in the databases, de novo sequencing will play 
an important role in its identification. Since no preliminary information about the peptide 
is necessary for de novo sequencing approach, continuous y ions or b ions are required 
for complete sequence elucidation.   
The Mascot database search engine60 is used for protein identification in this 
dissertation.  As one of the commonly used database searching algorithms, the Mascot 
database search engine is developed based on MOWSE algorithm.1  Mascot adds a 
probability-based algorithm to the Mowse algorithm.  Protein identification is based on 
the calculation of the probability (P) that the observed match between the experimental 
data and theoretical value is a random event. Therefore, the best match directly 
corresponds to the lowest probability value. In order to easily interprete search results, 
the calculated probability values are converted into Mowse scores using the 
equation )(*10log*10 P− , thus giving a high score for a good match. Using Mascot 
score allows the peptide or protein which best matches the data to be identified.  
Since Mascot is derived from MOWSE algorithm, the detail of MOWSE 
algorithm is discussed. At first, the calculated peptide masses in the sequence database is 
generated and used to compare with the experimental data set.  If one calculated value 
falls within a given mass range of an experimental value, it counts as a match. Each 
individual peptide match is statistically evaluated by Mowse using empirically 
determined factors. A matrix of weighting factors is created using a frequency factor 
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matrix (F).  In this matrix, each row represents an interval of 100 Da in peptide mass, and 
each column stands for an interval of 10 kDa in intact protein mass. As each calculated 
peptide mass is compared, the appropriate matrix element fi,j for each match is obtained. 
Then each element in the matrix is normalized via dividing individual fi,j value by the 
largest fi,j value in the same column to give the Mowse factor matrix mi,j (Eqn. 1.12): 
incolumnjji
ji
ji f
f
m
max,
,
, =                                                                                 Eqn. 1.12 
After finishing the search of the experimental mass values against a calculated peptide 
mass database, the score for each peptide is obtained based on Eqn.1.13: 
∏×=
n
jiot mM
score
,Pr
000,50                                                                           Eqn.1.13 
where Mprot is the molecular weight of the entry and ∏
n
jim , is the product of distribution 
factors for each match between the experimental data and peptide masses calculated from 
the entry.  
Compared to the MOWSE algorithm, Mascot not only can support peptide mass 
fingerprint search, but is also used for MS/MS Ion Searches. For an MS/MS Ions Search, 
the analysis begins with the conversion of MS/MS spectra into mascot generic format 
(MGF), which is a list of pairs of mass and intensity values, delimited by BEGIN IONS 
and END IONS statements for each MS/MS dataset. Then theoretical peptide mass or 
fragment ion masses are calculated based on the pre-selected parameters such like 
proteolytic enzyme used to cleave protein, potential modification and database used to be 
searched. The generated MGF files are searched against the computer-calculated peptide 
mass or fragment ion masses in a database entry.  Eventually, Mascot scores are 
generated and used to indicate if the match is a good match or not. 
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Figure 1. 9:  Illustration of the fragments formed through bond cleavages along the 
backbone of protonated peptides. Peptide CID fragmentation is usually carried out by 
cleaving amide bonds along the peptide backbone. Under low-energy collision-induced 
dissociation conditions, peptides typically form b, y. 
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Statement of Research 
This chapter is mainly focused on the introduction of background knowledge that 
involves the following chapters.  It includes the definition of proteomics, the 
development of bottom-up proteomics and methodologies used for bottom-up 
proteomics.  Tools employed in bottom-up proteomics, such as HPLC, ionization 
techniques, mass spectrometer and data analysis, have been discussed in detail.  
The remaining part of this dissertation mainly focuses on discussion of the 
research that has been conducted on method development and application in proteomics. 
Two parts, which involves the method developments in qualitative and quantitative 
proteomics, will be presented in detail.  Part one is method development for qualitative 
proteomic analysis and its application on qualitative analysis of the T. gondii 
Parasitophorous Vacuole Membrane (PVM).  Part two is regarding a novel methodology 
for selection of an appropriate labeling reagent for potential application on quantitative 
proteomics.   
Chapter two focuses on qualitative analysis of the T. gondii PVM proteins (part 
one).  In order to do this, a novel protein concentration and clean up method for 
challenging protein samples like PVM sample, “Three-layer Sandwich Gel 
Electrophoresis” (TSGE) was developed.  Its performance was compared with other 
available protein concentration and salt removal methods.  By coupling with MuDPIT, 
the application of TSGE method to proteomic analysis of whole T. gondii lysate was also 
discussed to prove that the new methodology can correctly reflect the composition of 
protein sample and is suitable for global proteomics.  Finally, application of the novel 
methodology on proteomic analysis of T. gondii PVM proteins is presented.  The 
identified PVM proteins were further analyzed and discussed. 
Chapter three describes the systematic study of mass spectrometric properties of 
N-terminal labeled peptides with various isocyanates using LC-ESI-MS/MS (part two).  
Stable isotope labeling strategies used for quatititive proteomics was introduced.  Then 
the effect of peptide labeling on peptide ESI properties and peptide fragmentations was 
explained.  Three commercially available isocyanates were chosen and their mass 
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spectrometric properties were systematically studied.  Eventually a new isocyanate 
reagent for better fragmentation was designed and evelated. 
Chapter four is the general conclusion of the dissertation, which provides some 
concluding remarks and highlights the significance and future direction of this work. 
 
Copyright © Ting Liu 2008 
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CHAPTER TWO 
 
 
 
 
 
METHOD DEVELOPMENT FOR QUALITATIVE PROTEOMICS AND ITS 
APPLICATION ON ANALYSIS OF THE T. GONDII PARASITOPHOROUS 
VACUOLE MEMBRANE (PVM)  
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Chapter 2.1 
Introduction 
High through-put bottom-up proteomics has been widely applied to the 
identification and characterization of proteins in various biological systems.  However, 
reliable identification and analysis of the targeted proteins still remains a key challenge in 
the study of sub-proteomes and protein interactomes which can play important roles in 
our understanding specific protein functions and biological pathways.  One main reason 
is the difficulty of obtaining high quality protein samples for subsequent well-established 
proteomic analysis. It is still hard to isolate low abundance target proteins from high 
abundance interfering proteins, especially for organelles that are not capable of being 
purified by traditional biochemical methods.  Therefore, it is critical to develop efficient 
isolation and purification methods for challenging biological samples. Recently, 
numerous isolation, purification and enrichment strategies based on affinity pull-down 
and immunoprecipitation for different target system have been developed35, 61, 62. These 
strategies successfully solved the biological sample preparation problem. However, since 
these strategies utilize a variety of reagents such as salts, detergents and other small 
molecule additives for the purpose of obtaining the highest amount of target proteins and 
simultaneously removing interfering proteins at most, those reagents can either inhibit 
protein digestion or impede subsequent MS analyses.   Therefore, sample cleanup prior to 
proteomic analysis is inevitable.  
In this part of the dissertation, we developed a novel proteomic methodology for 
qualitative analysis of a sub-proteome, the parasitophorous vacuole membrane (PVM) of 
Toxoplasma gondii. The new methodology includes the development of new biological 
sample preparation methods for isolation and purification of the PVM organelle 
(described in chapter 2.3), the development of the PVM sample concentration and 
cleanup methods (described in chapter 2.2), and analysis of the PVM proteins using a 
combination of the biological sample preparation and cleanup methods with 
multidimensional protein identification technology (MudPIT) (described in chapter 2.3).  
In the following part of this chapter, the background on Toxoplasma gondii PVM, gel 
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electrophoresis and multidimensional protein identification technology (MuDPIT), will 
be introduced. 
Toxoplasma gondii and the Parasitophorous Vacuole Membrane (PVM) 
Toxoplasma gondii is an obligate intracellular parasite in the phylum 
Apicomplexa with a worldwide distribution63. It is a type of parasitic protozoa whose 
definitive host is cats. But it also can be found in the majority of warm blooded animals, 
including humans. It is estimated that 1/3 of the human population, world wide, is 
infected with T. gondii64. As shown in Figure 2.1.1, T. gondii has three forms though its 
life65: tachyzoites, which are the rapidly multiplying forms, the quiescent bradyzoites, 
which is slow multiplying stage in tissues or non-feline hosts and the oocysts shed in 
feces of cats. When a cat ingests uncooked meat containing tissue cysts, the bradyzoites 
are released into the small intestine. One part of the bradyzoites first initiates the 
formation of several asexual generations. Then the sexual cycle begins with the formation 
of the male and female gametes. The male gamete fertilizes the female to produce the 
oocyst which is subsequently excreted in the feces. Other bradyzoites begin to multiply as 
tachyzoites. Within a few hours of infection, tachyzoites may either enter extra intestinal 
tissues or spread to any host cell and multiply. Parasite growth results in an immume 
response. This immune response forces the parasite into the quiescent bradyzoite stage.  
T. gondii may cause a disease known as toxoplasmosis, which can be most severe 
in certain “high risk” groups of individuals whose immunity is impaired63. As shown in 
Figure 2.1.2, The T. gondii tachyzoite possesses all the organelles of a typical eukaryotic 
cell including the nucleus (N), endoplasmic reticulum (E), Golgi apparatus (G), and 
mitochondrion (Mt). In addition to these organelles, the parasite also contains a set of 
unique secretory organelles including micronemes (M), club shaped rhoptries (R), and 
dense granules (D) that are critical for establisment and maintainence of infection.  
Additionally, the apicoplast (A), a unique four-membraned organelle, and an apical 
complex including the conoid, the polar ring complex, subpellicular microtubules, and 
secretory organelles are also found in the parasite66, 67.  Within host cells, T. gondii 
resides and multiplies in a specialized compartment called the parasitophorous vacuole  
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Figure 2.1. 1:  Life cycle of Toxoplasma gondii.  T. gondii has three forms though its 
life65: tachyzoites, which are the rapidly multiplying forms, the quiescent bradyzoites, 
which is slow multiplying stage in tissues or non-feline hosts and the oocysts shed in 
feces of cats. When a cat ingests uncooked meat containing tissue cysts, the bradyzoites 
are released into the small intestine. One part of the bradyzoites first initiates the 
formation of several asexual generations. Then the sexual cycle begins with the formation 
of the male and female gametes. The male gamete fertilizes the female to produce the 
oocyst which is subsequently excreted in the feces. Other bradyzoites begin to multiply as 
tachyzoites. Within a few hours of infection, tachyzoites may either enter extra intestinal 
tissues or spread to any host cell and multiply. Parasite growth results in an immume 
response. This immune response forces the parasite into the quiescent bradyzoite stage. 
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Figure 2.1. 2 : Structure of T. gondii tachyzoite.  (Scale bar = 1 µm). The T. gondii 
tachyzoite possesses all the organelles of a typical eukaryotic cell including the nucleus 
(N), endoplasmic reticulum (E), Golgi apparatus (G), and mitochondrion (Mt). In 
addition to these organelles, the parasite also contains a set of unique secretory organelles 
including micronemes (M), club shaped rhoptries (R), and dense granules (D) that are 
critical for establisment and maintainence of infection.  Additionally, the apicoplast (A), 
a unique four-membraned organelle, and an apical complex including the conoid, the 
polar ring complex, subpellicular microtubules, and secretory organelles are also found in 
the parasite 
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(PV)68, which is delimited by the parasitophorous vacuole membrane (PVM). The PVM 
is derived from host cell plasma membrane. It acts as interface between the growing 
parasite and the host cell. As such, the PVM plays many important roles in acquiring 
nutrients from the host cell69, 70, in signaling to and from the host cell71, 72, and in 
maintaining the structure of the vacuole73.  Nutrients required by the parasite must pass 
through the vacuole membrane in a controlled fashion. Proteins in the PVM are likely to 
have crucial functions that are essential to the survival of the parasite, so they are 
attractive targets for potential novel vaccines and drugs.   
T. gondii host-cell invasion and the PVM generation is a successive event74; 
taking place in 10 s75. The whole process includes gliding motility to reach a host cell, 
binding to host receptors and actively penetrating into the host cell. During infection, T. 
gondii secretory organelles including microneme, rhoptry and dense granule secrete 
proteins to help with parasite invasion and PVM formation. As shown in Figure 2.1.3, 
first, microneme proteins are discharged from the anterior end of the parasite when they 
attach to the surface of the host cell76-78. Then microneme and rhoptry proteins are 
released to form a moving junction with the host-cell plasma membrane that drives the 
parasite into the developing PV79. Once it penetrates into the host cell, T. gondii modifies 
the host-cell plasma membrane and forms the parasitophorous vacuole membrane 
(PVM)80.  Soon after penetration, a tubulovesicular membranous network (TMN) 
develops within the PV81. Some of the TMN membranes are connected to the 
parasitophorous Vacuole membrane (PVM)81. The dense granule proteins are secreted 
into the PV and the PVM continuously during the intracellular residence of the parasite 
80.  As such, many proteins from the three secretory organelles are likely located in the 
PVM. Another striking feature of T. gondii is the morphologically intimate interactions 
between the PVM and host cell mitochondria and endoplasmic reticulum (ER)82, 83.  
Figure 2.1.4 shows an electron micrograph of a T gondii infected host cell. It can be seen 
that the PVM intimately associates with both host mitochondria and ER. Studies indicate 
that the maintenance of the organelle associations does not need the viability of 
parasites84.  Killing the parasite does not affect the established organelle associations. 
Also, the extent of mitochondrial-PVM association stays constant as the vacuole grows, 
while the extent of ER-PVM association decreases84.  
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Figure 2.1. 3:  T. gondii host cell invasion. The whole process includes gliding motility 
to reach a host cell, binding to host receptors and actively penetrating into the host cell. 
First, microneme proteins are discharged from the anterior end of the parasite when they 
attach to the surface of the host cell76-78. Then microneme and rhoptry proteins are 
released to form a moving junction with the host-cell plasma membrane that drives the 
parasite into the developing PV79. Once it penetrates into the host cell, T. gondii modifies 
the host-cell plasma membrane and forms the parasitophorous vacuole membrane 
(PVM)80. The dense granule proteins are secreted into the PV and the PVM continuously 
during the intracellular residence of the parasite 80. *: used with permission from a 
presentation by A.P. Sinai, 2006 
 
 39
 
 
 
 
Figure 2.1. 4 : The association of the PVM with both host mitochondria and 
endoplasmic reticulum ER.  *: used with permission from a presentation by A.P. Sinai, 
2006 
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Multidimensional Protein Identification Technology (MuDPIT) 
In order to deal with the complex protein mixtures, John Yates and coworkers85 
developed a new protein separation and identification technology: Multidimensional 
Protein Identification Technology (MudPIT), which has been widely applied to bottom-
up proteomics.  Rather than use traditional two-dimensional gel electrophoresis to 
separate proteins, MudPIT peptides generated from protein proteolytic digests in 2D 
liquid chromatography, which allows the direct interfacing with a mass spectrometer. The 
approach is demonstrated in Figure 2.1.5.  MudPIT online couples fused silica capillary 
strong cation exchange (SCX) column with a reversed-phase C18 column.  Ammonium 
acetate is chosen as the salt to elute peptides from the SCX column due to its high 
volatility.  Water with 0.1% formic acid and acetonitrile with 0.1% formic acid are 
chosen as mobile phases for reversed-phase C18 chromatography.  First, the protein 
complex is subjected to proteolytic digestion, and then the resultant peptide mixture is 
loaded onto a SCX column.  Peptides with little net charge will pass through the SCX 
column and reach reversed- phase C18 column where they are separated by enhancing 
the hydrophobicity of the mobile phase and eventually identified by MS/MS once eluted 
from the column.  Then the elution cycles start.  Each cycle contains an isocratic salt 
elution followed by C18 reversed phase gradient elution.  Low salt concentrations are 
used in initial cycles to elute peptides that have weak interactions with the SCX column.  
Increased salt concentrations in the following cycles are used to fractionally "bump" 
peptides off the SCX followed by a gradient of increasing hydrophobicity to 
progressively elute peptides from the RP column into the ion source.  The advantage of 
MuDPIT is that by online coupling the SCX column with RP-HPLC, the peptide 
separation capacity is significantly increased. Also, since the separation can be interfaced 
directly with the ion source of a mass spectrometer, sensitivity of the detection is 
maximized.  
Study Rationale 
The PVM acts as an interface between the growing parasite and the host cell. 
Nutrients required by the parasite must pass through the vacuole membrane in a 
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Figure 2.1. 5: Schematic illustrating the MuDPIT. Protein mixtures are directly 
subjected to enzymatic digestion. The generated peptides are resolved by strong cation 
exchange (SCX) column coupled with a reversed-phase C18 column followed by mass 
spectrometric analysis using tandem MS. The resultant spectra are eventually searched 
against database and the corresponding proteins are identified.  
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 controlled fashion. Proteins in the PVM are likely to have crucial functions that are 
essential to the survival of the parasite, so they are attractive targets for potential novel 
vaccines and drugs.  In spite of its importance, the PVM is understudied due to inherent 
challenges. First, since the PVM is formed and found only within infected cells68, it is 
very difficult to obtain PVM protein samples in large quantities. In addition, since the 
PVM intimately associates with host mitochondria and endoplasmic reticulum, 
biochemical methods cannot isolate it from the host mitochondria and ER86. The problem 
is the amount of the PVM proteins is very low compared to that of the host mitochondria 
and ER, seriously affecting the characterization of the PVM proteins. These unique 
structural characteristics of the PVM impede thorough study of its composition and 
biochemical analysis of its functions in spite of its importance as an interface between the 
host cell and the parasite. To date, the PVM composition and PVM proteins responsible 
for activities are largely unknown.  
Study Goals 
Since parasitophorous vacuole membrane (PVM) plays important roles in the 
survival of T.gondii, identification of proteins in the PVM can establish the foundation 
for the characterization of activities associated with the T.  gondii PVM and contribute to 
the discovery of potential novel vaccines and drugs.  The purpose of this study is to 
develop a proteomic method for high throughput identification of proteins isolated from 
immunoprecipitation by using multidimensional protein identification technology 
coupled with mass spectrometry. We then applied the developed methodology to PVM 
proteomic analysis and characterize of the PVM proteome of T. gondii.  
Study Hypothesis 
The hypothesis of this study is that proteomic approaches coupled with 
immunoprecipitation using polyclonal antisera as affinity reagents can successfully 
characterize the proteome of the T. gondii PVM. 
A.P. Sinai and coworkers developed a novel PVM purification method based on 
the use of two polyclonal rabbit antisera raised against PVM-enriched cell fractions of 
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infected rabbit fibroblasts; by matching the species, reactivity to host proteins was 
minimized and specificity to parasite proteins was maximal.  The PVM proteins were 
extracted from infected host cells using the PVM antibodies crosslinked to protien A 
magnetic beads and eventually eluted from the magnetic beads for the subsequent 
proteomic analyisis.  
However, the protein samples obtained from immunoprecipitaiton had the 
characteristics of small amount of proteins, large volume and contain various 
contaminants including salts, other small molecules, and more severely, non-ionic 
detergent triton-X 100 in the protein sample. All these factors lead to low yield of 
enzymatic digestion and interfered with mass spectrometric analysis. Therefore the 
sample must be concentrated and purified prior to mass spectrometric analysis. In the 
following chapters, a new protein concentration and purification method is introduced. 
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Chapter 2.2 
Method Development of Salt Removal and Protein Concentration for Challenging 
Protein Samples 
Introduction 
Bottom-up proteomics has been successfully applied to global protein profiling87-
89 and protein-expression profiling90-93.  In addition, bottom-up proteomics is also a 
powerful approach for the study of sub-proteomes94-96, protein interactomes97, 98 and 
protein posttranslational modifications99, 100 which can play important roles in our 
understanding specific protein functions, biological pathways and disease.  However, 
reliable identification and analysis of the targeted proteins still remains a key challenge in 
the study of proteomes.  Targeted proteomes are accessible via numerous isolation, 
purification and enrichment strategies, including the affinity pull-down approach35, 61, 101, 
immunoprecipitation62 and subcellular fractionation102.  In these strategies, a variety of 
reagents such as salts, detergents and other small molecule additives are utilized that can 
either inhibit protein digestion or impede subsequent MS analyses.  Multiple enrichment 
steps are typically needed for particularly low abundant proteins in biological samples.  
These enrichment steps can lead to a large volume of tremendously diluted protein 
sample.  Therefore, development of an efficient concentration and cleanup methods for 
these challenging samples is critical before successful analysis of targeted proteins in 
proteomics can be realized. 
One of the most frequently used methods for sample cleanup and buffer exchange 
is dialysis103.  However, instead of reducing sample volume, dialysis can actually 
increase sample volume and result in serious sample loss from dilution and binding to 
dialysis membranes and vessels.  Various commercially available microcentrifugation 
devices (spin filters) have been used for protein concentration and contaminants removal.  
These devices can usually deliver rapid sample concentration and cleanup, and 
simultaneously provide high protein recoveries.  But for samples containing low protein 
concentrations, high concentration of salts, detergents or other contaminants, significant 
protein losses can take place.  Arnaud et al.104 developed a new salt removal method 
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referred to as the “Off-Gel technology”, which is based on Off-Gel electrophoresis105, 106.  
Unfortunately, this method is only useful for removal of charged species and is not 
suitable for nonionic contaminants like detergent Triton X-100, which are often used in 
the preparation of biological samples.  Additionally, the sample volume is limited by the 
dimensions of the flow-chamber in Off-Gel devices and cannot be practiced on large 
volume samples or used to concentrate samples during operation.  Recently, another new 
method was reported, the Tube-Gel digestion protocol107.  The Tube-Gel protocol directly 
incorporates protein samples into the acrylamide monomer solution prior to gel 
polymerization.  Contaminants present in the sample are removed by washing gel pieces 
before in-gel digestion.  The advantage of this method is that various MS-incompatible 
detergents can be used for sample preparation and removed prior to mass spectrometry.  
Unfortunately, this method is not suitable for large volume samples.  Additionally, 
acrylamide can react with amino acid residues in proteins, such as His, Lys, Tyr, Cys or 
the N-terminus under appropriate pH conditions108.  The addition of proteins into 
acrylamide monomer prior to gel polymerization can lead to modification and/or 
crosslinking of proteins.  Most damaging would be protein dependant modifications that 
could lead to losses of specific proteins during purification.  Acrylamide modified 
proteins can significantly reduce digestion efficiency and sequence coverage during 
enzymatic digestion, and consequently affect the overall proteomic analysis. 
In this part, we combined the properties of agarose gels, and low and high 
percentage acrylamide gels to develop a new protein concentration and cleanup method, 
the “Three-layer Sandwich Gel Electrophoresis” (TSGE).  In this three-layer system, a 
high percentage acrylamide gel was employed as the bottom or sealing layer.  The middle 
or concentration layer was 100-150µL of a 12% acrylamide gel.  Protein samples were 
directly mixed with a stock agarose solution to make the top agarose layer.  Therefore, in 
practice, proteins are first trapped in the top, adjustable volume agarose layer and then 
forced to move to the middle layer under voltage.  Because of the obstacle presented by 
the high percentage sealing layer, all proteins will eventually concentrate in the middle 
layer and be available for subsequent in-gel digestion and analysis.  In addition, most of 
the salts, detergents and other contaminants in the protein sample, which are not 
compatible with subsequent trypsin digestion and/or mass spectrometric analysis, will be 
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removed during electrophoresis.  Any remaining contaminants in the concentration layer 
are easily removed by washing the concentration layer prior to in-gel digestion.  
Compared to other methods, the TSGE method not only efficiently removed solvents and 
contaminants, but also produced significantly improved protein recoveries.  Furthermore, 
the TSGE method in combination with 2D-LC-MS/MS can be applied to complex 
proteomic analysis as evidenced by our proteomic interrogation of the intracellular 
protozoan parasite, Toxoplasma gondii.  Valuable insights obtained from this study 
highlight the utility of the TSGE method for high through-put protein analysis.   
Experimental  
Materials 
 SDS-PAGE low range protein standards, Laemmli sample buffer, Coomassie 
Brilliant Blue G-250, Tris base, SDS, acrylamide, N,N-methylene-bis-acrylamide (Bis), 
ammonium persulfate (APS), N,N,N,N-tetramethylethylenediamine (TEMED), glycine 
and Agarose (Standard Low-mr) were obtained from BioRad (Hercules, CA).  
Ammonium sulfate was obtained from EMD Chemicals (Gibbstown, NJ).  Hydrochloric 
acid, o-phosphoric acid, formic acid, methanol, HPLC grade acetonitrile, and HPLC 
grade water were purchased from Fisher Scientific (Chicago, IL).  Sequencing grade 
modified trypsin was supplied by Promega (Madison, WI).  Buffers involved include: 
PBS (137mM NaCl, 2.7mM KCl, 10mM NaH2PO4, and 1.8mM KH2PO4 adjusted to pH 
7.4) and RIPA buffer (10mM Tris-HCl (pH 8.0), 140 mM NaCl, 1% Triton X-100, 0.5% 
sodium deoxycholate, 0.1% SDS and 0.025% sodium azide).  2% agarose stock gel was 
made by mixing agarose powder with water, and then the mixture was heated in a 
microwave oven until completely melted. 
Equipment 
A model 422 Electro-Eluter (BioRad) coupled with a power PAC 1000 power 
supply (BioRad) was used to perform three-layer “sandwich” gel electrophoresis.  A Mini 
PROTEAN II electrophoresis cells (BioRad) was used for SDS-PAGE.  A Finnigan LCQ 
Deca ion trap mass spectrometer (San Jose, CA) coupled with LC Packings ULtimate 
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quaternary capillary LC system (San Francisco, CA) was used for mass spectrometric 
analysis. 
Standard Protein Solution Preparation 
SDS-PAGE low range protein standards were used for method evaluation and 
optimization.  Two buffer systems, PBS and 100mM glycine-HCL (pH 1.8), were 
employed to dilute the standard proteins.  Standard proteins (1µL, 2ug/µL) were added to 
either 2.7 mL PBS buffer or 2.4 mL 100mM glycine-HCL (pH 1.8) buffer.  
Neutralization of the glycine system was carried out by addition 220 µL of 1M Tris 
solution.  
Cell Culture and T. gondii Parasite Infection 
Vero cell lines were maintained in α-Minimal Essential Medium (α-MEM) 
supplemented with 7% heat-inactivated fetal bovine serum, 2 mM L-glutamine, 100 
U/mL penicillin, and 100 µg/mL streptomycin.  The RH∆HX strain of Toxoplasma 
gondii (obtained from the NIH AIDS Research and Reference Program) was maintained 
in Vero cells by serial passage as previously described 69.  For proteomic analysis, 
parasite pellets were obtained by infecting confluent Vero monolayers with 2x107 
parasites for 24 hours.  The plates were then washed with sterile PBS, scraped and 
centrifuged at 2000 rpm for 10 minutes.  Parasite containing cells were selectively lysed 
by passage through in a 27 gauge needle.  An intact parasite pellet was obtained by low 
speed centrifugation.  The resulting parasite pellet was washed three times by sequential 
centrifugation and re-suspended in 10 mL sterile PBS and finally pelleted by a 2000 rpm 
10 minute spin. 
Toxoplasma gondii Lysate Preparation 
Toxoplasma gondii pellets were lysed in 400 µL RIPA buffer (10mM Tris-HCl 
(pH 8.0), 140 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS and 
0.025% sodium azide) for 30min on ice.  The resulting sample solution was centrifuged 
at 16000 x g for 5 min.  The supernatant was transferred and diluted with 2.3mL glycine-
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HCl (pH 1.8) buffer.  The resulting protein sample was neutralized by adding 210 µL of 
1M Tris.   
The “Three-layer Sandwich Gel Electrophoresis” 
A “Three-layer sandwich” gel, generated in a 4 mL Electro-Eluter glass tube, 
consisting of an acrylamide sealing layer (bottom), an acrylamide concentration layer 
(middle) and an agarose loading layer (top).  Before gel casting, a model 422 Electro-
Eluter frit was first placed at the bottom of the glass tube.  The glass tube was sealed with 
an Electro-Eluter stopper to prevent liquid leakage during the gel casting process.  
Recipes for casting the sealing layer and the concentration layer gels are given in Table 
2.2.1.  Once the monomer solution was loaded, 200 µL of a 1-butanol overlay was 
applied immediately.  Each acrylamide gel layer was allowed to polymerize for 30 
minutes.  The agarose loading layer was prepared using the following steps: 11µL of a 
10% SDS solution per milliliter protein sample was transferred to the protein sample and 
incubated at 60°C for 10 min.  A 2% agarose gel was melted by heating in a microwave 
for 1min and added to the protein sample at a ratio of 110 µL agarose per milliliter 
sample.  After mixing, the sample/agarose solution was quickly transferred to the top of 
the acrylamide concentration layer and allowed to cool at 4°C for 10 min.  Finally, 10 µL 
of 0.5% agarose with 1% Bromphenol Blue was overlaid on the gel to monitor 
electrophoresis.  The running buffer preparation for the TSGE followed Laemmli’s 
protocol16.  The gel was run at 15V for 30min, 5V overnight and at gradually increased 
voltage to 150V until the dye front moved to the concentration layer.  
Microcon 3K Membrane Concentration and Tube-Gel Method 
To facilitate evaluation of the Tube-Gel method, samples were dissolved in 
minimum volume of H2O and mixed with acrylamide (40%, 29:1) solution, 1% 
ammonium persulfate, and TEMED at a ratio of 14:5:0.7:0.3.  The resulting solution was 
immediately transferred to a well of pre-cast small-format gel.  After 30 min, the Tube-
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Table 2.2. 1: Protocols used for the concentration layer and the sealing layer preparation 
The sealing layer:  
Reagents Amount 
Acrylamide 0.389g 
Bis-acrylamide 0.0205g 
1.5M Tris (pH 11) 250µL 
10% (w/v) SDS stock 10µL 
Deionized water 360µL 
10% freshly made ammonium persulfate 5µL 
TEMED 0.5µL 
total amount loaded onto electro-eluter glass tube  1mL 
  
The concentration layer:  
Reagents Amount 
Acrylamide/Bis (30% stock) 400µL 
0.5M Tris-HCl (pH 6.8) 250µL 
10% (w/v) SDS stock 10µL 
Deionized water 335µL 
10% freshly made ammonium persulfate 5µL 
TEMED 0.5µL 
total amount loaded onto electro-eluter glass tube  250µL 
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 Gel solution polymerized in the well effectively crosslinks with the stacking gel section 
of the mini gel.  The entire mini gel with Tube-Gel in the wells was fixed in fixing 
solution (40% methanol, 10% acetic acid) overnight, and incubated with H2O for 10 min.  
After fixing and desalting the Tube-Gels were excised from the mini gel and used for 
further evaluation (see below). 
An YM-3 model Microcon centrifuge filter device (Millipore) was also evaluated 
using the same standard protein sample for comparison to the TSGE method.  A 500 µL 
protein sample was loaded onto the 3K membrane filter and centrifuged at 14,000 x g for 
80 min.  The procedure was repeated until all solution was loaded onto the same filter.  
Then the concentrated protein sample was collected by centrifuging the same reservoir 
upside down at 1000 x g.  
SDS-PAGE 
Small format gels (7 cm x 8 cm) with 1.5mm thickness and 5 wells were 
employed for evaluation of various concentration methods.  The gel consisted of a 12 % 
acrylamide separating gel and a 4% stacking gel.  For the TSGE method, the three layer 
gels were collected by pushing the bottom of the whole gel structure through the glass 
tube with a glass stir rod.  The concentration layer was excised from the three-layer 
“sandwich” gel and vertically inserted into a well of the small-format gel.  For the Tube-
Gel method, desalted Tube-Gel pieces were inserted into a freshly made mini gel.  For 
membrane filter concentration, the resultant solution was mixed with Laemmli sample 
buffer and loaded onto a mini gel.  The same amount of standard proteins were dissolved 
in Laemmli sample buffer and directly loaded onto the adjacent lanes of the interested 
samples so that the relative quantification of the standard proteins could be carried out.  
Laemmli’s protocol16 was used to run SDS-PAGE.  After staining with Coomassie 
Brilliant Blue G-250, the gel images were captured with a Microtek ScanMaker V6UPL 
Flatbed Scanner (Microtek, Inc.).  The quantitative protein analysis was performed by 
comparing the protein abundances between the control and the interested samples using 
BioRad Quantity One software.  
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Statistical Analysis 
Single factor analysis of variance (ANOVA) was used for statistical analysis of 
TSGE gel optimization.  The ANOVA analysis tool was obtained from the website: 
(http://www.physics.csbsju.edu/stats/anova_pnp_NGROUP_form.html).  Paired student 
T-test (http://www.physics.csbsju.edu/stats/Paired_t-test_NROW_form.html) was 
employed for comparison of TSGE with the other available protein concentration 
methods. 
 Sample Preparation for Mass Spectrometric Analysis 
The obtained concentration layer from TSGE was fixed in 40% methanol, 10% 
acetic acid overnight.  Then the gel was washed with water and 25mM ammonia 
bicarbonate, dried with acetonitrile, and incubated with trypsin solution at 4°C for 40 
min.  The swelled gel pellet was cut into 1mm3 pieces and covered with 100 µL of 25mM 
ammonia bicarbonate.  Trypsin in-gel digestion was performed at 37°C overnight, and 
the resultant peptides were extracted from gel pieces by using 5% formic acid: 
acetonitrile (1:1) twice to incubate the gel pieces. The peptide solution was concentrated 
using vacuum centrifuge, and desalted using 350 um (I.D.) x10 cm laboratory fabricated 
C18 column. 
2D-LC-MS/MS Analysis 
A Finnigan LCQ Deca ion trap mass spectrometer coupled with a LC Packings 
Ultimate quaternary capillary LC system was used for 2D-LC-MS/MS analysis.  Desalted 
digests from T. gondii whole cell lysate (20 µL) were injected onto a laboratory-
fabricated SCX column (350 µm I.D. x 5 cm, 10 µm particles), which was directly 
connected to a laboratory fabricated fused silica capillary C18 column (350 µm (I.D.) x15 
cm, 5 µm particles and 300 µm pore size).  Mobile phase A was 0.1% formic acid in 
HPLC grade H2O, mobile phase B was acetonitrile (ACN) with 0.1% formic acid, mobile 
phase C was 300 mM ammonium acetate, and  mobile phase D was 95% H2O, 5% ACN 
with 0.1% formic acid.  Two-dimensional LC separation was performed with 12 isocratic 
salt elution by using x% C (x = 0, 1.67, 3.33, 5.00, 6.67, 10.00, 13.33, 16.67, 33.33, 50, 
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75, and 100) and corresponding (100-x) % solvent D.  Each salt elution was followed by 
a 90 min C18 reversed phase gradient elution.  The mobile phase composition was first 
held at 95% solvent A for 6 min, then was linearly changed from 95% to 50% over 44 
min.  For the next 20 min, a linear increase of solvent B was carried out to reach the 
composition of 80%.  Then solvent A was changed back to 95% in 5 min and held at 95% 
for the following 5 min.  The mass spectrometer was operated in a data-dependent mode 
with dynamic exclusion enabled.  During the full MS acquisition, masses were scanned 
from 400 to 2000 m/z.  The most intense precursor ion was selected from the previous 
full MS scan to undergo CID with parameters of an activation Q of 0.250, activation time 
of 45 ms, and 35% normalized collision energy (NCE).  
Protein Data Analysis 
Individual mgf files obtained from the tandem mass spectra of each fraction were 
manually combined.  The composite mgf file was searched against Toxoplasma gondii 
genome database (www.Toxodb.org) using the MASCOT daemon software.  The 
parameters were set as followed: trypsin was used as the cleavage enzyme with one 
missed cleavage allowed.  Both the peptide tolerance and the MS/MS tolerance were set 
to 0.8 Da, and oxidized methionine was chosen as a variable modification.  MudPIT 
scoring was chosen and the ion score cut-off was set to 20.  Bold red was required for 
positive protein identification, which requires the protein hit to include at least one bold 
red peptide match. Red indicates that the peptide is the highest scoring match to the 
MS/MS spectra. Bold is used to show that the spectrum has not appeared in a higher 
scoring protein. 
The cellular location of each T. gondii protein identified by TSGE-MuDPIT was 
predicted using the Toxoplasma database (www.toxodb.org).  In addition, each 
identified protein was examined for the presence of trans-membrane domains and signal 
sequences using InterProScan (www.ebi.ac.uk/InterProScan).  For comparison, all 
theoretical proteins present in the Toxoplasma database were submitted to JVirGel v 2.0 
(http://www.jvirgel.de/) for calculation of theoretical protein molecular weights and PI 
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values as well as evaluating the number of trans-membrane domains and signal peptides 
in those proteins.  
Results 
Development of the TSGE 
A schematic representation of the TSGE method is shown in scheme 1.  The 
TSGE setup is assembled in a glass electoeluter tube blocked on one end by a frit 
(Scheme 1, F).  The bottom sealing layer (40% polyacrylamide) serves as a blocking 
layer (Scheme 2.2.1, layer A).  The middle layer of the TSGE setup is the critical 
concentration layer made up of 100-150 µL of a 12% polyacrylamide gel (Scheme 2.2.1, 
layer B).  The protein solution is incorporated into molten agarose that is layered upon 
the concentration layer and allowed to gel (Scheme 2.2.1, layer C).  The volume of the 
agarose layer is adjustable to the volume of the protein sample solution.  The classic 
Laemmli SDS-PAGE system was employed to electrophoretically drive proteins from the 
agarose into the polyacrylamide layer.  Proteins driven into the 100-150 µL concentration 
layer are retained due to their inability to enter the sealing layer.  Following 
electrophoresis the TSGE gel assembly is extruded from the glass tube and the 
concentration section containing trapped proteins is retained (Scheme 2.2.1).  This 
concentration layer is amenable to buffer exchanges as well as in-gel digestion and thus 
provides an efficient and concentrated source of peptides for mass spectrometric analysis.   
In order to optimize and standardize the TSGE protocol, the individual elements 
were evaluated separately.  This evaluation employed commercially available molecular 
weight markers as these represented a broad range of molecular weights (14-98 kDa) as 
our test samples.  
The Design of the Agarose Loading Layer 
Agarose gel (standard Low-mr, BioRad) was chosen for gel preparation because 
of its characteristic large pore size and low temperature melting point.  A stock agarose 
solution was added to protein samples at an agarose/protein ratio of 1:10 (v/v) to avoid 
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Scheme 2.2. 1:  Preparation of the TSGE gel and the combination of TSGE 
with LC-MS/MS. F: model 422 Electro-Eluter frit, A: the 40% polyacrylamide sealing 
layer, B:  The 12% polyacrylamide concentration layer, C: agarose layer with protein 
solution incorporated. Proteins driven into the concentration layer are retained due to 
their inability to enter the sealing layer under voltage.  Following electrophoresis the 
TSGE gel assembly is extruded from the glass tube and the concentration section 
containing trapped proteins is retained.  This concentration layer is fixed, desalted, and 
then performed in-gel digestion. The resulting peptides are extracted from gel pieces and 
analyzed by LC-MS/MS.   
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considerable volume increases of the original protein sample.  We evaluated stock 
agarose solutions at concentrations of 0.1%, 0.2%, 0.3%, 0.5%, 1%, 2%, 3% and 5%.  
Results indicated that the melting point and gelling temperature of agarose gel 
dramatically increased with increasing concentration.  At high agarose concentrations, 
longer melting times were required and gels rapidly re-solidified at room temperature.  In 
contrast, low agarose solutions (less than 0.1%) exhibited difficulty forming gels and had 
low gel strength and deformed easily.  Agarose concentrations of 2 and 3% were found to 
provide the best compromise between relative melting points and gelling temperatures, 
thus 2% agarose was chosen for TSGE.   
Bromophenol blue (BPB) was observed to migrate in advance of proteins during 
TSGE and served as an indicator of protein migration.  In practice, 20 µL commercial 
overlay agarose (BioRad) containing 1% BPB was applied on top of the sample agarose 
gel prior to electrophoresis.  
Optimization of the Composition of the Sealing Layer 
The gel pore size in the sealing layer should be small enough to impede protein 
migration into the layer.  Gel pore size is inversely proportional to percent of monomer T 
and the percent of crosslinker C109, 110.  Gels with 40% T can be used for peptide 
separations111.  We evaluated three polyacrylamide compositions for the sealing layer, 
20%T-2.67%C, 30%T-2.67%C and 40%T-5%C.  The TSGE gels were prepared based on 
the protocol present in Table 1 except for changing amounts of T and C.  Results were 
monitored using SDS-PAGE (Figure 2.2.1).  TSGE using 40%T-5%C in the sealing layer 
had the highest average percent yields for all inspected proteins (Figure 2.2.2A).  The 
average percent recovery for all proteins ranged from 95.62%±1.31% to 97.50%±2.57% 
for 40%T-5%C composition. An ANOVA statistical analysis of protein recoveries versus 
gel composition confirmed the hypothesis that sealing gel composition was a significant 
factor in protein recoveries (p<0.01, n=3).  Figure 2.2.2B shows mean protein recoveries 
versus gel with error bars at 95% confidence.  Since protein recoveries obtained from the 
40%T-5%C approached 100%, this composition was employed in further experiments.  
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Figure 2.2. 1:  SDS-PAGE gel image for optimization of acrylamide and Bis 
composition in the sealing layer of the three-layer “sandwich” gel. BioRad SDS-PAGE 
low range standards were used to evaluate performance of the system.  The 100mM 
glycine-HCL (pH 1.8), one of the most common elution buffers employed in 
immunoprecipitation, was used to dilute the standard proteins.  Proteins were 
concentrated using TSGE method as described in experiment section and the results were 
visualized using SDS-PAGE.  Lanes: lane 1, control; lane 2, 20%T-2.67%C in sealing 
layer; lane 3, 30%T-2.67% C in sealing layer; lane 4, 40%T-5%C in sealing layer. 
BSA 
Ovalbumin 
Carbonic 
anhydrase 
 
 
lysozyme   1                           2                                3                      4 
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Figure 2.2. 2: The effect of acrylamide and Bis composition in an acrylamide sealing 
layer on protein concentration. (A). % yield of different proteins concentrated by TSGE 
in which different composition of sealing layer were used. Protein recoveries of four 
selected proteins, BSA, ovalbumin, carbonic anhydrase and lysozyme, were calculated 
using Quantity One software by comparing % adjusted volume of the tested to that of the 
control sample. Error bars presented in the figure shows the standard deviations of 
average protein recoveries for each selected proteins. (B). ANOVA data comparison 
chart of protein % yields obtained under various acrylamide-bis compositions in the 
sealing layer: a plot of the group means with 95% confidence intervals (n=3). 
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Selection of pH Values for Concentration and Sealing Layers 
The purpose of the three-layer design is to concentrate various proteins at the 
concentration layer.  Since pH of the gel can affect protein mobility during 
electrophoreses 112, finding an appropriate pH was critical for optimization for both 
concentration and sealing layers.  Previous studies indicate that SDS-PAGE can be 
conducted at a pH range of 2.5 to 11111.  Taking a lead from Lammeli’s SDS-PAGE 
protocol 109, we opted to evaluate pH 6.8 and 8.8 for the concentration layer and pH 6.8, 
8.8 and 11 for the sealing layer resulting in four pH pairs, 6.8-6.8, 6.8-8.8, 6.8-11 and 
8.8-11.  TSGE concentration efficiencies in this pH study were evaluated using SDS-
PAGE (Figure 2.2.3.).  Figure 2.2.4A shows that TSGE with pH 6.8-11 combination in 
the concentration layer and the sealing layer, respectively, provided the highest average 
recoveries for all tested proteins. The average percent recovery for all proteins ranged 
from 98.51%±2.87% to 100.60%±2.67%.  Again, an ANOVA confirmed that pH in the 
concentration layer and the sealing layer is an impact factor that significantly affects 
protein recovery (p<0.01, n=3).  Figure 2.2.4B shows the mean protein recoveries versus 
pH pairs with error bars at 95% confidence.  Since high recoveries (>98%) were obtained 
for all tested proteins, the pH combination 6.8-11 was chosen for further investigation. 
The Effect of Sample Buffers on the TSGE Method 
Large volume and extremely diluted protein samples were prepared in various 
buffers, such as isotonic buffer (150mM NaCl), high salt buffer (PBS), highly acidic 
buffers used for elution of antigens from antibodies (100mM glycine-HCl (pH 1.8), 0.1% 
formic acid,) and a complex buffer (RIPA) that contains both high salt and several 
detergents, to represent typical protein samples obtained from different experimental 
designs.  These buffers are not compatible with trypsin digestion and/or subsequent mass 
spectrometric analysis.  Neutral or weakly basic sample solutions produced better results 
in TSGE than acidic sample solutions.  Acidic sample solutions produced excessive heat 
during electrophoresis which caused increased conductivity, increased diffusion, 
decreased viscosity and even melted the agarose gel.  Therefore, acidic samples were 
neutralized by addition of 1M Tris prior to mixing with agarose gel.  For example,  
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Figure 2.2. 3: SDS-PAGE gel image for optimization of pH values employed in the 
concentration layer and the sealing layer of the three-layer “sandwich” gel. Molecular 
weight marker was loaded onto TSGE gel. Lanes: lane 1, control; lane 2, pH 6.8-6.8 
combination in the concentration layer and the sealing layer; lane 3, pH 6.8-8.8; lane 4, 
pH 6.8-11; lane 5: pH 8.8-11. 
BSA 
Ovalbumin 
Carbonic 
anhydrase 
 
lysozyme 
1               2                 3               4               5 
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Figure 2.2. 4: The effect of pH employed in the acrylamide concentration layer and the 
acrylamide sealing layer on % yield of protein concentration. Four combinations of pH in 
the two layers, pH 6.8-6.8, 6.8-8.8, 6.8-11 and 8.8-11, were used to make TSGE gel. (A). 
% yield of different proteins concentrated using various pH combinations in TSGE gel. % 
yield was calculated by comparing adjusted % volume of protein bands obtained from 
TSGE to that of protein band from control. Error bars presented in the figure shows the 
standard deviations of average protein recoveries for each selected proteins. (B). 
ANOVA data comparison chart of protein recoveries obtained using various pH 
combinations in TSGE gel: a plot of the group means with 95% confidence intervals 
(n=3). 
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100mM glycine-HCl (pH 1.8), a typical elution reagent used in immunoprecipitation 
reactions was treated with 1M Tris.  TSGE successfully concentrated proteins from all of 
the above solutions (data not shown).  
Comparison of TSGE with the Microcon YM-3 Membrane Concentration and 
Tube-Gel Methods 
  We compared the optimized TSGE method to Microcon YM-3 with a 
3000MWCO filtration and the Tube-Gel method.  When a glycine (pH 1.8) buffer was 
used to prepare protein samples, TSGE dramatically improved protein recoveries 
compared to both the Microcon YM-3 and the Tube-Gel method (Figure 2.2.5, Figure 
2.2.6A).  A paired student T-test indicated a statistically significant difference when 
comparing TSGE with 3K membrane and TSGE with the Tube-Gel method (p<0.05, 
n=3).  The average percent recovery for all proteins ranged from 96.46%±3.42% to 
100.69%±3.66% for TSGE method, while the average percent recovery ranged from 
45.04%±2.62% to 80.10%±4.02% and from 76.57%±3.11 to 82.49%±4.52% for 3K 
membrane concentration and Tube-Gel method, respectively (Figure 2.2.6B).  We also 
tested the most common buffer used for biological samples, PBS.  For volumes up to 
3mL and protein concentration as low as 0.7 µg/mL, TSGE produced consistently higher 
protein recoveries than the conventional Microcon YM-3 membrane or the Tube-Gel 
method (Figure 2.2.7, Figure 2.2.8A).  Recovery differences were significant (p<0.05, 
n=3) when comparing TSGE (92-97% recovery) to Microcon YM-3 membrane 
concentration (56-76% recovery) and the Tube-Gel method (56-76% recovery) (Figures 
2.2.8B).   
Application of the TSGE Method to Analysis of Toxoplasma gondii Proteome 
 Application of TSGE for proteomic analysis of complex biological samples was 
investigated using a whole parasite lysate from Toxoplasma gondii.  As a single celled 
eukaryote, T. gondii contains organelles typical of most eukaryotes (nucleus, 
mitochondrion, Golgi, endoplasmic reticulum) in addition to several entities that are 
unique to the Phylum (Apicomplexa) including micronemes, rhoptries, conoid and 
apicoplast. This balance of both common and unique entities makes T. gondii an ideal 
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Figure 2.2. 5: Comparison of TSGE method with 3K membrane concentration and Tube-
Gel method. Standard proteins were diluted by 100mM glycine (pH 1.8) sample buffer. 
SDS-PAGE gel images of standard proteins concentrated using different methods. lane 1, 
control; lane 2, tested. 
TSGE method 3K membrane Tube-Gel method 
1                2                               1                      2                              1                    2   
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Figure 2.2. 6: Comparison of TSGE method with 3K membrane and Tube-Gel methods.  
Standard proteins were diluted by 100mM glycine (pH1.8) sample buffer. (A). Histogram 
illustrates that comparison of protein recovery from different concentration methods. 
Error bars presented in the figure shows the standard deviations of average protein 
recoveries for each selected proteins. “*” indicates statistically significant differences 
when comparing TSGE with 3Kmembrane or TSGE with the Tube-Gel method; T-test, 
p<0.05, n=3. (B). Average %yields of different proteins. The highest average value for 
each protein is listed in bold type. 
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Figure 2.2. 7:  Comparison of TSGE method with 3K membrane concentration and Tube-
Gel method. Standard proteins were diluted by PBS buffer. SDS-PAGE gel images of 
standard proteins concentrated using different methods. lane 1, control; lane 2, tested.
TSGE method 3K membrane Tube-Gel method 
1                      2                                 1                 2                                  1                    2 
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Figure 2.2. 8:  Comparison of TSGE method with 3K membrane and Tube-Gel methods.  
Standard proteins were diluted by PBS buffer.  (A). Histogram illustrates that comparison of 
protein recovery from different concentration methods. Error bars presented in the figure 
shows the standard deviations of average protein recoveries for each selected proteins. “*” 
indicates statistically significant differences when comparing TSGE with 3Kmembrane or 
TSGE with the Tube-Gel method; T-test, p<0.05, n=3. (B). Average %yields of different 
proteins. The highest average value for each protein is listed in bold type. 
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 sample to validate TSGE.  The sample solution was made by the extraction of pelleted T. 
gondii in using 400 µL RIPA buffer followed by the addition of 2.3 mL of 100mM glycine-
HCl (pH 1.8) buffer.  This treatment resulted in a large volume protein solution replete with 
high salt and detergents at an extremely low pH.  Concentration and desalting was done by 
the TSGE and samples were subsequently subjected to trypsin in-gel digestion and analyzed 
by 2D-LC-MS/MS.  Totally, 627 peptides corresponding to 260 proteins were identified 
using MASCOT with parameters set as described in experimental section (identified proteins 
are listed in appendix).  The availability of the Toxoplasma gondii genome database 
(www.toxodb.org) facilitated protein identification.  Cellular localization of the identified T. 
gondii proteins was assigned using annotation at www.toxodb.org.  Based on the annotation, 
half of the identified proteins were assigned to specific cellular locations (Figure 2.2.9A).   
All the identified proteins were also submitted to InterProScan 
(www.ebi.ac.uk/InterProScan) to predict the presence of signal peptides (SP) and trans-
membrane domains.  Secreted and transmembrane domain containing proteins are defined by 
the presence of hydrophobic domains that can complicate biochemical purification and 
protein identification.  The distribution of proteins predicted to have N-terminal signal 
sequences reveals 50 of the 259 proteins (19.3%), which is remarkably similar to the 19.7% 
obtained from total protein coding genes using solely bioinformatic criteria (Figure 2.2.9B).  
The distribution of putative membrane proteins based on a presence of one or more predicted 
membrane spanning domains revealed a total of 51 proteins (20%) a number considerably 
lower than the 42% of proteins contained trans-membrane domains based on bioinformatic 
criteria predicted for the Toxoplasma genome.  The high value of the in silico prediction is 
almost certainly spurious as it reflects an inherent complication in defining transmembrane 
domains as the amino acid composition alone is not the sole predictor of membrane insertion 
for diverse organisms with a typical proportion of transmembrane proteins ranging from 18-
30% from Archea to humans113.  Thus our experimentally defined ratio for Toxoplasma in 
the 20% range is entirely consistent with typical ranges across the major Kingdoms of life.  
In addition for T. gondii ROP2 family of proteins, a domain annotated as a transmembrane 
domain is quite possibly a hydrophobic kinase fold required for enzymatic activity114, 115.  
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Figure 2.2. 9: A. Cellular Localization of Identified T. gondii Proteins.  The proteins 
identified from RH lysate using TSGE localize to parasite organelles as characterized by the 
Toxoplasma database (www.toxodb.org).  The proteins with no listed localization were 
classified as unknown even if their predicted function could be used to predict localization.  
B. The percentage of secreted proteins from the total proteome. Theoretical: all theoretical 
proteins present in Toxoplasma database were submitted to JVirGel v 2.0 
(http://www.jvirgel.de/) for analysis the presence of signal peptides in those proteins. A total 
of 1538 out of the 7793 possible proteins contain signal peptides (SP). Experimental: 
Secreted and nonsecreted proteins were identified using the TGSE.  The identified protein 
sequences were submitted to InterProScan (www.ebi.ac.uk/InterProScan) to identify those 
proteins with predicted signal peptides (SP) and no signal peptides (No SP).  In total, 50 of 
the 259 proteins (19%) contain signal peptides while 209 (81%) do not.  C. The percentage of 
membrane proteins from the total proteome. Theoretical: Total 3248 of the 7793 proteins 
(42%) contain trans-membrane domain (TM). Experimental:  51 proteins (20%) contained at 
least one predicted trans-membrane domain and were classified as trans-membrane proteins 
(TM).  208 proteins (80%) contained no predicted trans-membrane domains and were 
classified as not trans-membrane proteins (Not TM).   
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The MW and PI distributions for the identified proteins were also investigated by comparing 
experimental results with corresponding theoretical distributions (Figure 2.2.10.).  
Distributions of the identified proteins directly coordinated the theoretical distributions in 
relation to both MW (Figure 2.2.10A) and PI (Figure 2.2.10B).  The observed protein MW 
range was 7.6 kDa to 650 kDa, which corresponded with the theoretical T. gondii proteome.  
The applicability of TSGE in the identification of proteins across a very broad range 
eliminates a major limitation in protein identification.  
The ability of TSGE to concentrate proteins across a broad predicted pI range (pI 3.5 
to 12.5) was assessed.  The majority of proteins (99.6%) in the theoretical proteome fell in 
this PI range where 46% were acidic and 54% basic matching the experimental proteome 
(45% acidic and 55% basic) with overlapping profiles across the pI spectrum.  Notably, the 
ability of TSGE to accommodate proteins at both extremes of the pI range circumvents one 
of the major limitations of conventional IEF/2D gel electrophoresis. Together these data 
demonstrate that the TSGE protocol provides a highly robust and adaptable methodology to 
deal with difficult samples in mass spectrometric protein identification.  
Discussion 
Current protein desalting and concentration methods are limited, especially when 
working with samples that are in uncharacteristically large volumes, contain high salt or 
other contaminants, and/or are extremely diluted.  Under these circumstances, significant 
protein losses can occur.  To address these circumstances, we developed the new protein 
desalting and concentration method, the TSGE system which consists of an agarose loading 
layer, a concentration layer and a sealing layer.  We observed that sealing layer gel pore size 
and pH in concentration and sealing layers affected TSGE performance.  The TSGE with 
40%T-5%C in the sealing layer and the pH 6.8-11 combination in the concentration layer 
and the sealing layer, respectively, provided the highest average % recovery, which could be 
explained by invoking the moving boundary theory 112.  In brief, glycine is a weak acid and 
can exist as a zwitterion, or glycinate anion depending on pH values.  For TSGE, glycine is 
present in the running buffer (pH 8.3) and all the three gel layers.  Since the pH is low in 
both the agarose layer (pH≈7) and the concentration layer (pH=6.8), once glycinate anions  
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Figure 2.2. 10: Protein PI distribution and Protein MW distribution. A: Histogram of 
theoretical T. gondii protein molecular weight distribution (blue) and experimental protein 
molecular weight distribution (red) within the mass range of 3 to 300 kDa.  B: Histogram of 
theoretical T. gondii protein PI distribution (blue) and experimental protein PI distribution 
(red). 
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from the running buffer (pH=8.3) have moved into the agarose layer, a large portion of the 
glycinate anions protonate to form zwitterions which slows their movement.  Highly mobile 
chloride ions in both the agarose and concentration layer experience high mobility and rapid 
movement toward the anode.  This ion movement creates a narrow zone with high field 
strength at the top of the agarose gel that forces proteins to move forward.  Thus, proteins 
move from the top to the bottom of the agarose gel, stack into a narrow band and 
subsequently move into the concentration layer.  However, the pH changes from 6.8 to 11 at 
the junction between the concentration and sealing layer resulting in deprotonation of the 
glycine zwitterions in the sealing layer to glycinate anions, and rapid acceleration past the 
proteins.  Consequently, proteins are no longer in the high field strength zone and confront 
the barrier created by 40% T-5% C polyacrylamide sealing layer, stop moving forward and 
accumulate in the concentration layer. 
To address potential applications of TSGE, we investigated protein samples with 
various sample buffers and confirmed that this method is suitable for a broad range of protein 
samples.  Furthermore, TSGE exhibited very high protein recovery compared to Microcon 
YM-3 membrane concentration and Tube-Gel methods.  Application of TSGE for proteomic 
analysis of complex biological samples was evaluated with a whole parasite lysate from 
Toxoplasma gondii.  The RIPA sample buffer used in this process not only contained high 
salts, but also had Triton X-100, SDS and small molecules like sodium deoxycholate.  
Numerous proteins were identified from this complex sample indicating the utility of TSGE 
coupled with mass spectrometric proteomic analysis.  Further bioinformatic investigation of 
the identified proteins indicated that these proteins originated from all organelles of T. gondii 
as well as the cytoplasm and cell surface supporting the broad applicability of the TSGE-2D-
LC-MS/MS methodology.   
As such, the TGSE-2D-LC-MS/MS methodology showed enhanced capability for the 
analysis of membrane proteins compared to IEF/2D gel electrophoresis, which is not 
particularly useful for resolving insoluble proteins such as membrane proteins, as well as 
proteins at the extremes of the pI spectrum.  The investigation of protein MW and PI 
distributions from identified T. gondii proteins also indicated that TSGE coupled with 2D-
LC-MS/MS method was capable of identifying any type of protein, including high molecular 
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weight proteins, acidic proteins, and basic proteins (Figure 2.2.9.).  Therefore, TSGE coupled 
with 2D-LC-MS/MS methodology is suitable for global proteomic studies of various protein 
samples and allows for high-throughput proteomics. Its superior performance with low levels 
of protein, dilute protein solutions and difficult buffer conditions suggest applicability in 
problematic protein identification approaches including those from limiting clinical 
materials.  In addition, with protein recoveries consistently above 90% and for certain 
proteins approaching 100% TSGE is broadly applicable in comparative proteomic studies 
where differences between protein samples due to sample preparation can be misinterpreted 
as evidence of differential levels.  
Conclusion 
The TSGE method described here provides a relatively easy approach to 
concentrating, desalting and purifying protein samples.  The TSGE method can be readily 
incorporated into the protein processing workflows and relies on analysis skills already 
available in any laboratory routinely conducting SDS-PAGE analyses.  The TSGE method 
couples nicely with downstream mass spectrometry and even provides sample preparation for 
MudPIT protocols.  Taken together, this new TSGE method should greatly improve protein 
identifications from less than optimal samples. In the next part of dissertation, the application 
of the TSGE-MuDPIT methodology on the analysis of PVM of T. gondii will be presented.  
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Chapter 2.3 
Application of TSGE-2D-LC-MS/MS Methodology to Analysis of T. Gondii PVM 
Proteome 
Introduction 
Apicomplexan parasites are one kind of protozoan parasites which are characterized 
by the presence of a specialized organelles at their apical end116. Apicomplexan parasites 
include many important pathogens of humans such as Plasmodium spp. the causative agent 
of malaria, and Toxoplasma gondii, the causative agent of toxoplasmosis.  Toxoplasma 
gondii is one of the most successful protozoan parasites since it can infect almost any warm 
blooded animal including humans.  Within host cells, T. gondii resides and multiplies in the 
parasitophorous vacuole (PV), which is delimited by the parasitophorous vacuole membrane 
(PVM). The PVM is a critical extracellular organelle of the parasite which is derived from 
the host cell plasma membrane. Formation of the PVM is achieved by the release of various 
proteins from the parasite secretory organelles such as rhoptries and dense granules 117-119. 
The PVM surrounding the parasite functions as a molecular sieve70.  The PVM contains 
nonselective pores that allow passive bidirectional permeation of small molecules116. So far 
the cellular function of the PVM is still elusive.  The PVM composition and PVM proteins 
responsible for its activity are largely unknown.  
Two breakthroughs make proteomic analysis of PVM proteins possible. One is the 
development of a new methodology for purifying the PVM containing fraction. Many 
secretory proteins from dense granules and rhopties of the parasite are found to be localized 
at PVM,  Sinai and coworkers developed a protocol for generating polyclonal antisera against 
the PVM enriched fraction from infected cells.  They grew T. gondii in rabbit host cells and 
use selective mechanical disruption of the host cell (leaving the parasites intact) combined 
with differential centrifugation and sucrose floatation gradients to purify the fractions 
containing markers of the PVM. Then the PVM enriched fraction was injected into rabbits. 
Since the PVM cannot be separated from host mitochondria and endoplasmic reticulum. 
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Most of proteins in the enriched PVM fraction are from mitochondria and endoplasmic 
reticulum, and the concentration of PVM is very low. However, once injected into rabbits, 
the immune system of the rabbit will ignore “self” proteins and only recognize parasite 
proteins and produce antibodies recognizing antigens in the PVM. Using the polyclonal 
antisera against the PVM, A. Martin in Dr. Sinai’s group successfully developed and 
performed immunoprecipitation to isolate and purify the PVM proteins. The other 
breakthrough is the completion of the T. gondii genome as well as Expressed Sequence Tag 
(EST) database, which makes it feasible to high throughput characterize multiple proteins 
generated from immunoprecipitation using ethe merging novel technology Multidimensional 
Protein Identification Technology (MuDPIT). Proteomic analysis of the protein composition 
in the PVM through MuDPIT can eventually establish the foundation for characterization of 
activities associated with the T. gondii PVM. 
In this chapter, the novel biological sample preparation developed by A. Martin will 
be briefly introduced. The resultant PVM enriched sample was further concentrated and 
purified using the novel sample preparation method, Three-layer Sandwich Gel 
Electrophoresis (TSGE), described in chapter 1.2. After analyzing the sample using 2D-LC-
MS/MS, the proteins were identified and will be discussed here.  
Experimental  
Biological Sample Preparation 
PVM biological sample preparation, which involved cell culture, isolation of parasite, 
purification and modification of Ig, and immunoprecipitation, was performed by A. Martin in 
Dr. Sinai research group. The experimental procedure was briefly described as follow120.  
Cell Culture and T. gondii Parasite Infection 
As described in chapter 2.2, Vero cell lines were maintained in α-MEM supplemented 
with 7% heat-inactivated fetal bovine serum, 2 mM L-glutamine, 100 U/mL penicillin, and 
100 µg/mL streptomycin.  The RH∆HX strain of Toxoplasma gondii was maintained in Vero 
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cells by serial passage.  For proteomic analysis, parasite pellets were obtained by infecting 
confluent Vero monolayers with 2x107 parasites for 24 hours.   
Isolation of T. gondii Parasite 
The plates were washed with sterile PBS, scraped and centrifuged at 2000 rpm for 10 
minutes.  Parasite containing cells were selectively lysed by passage through in a 27 gauge 
needle.  An intact parasite pellet was obtained by low speed centrifugation.  The resulting 
parasite pellet was washed three times by sequential centrifugation and re-suspended in 10 
mL sterile PBS and finally pelleted by a 2000 rpm 10 minute spin. 
Purification and Biotinylation of Ig 
Two volumes 60 mM NaC2H3O2 (pH 4.0) were added to antisera while stirring.  
Dropwise, 7.5 µL of caprylic acid was added per 100 µL antisera and allowed to stir for 30 
minutes.  Precipitate was removed by 3 cycles of centrifugation at 5000xg for 10 minutes.  
The supernatant was dialyzed overnight against 1X PBS and the pH adjusted to 7.0.  
Antibody supernatant was brought to 1 mg/ml.  10 mM EzLink Sulfo-NH-LC-Biotin (Pierce) 
was added to a final molar equivalent of 10:1 and incubated on ice for 2 hours and dialyzed 
overnight against 1x PBS.  Biotinylation of Ig was confirmed by immunoblot analysis using 
streptavidin-HRP (Jackson ImmunoResearch Laboratories) (1:10,000). 
PVM Protein Immunoprecipitation 
3x108 RH strain of T. gondii were lysed for 30 minutes on ice in RIPA buffer (10 mM 
Tris pH 8.0, 140 mM NaCl, 1% Triton X-100, 0.5% NaC29H34O4, 0.1% SDS, 0.025% NaN3, 
protease inhibitor cocktail).  Insoluble material was pelleted by 10,000xg centrifugation for 
10 minutes.  The supernatant was precleared with 100 µl 10% protein A sepharose beads for 
4 hours at 4°C.  The beads were removed by centrifugation at 5000xg for 10 minutes.  The 
lysate was incubated overnight with 5 µg biotinylated Ig chemically crosslinked to protein A 
magnetic beads (Dynal) using DMP (Pierce).  The beads were washed 3 times with RIPA 
buffer using a magnet and once with 10 mM phosphate buffer pH 6.8.  Proteins were eluted 
with 100 mM glycine pH 1.8 for five minutes and brought to neutral pH with 9 µl 1 M Tris 
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base.  Magnetic beads conjugated to streptavidin (Dynal) were incubated with the 
immunoprecipitate for 2 hours per manufacturer’s instructions to capture Ig.  A magnet was 
used to collect the beads and the supernatant was obtained for following proteomic analysis. 
TSGE 
The PVM sample obtained from Dr. Sinai’s lab was not compatible with subsequent 
protomic analysis, therefore, we pre-treated the sample with TSGE method. A “Three-layer 
sandwich” gel was made based on the protocol provided in chapter 2.2.  Briefly, Three-layer 
Sandwich gel was generated in Electro-Eluter glass tube, consisting of a polyacrylamide 
sealing layer (bottom), a polyacrylamide concentration layer (middle) and an agarose loading 
layer (top).  Recipes for casting the sealing layer and the concentration layer gels are given in 
Table 2.2.1.  Each polyacrylamide gel layer was allowed to polymerize for 30 minutes.  The 
agarose loading layer was prepared using the following steps: 11µL of a 10% SDS solution 
per milliliter protein sample was transferred to the protein sample and incubated at 60°C for 
10 min.  A 2% agarose gel was melted by heating in a microwave for 1min and added to the 
protein sample at a ratio of 110 µL agarose per milliliter sample.  After mixing, the 
sample/agarose solution was quickly transferred to top of the acrylamide concentration layer 
and allowed to cool at 4°C for 10 min.  The elelctrophoresis was monitored by applying 10 
µL of 0.5% agarose with 1% Bromphenol Blue on the gel.  The running buffer preparation 
for the TSGE followed Laemmli’s protocol.  The gel was run at 15V for 30min, 5V overnight 
and at gradually increased voltage to 150V until dye front moved to the concentration layer.  
The obtained concentration layer from TSGE was fixed in 40% methanol, 10% acetic 
acid overnight.  Then the gel was washed with water and 25mM ammonia bicarbonate, dried 
with acetonitrile, and incubated with trypsin solution at 4°C for 40 min.  The swelled gel 
pellet was cut into 1mm3 pieces and covered with 100 µL of 25mM ammonia bicarbonate.  
Trypsin in-gel digestion was performed at 37°C overnight, and the resultant peptides were 
extracted from gel pieces, concentrated using vacuum centrifuge, and desalted using 350 um 
(I.D.) x10 cm laboratory fabricated C18 column. 
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2D-LC-MS/MS Analysis 
A Finnigan LCQ Deca mass spectrometer coupled with a LC Packings Ultimate 
quaternary capillary LC system was used for 2D-LC-MS/MS analysis.  Desalted digest from 
T. gondii whole cell lysate (20 µL) were injected onto a laboratory-fabricated SCX column 
(350 µm I.D. x 5 cm, 10 µm particles), which was directly connected to a laboratory 
fabricated fused silica capillary C18 column (350 µm (I.D.) x15 cm, 5 µm particles and 300 
µm pore size).  Mobile phase A was 0.1% formic acid in HPLC grade H2O, mobile phase B 
was acetonitrile (ACN) with 0.1% formic acid, mobile phase C was 300 mM ammonium 
acetate, and  mobile phase D was 95% H2O, 5% ACN with 0.1% formic acid.  Two-
dimensional LC separation was performed with 12 isocratic salt elution by using x% C (x = 
0, 1.67, 3.33, 5.00, 6.67, 10.00, 13.33, 16.67, 33.33, 50, 75, and 100) and corresponding 
(100-x) % solvent D.  Each salt elution was followed by a 90 min C18 reversed phase 
gradient elution.  The mobile phase composition was first held at 95% solvent A for 6 min, 
then was linearly changed from 95% to 50% over 44 min.  For the next 20 min, a linear 
increase of solvent B was carried out to reach the composition of 80%.  Then the solvent A 
was changed back to 95% in 5 min and held at 95% for the following 5 min.  The mass 
spectrometer was operated in a data-dependent mode with dynamic exclusion enabled.  
During the full MS acquisition, masses were scanned from 400 to 2000 m/z.  The most 
intense precursor ion was selected from the previous full MS scan to undergo CID with 
parameters of an activation Q of 0.250, activation time of 45 ms, and 35% normalized 
collision energy (NCE).  
Protein Data Analysis 
Individual mgf files obtained from the tandem mass spectra of each fraction were 
manually combined.  The composite mgf file was searched against both Toxoplasma gondii 
genome database (www.Toxodb.org) and NCBInr database using the MASCOT daemon 
software.  The parameters were set as followed: trypsin was used as the cleavage enzyme 
with one missed cleavage allowed.  Both the peptide tolerance and the MS/MS tolerance 
were set to 0.8 Da, and oxidized methionine was chosen as a variable modification.  For 
NCBInr database searching, other alveolata was chosen as taxonomy.  
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Result and Discussion 
To employ mass spectrometric analysis characterizing the proteome of PVM, it is 
essential to develop a protocol for highly purified PVM sample preparation so that sufficient 
quantities can be obtained for MS analysis. Sinai and coworkers described a methodology to 
enrich for the PVM using the selective mechanical disruption of the host cell combined with 
differential centrifugation and sucrose floatation gradients (scheme 2.3.1.). However, results 
showed a co-fractionation of the PVM fraction with host organelles including mitochondria 
and ER. Compared to that of the host mitochondria and ER, the amount of PVM proteins is 
exceptionally low, which seriously affects the characterization of PVM proteins using 
proteomic methodology. The novel immunoprecipitation method based on the generation of 
PVM antibodies by injecting PVM containing fractions from cultured rabbit fibroblasts back 
to rabbits was shown in scheme 2.3.1.  Using this method, they obtained two resultant 
polyclonal antisera (PVM45 and PVM46). They found both both PVM45 and PVM46 are 
capable of immunoprecipitating proteins unique to T. gondii infected cells and simutaniously 
exhibit minimal reactivity in uninfected cells based on the western blot results.  A. Martin et 
al also evaluated the PVM antisera using immunofluoresence assay and found the generated 
antisera contain enriched PVM antibodies due to colocalization with three well-known PVM 
proteins in the PVM.  
Elimination of Serum Proteins and Ig from Immunoprecipitations 
The resultant polyclonal antisera (PVM45 and PVM46) contain rabbit serum proteins, 
which seriously affect the following proteomic analysis. Therefore, serum proteins must be 
removed prior to application of immunoprecipitation. A. Martin et al 120developed a novel Ig 
purification method. They used capryilic acid precipitation protocol to remove serum 
proteins from immunoglobins. Then the antisera are ready to be crosslinked to magnetic bead 
for immunoprecipitation. However, in order to maximize elution of the low concentration 
proteins of interest, the harsh elution condition (200 mM glycine pH 1.8) was used which 
caused a small percentage of Ig being leached from the beads.  This amount was significant 
when compared to our target protein concentration. Therefore, as shown in Scheme 2.3.1B,  
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Scheme 2.3. 1:  purification and enrichment of PVM proteins. (A) generation of PVM 
fraction for preparing polyclonal antisera against the PVM. (B) immunoprecipitation. 
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A 
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Martin et al121 biotinylated the purified Igs prior to crosslinking Igs to protein A beads. The 
biotinylated Igs leached from the beads during immunoprecipitation was selectively removed 
from the eluate by using streptavidin capture prior to mass spectrometry using streptavidin 
bound to magnetic beads.   
 Identified Secretory Proteins 
Once the PVM sample was obtained, I applied the TSGE-2D-LC-MS/MS 
methodology described in chapter 2.2 to PVM proteome analysis. A total of 59 proteins were 
identified. Table 2.3.1 shows all 17 identified proteins secreted by secretory organelles 
rhoptry and Dense Granule.  When comparing protein distribution of the identified proteins 
from T. gondii whole cell lysate (chapter 1.2) with those from PVM sample. A fraction of 
29% of proteins identified from PVM sample belong to microneme, rhoptry, dense granule 
organelle, where only 4% proteins belong to those organelles in whole cell lysate, which 
proved that the novel PVM purification method based on immunoprecipitation successfully 
enriched secretory proteins. The highly confident identification of those proteins from 
another aspect proved the success of PVM purification. The highest Mowse score obtained in 
table 1 is 480 for protein GRA3, which implies 10-48 probability that this match between the 
experimental data and the database sequence is a random event. 
In Table 2.3.1, nine out of 17 proteins are rhoptry proteins. Rhoptries are unique 
secretory organelles found exclusively in the Apicomplexia of T. gondii.  Rhoptry proteins 
are discharged during host cell invasion79.  Studies reveal that rhoptry proteins are critical in 
the establishment of the machinery for both parasite invasion and the formation of nascent 
parasitophorous vacuole.  To date, all rhoptry proteins either associate with the PVM or are 
transported across the PVM into the host cell cytoplasm.  Among these rhoptry proteins, the 
ROP2 family has received more attention due to its importance for parasite invasion.  We 
identified 6 proteins belonging to ROP2 family, which include, ROP2A ROP2B, ROP2, 
ROP5, ROP18 and ROP4122.  It has been shown that all these identified ROP2 family 
members associate with the PVM.  Protein ROP2 is secreted to the PVM during infection.  It 
is located in the PVM with its N-terminus exposed to the host cell cytoplasm, where it 
mediates an association between the PV and host cell mitochondria123.  Protein ROP2A and 
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ROP2B are paralogs of ROP2, which have similar function as ROP2.  ROP5 exhibits unique 
features among the ROP2 family proteins.  Compared to ROP2 and 4, ROP5 is not processed 
during biosynthesis, and although it is targeted to the PVM during invasion, its topology in 
the PVM shows ROP5 exposes its C-terminus toward the host cell cytoplasm124, which is 
inverted compared with ROP2.  ROP4 is secreted from the parasite during host cell invasion 
and is related to the PVM125.  Like other ROP2 family proteins, ROP18 is also secreted to the 
PVM126. It is described as genuine kinase.  The mature recombinant ROP18 can selectively 
phosphorylate an unknown parasite protein, demonstrating its kinase activity115.  Beside 
ROP2 family proteins, ROP1 was also identified using TSGE- MuDPIT technology.  
Although the function of ROP1 still remains unknown,  it is believed to be an active 
component of the penetration-enhancing factor, which can increase the efficiency of host cell 
invasion127, 128.  However it is not essential for invasion129.  ROP1 has been used as a model 
for studying rhoptry protein trafficking and processing130. 
We also identified a recently verified rhoptry protein, toxofilin, in the PVM 
fraction131. Toxofilin is found localized within the luminal domain of rhoptries. However, its 
functional roles have not been thoroughly studied. Some research indicated that toxofilin 
may bind to actin and protein phosphatase 2C and play an important role in parasite gliding 
motility and host cell invasion132, 133. The co-characterization of actin in our experiment can 
be explained by this theory.  The identification of toxofilin in the PVM sample might be due 
to its secretion into PV where it interacts with actin and/or a protein phosphatase 2C.  
Five dense-granule proteins were also identified. They are GRA1, GRA2, GRA3, 
GRA5 and GRA8. All these proteins are associated with the PVM134. The dense granule 
proteins are secreted into the PV and the PVM after the parasite penetrates into host cell. The 
secretion continues during the entire intracellular residence of the parasite.  Within a few 
minutes after penetration, parasites modify the newly formed PV and the PVM with parasite 
proteins.  A tubulovesicular membranous network (TMN) also develops within the PV, 
which is a pore structure that allows small charged molecules with MW less than 1,200 Da to 
pass through between the PV and the host cell cytoplasm,.  It was proved that GRA3 and 
GRA5 are localized on the PVM135, 136, while GRA1 and GRA2 associate with the
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Table 2.3. 1: Proteins Secreted by Rhoptry and Dense Granule 
 
database protein 
# protein name(Toxdb/NCBInr) NCBInr Toxodb
ID #(Toxdb/NCBInr) gene name mass 
Mowse 
Score 
queries 
matched 
1 
rhoptry antigen, putative/rhoptry 
protein 5 x x 551.m00238/gi|72536429 ROP5 60933 169 5 
2 rhoptry antigen, putative  x 33.m01398 ROP2A 66706 63 1 
3 
rhoptry protein, putative/rhoptry 
protein 18 x x 20.m03896/gi|84618297 ROP18 62626 57 1 
4 rhoptry antigen, putative  x 83.m02145 ROP4 103803 53 3 
5 /rhoptry protein x  /gi|897823 ROP1 42645 162 11 
6 /54-kda antigen or ROP2 x  /gi|235333  ROP2 61167 66 3 
7 54-kDa antigen, partial  x 63.m00146 ROP2B 42334 63 1 
8 Rhoptry protein or rhoptry protein 4 x  /gi|6689341 ROP4 63937 42 5 
9 dense granule protein 5 precursor,putative x x 76.m00004 GRA5 12831 62 4 
10 /23K calcium-binding major antigen precursor x  /gi 102305  20137 38 1 
11 28 kDa antigen x x 42.m00015/gi|161913 GRA2 19792 49 3 
12 
P35 surface antigen/dense granule 
protein x x 52.m00002/gi|5901701 GRA8 28610 105 3 
13 
dense granule protein 3/dense 
granule protein x x 42.m00013/gi|22652337 GRA3 23861 480 17 
14 major surface antigen p30 x x 44.m00009/gi|10725 SAG1 34709 101 10 
15 
/Dense granule protein 1 precursor 
(Major antigen p24) x 
 
/gi|129322 GRA 1 20137 102 4 
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16 /surface antigen x  /gi 13447088 SAG3 41747 42 1 
17 toxofilin x x 33.m02185/gi|27763993  75026 36 1 
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tubulovesicular membranous network (TMN)137.  GRA5 is inserted into the PVM as a 
transmembrane protein with its N-terminal domain extending into the cytoplasm and its C 
terminus in the vacuole lumen138. Two surface proteins, SAG1 and SAG3, were also 
identified.  They are highly immugenic surface proteins and contaminant in the preparation. 
They have been shown to act as attachment factors, mediating the contact between the 
parasite and host cell during host cell invasion139.  
The facts of all identified secretory proteins directly or indirectly associating with the 
PVM further indicates the novel methodology of combination immunoprecipitation with 
TSGE-MuDPIT effectively enriched and characterized the proteins from the PVM. 
Other Identified Proteins 
Beside secretory proteins, 42 other proteins were also identified using the novel 
method. Those proteins are listed in Table 2.3.2.  Surprisingly, we identified large number of 
translational machinery proteins and DNA related proteins. A total of 11 out of 59 proteins 
were translational machinery proteins (19%), including eight ribosomal proteins and three 
elongation factor proteins. Also, five DNA related proteins (8%) were characterized. Even 
though it is not clear yet how ribosomal proteins gets transported on the surface, it has been 
reported that some ribosomal proteins like P0 are presented on the surface of T. gondii140.  
The function of P0 is mediated through a P12.P0.P22 complex and P0 also interacts with the 
elongation factor eEF2141, 142. Therefore, identification of large number of ribosomal and 
elongation factor proteins may be due to the cell surface localization of those proteins. 
Further biological investigation is needed to confirm these results. The possibility of nucleus 
contamination during subcellular fractionation and the subsequent immunoprecipitation can 
not be excluded, since the high percentage of translational machinery proteins and DNA 
related proteins were identified. The whole parasite cell lysate was centrifuged by 10,000xg 
for 10 minutes, and the remaining supernatant was directly subjected to immunoprecipitation, 
the supernatant contains various subcellular components such as nuclei, mitochondria, 
lysosomes and ribosome sediments. Ribosomal proteins from ribosome sediments or nuclei 
are likely to be extracted from sample by nonspecific interaction with magnetic beads during 
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the immunoprecipitation. Other proteomic analysis for the Toxoplasma Conoid reveals the 
same sorts of contaminants. 
Five chaperones were also identified, which are two heat shock 90 homologs, two 
putative heat shock 70 homologs and protein disulfide isomerase. All these chaperone 
proteins were also identified in the proteomic study of the parasitophorous vacuole of 
Plasmodium falciparum, which is also an intracellular parasite of the phylum Apicomplexa 
like T. gondii143. HSPs in T.gondii share significant homologies with their host counterparts, 
but there is very limited information about their functional roles for the parasite144. The 
chaperones may mediate protein translocation into and across the PVM.  Protein disulfide 
isomerases might play an essential role on unfolding proteins in the vacuole by breaking 
disulfide bridges so that they can translocate across the PVM 145. The novel 
immunoprecipitation method used in our experiment not only can enrich protein located in 
the PVM, but also extract any proteins that have interaction with the PVM proteins. So 
proteins those locate in PV or are secreted into the host cytoplasm at any stages of host-cell 
invasion and have protein-protein interactions with the PVM proteins can also be 
characterized using the subsequent TSGE-2D-LC-MS/MS. The identification of the 
chaperones implied that these proteins may either locate at the PVM at certain stage of the 
invasion or have intimate interaction with the PVM proteins. In order to elucidate structural 
and functional roles of the chaperones, further biochemical research is required.  
One interesting finding of our study is identification of the cyst matrix protein, a 65 
kDa antigen that is expressed in the tissue and the cyst wall. Tissue cysts are specialized 
parasitophorous vacuoles containing bradyzoites, the slowly replicating form of the parasite. 
The cyst wall of this structure is produced by modification of the parasitophorous vacuole by 
the parasite81. The PVM is the innermost cyst wall layer146. The identification of the the cyst 
matrix protein indicates the recognition of cyst wall components is surprising, given that the 
stain of Toxoplasma used (RH) does not form systs. So far neither the characterization of this 
protein and nor functional roles of this protein has been studied or reported. Actin and a 
membrane anchor protein for myosin XIV precursor were also identified from the enriched 
PVM sample in our experiments, which is consistent with other biochemical studies. It has 
been shown that T. gondii invade host cells in an actin-myosin- 
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Table 2.3. 2:  Other Proteins Identified from PVM Samples 
 
database protein 
# protein name(Toxdb/NCBInr) NCBInr Toxodb
ID #(Toxdb/NCBInr) mass Mowse Score 
queries 
matched protein description 
1 60s ribosomal protein L36, putative  x 49.m03096 11401 89 1 Translational Machinery 
2 60s ribosomal protein L19, putative  x 80.m02220 22146 64 1 Translational Machinery 
3 60S ribosomal protein L18a, putative  x 55.m05004 21317 56 1 Translational Machinery 
4 60s ribosomal protein l6, putative  x 583.m05552 21506 31 2 Translational Machinery 
5 40S ribosomal protein S11, putative  x 42.m00125 18665 37 1 Translational Machinery 
6 ribosomal protein L32, putative  x 57.m00005 15607 38 1 Translational Machinery 
7 60s ribosomal protein L36, putative  x 49.m03096 11401 45 3 Translational Machinery 
8 60S acidic ribosomal protein P2, putative  x 583.m00610 11761 45 1 Translational Machinery 
9 elongation factor 1-alpha, putative x x 76.m00016/gi|10140 48974 333 9 Translational Machinery 
10 elongation factor 2, putative x x 20.m03912/gi|3122059 106504 44 1 Translational Machinery 
11 elongation factor TS, putative  x 547.m00087 60260 31 1 Translational Machinery 
12 histone H2A/histone h2A x x 145.m00002/gi|68060347 15910 158 8 DNA related proteins 
13 histone H4, putative/histone 4 x x 49.m03134/gi|19880139 11432 57 2 DNA related proteins 
14 histone H4 x  /gi|223273 11190 85 3 DNA related proteins 
15 seryl-tRNA synthetase, putative  x 50.m00020 54082 55 1 DNA related proteins 
16 DNA replication licensing factor, putative  x 49.m00049 88157 92 7 DNA related proteins 
17 protein disulfide isomerase, putative x x 27.m00003/gi|14494995 52769 62 1 Heat Shock Proteins 
18 heat shock protein 90 x x 80.m00001/gi|33669480 81882 115 2 Heat Shock Proteins 
19 heat shock protein 90, putative x x 49.m00060/gi|66735118 96763 37 1 Heat Shock Proteins 
20 heat shock protein 70, putative x x 583.m00009/gi|3098140 73208 86 2 Heat Shock Proteins 
21 heat shock protein 70, putative x x 59.m00003/gi|3323502 72834 68 2 Heat Shock Proteins 
85
 86
22 
cyst matrix protein, putative/65-kilodalton 
antigen that is expressed in the tissue cyst 
matrix and the cyst wall 
x x 59.m00006/gi|520474 49150 510 16 Cyst Proteins 
23 actin x x 25.m00007/gi|89214066 41881 63 2 Structural Proteins 
24 acid phophatase, putative/membrane anchor for myosin XIV precursor x  38.m01061/gi 46948064 46577 40 2 Structural Proteins 
25 serine-threonine phosphatase 2C x x 44.m00037 36767 59 3 Structural Proteins 
26 superoxide dismutase x x 583.m00021 22536 265 12 Enzymes 
27 ubiquitin-conjugating enzyme E2, putative  x 641.m01538 42598 39 1 Enzymes 
28 
calcium-dependent protein kinase, putative / 
calmodulin-domain protein kinase, putative x 162.m00001 65380 33 1 Enzymes 
29 lactate dehydrogenase x x 44.m00006/gi|1695772 35525 62 4 Enzymes 
30 fructose-1,6-bisphosphate aldolase x x 46.m00002/gi|25989716 46930 93 4 Enzymes 
31 enolase, putative x x 59.m03410/gi|12619316 52080 77 1 Enzymes 
32 SRS domain-containing, N-acetylglucosamine-
phosphate mutase, putative x 57.m01692 324180 471 23 Enzymes 
33 
nucleoside-triphosphatase 
I/adenosinetriphosphatase (EC 3.6.1.3) x x 65.m00001/gi|84176 69112 98 3 Enzymes 
34 
glyceraldehyde-3-phosphate 
dehydrogenase x x 80.m00003/gi|13377044 36605 49 3 Enzymes 
35 
translationally-controlled tumor protein, 
putative  x 50.m03408 19160 75 1 Enzymes 
36 14-3-3 protein homolog-related  x 42.m03594 189418 39 2 Enzymes 
37 thioredoxin, putative  x 50.m00069 46946 47 1 Enzymes 
38 hypothetical protein  x 44.m02649 172258 39 3 hypothetical proteins 
39 hypothetical protein  x 80.m02161 47892 91 2 hypothetical proteins 
40 hypothetical protein  x 20.m03773 187499 36 2 hypothetical proteins 
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41 hypothetical protein  x 46.m02915 72948 35 2 hypothetical proteins 
42 /hypothetical protein PC000659.03.0 x  /gi|70944159 9490 66 9 hypothetical proteins 
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dependent way147.  It has been proved that actin and myosin are localized at the apical end 
and in the space between the plasma membrane and the inner membrane complex (IMC), 
which lies beneath the cell membrane of T. gondii. Actin filament was observed at the 
anterior end of the parasite in association with the conoid when treating with filament-
stabilizing drug, Jasplakinolide148. Study also showed a class XIV myosin is critical for the 
gliding motility of the parasite.  Since actin and myosin XIV is intimately associated with the 
host-cell invasion, it is likely that actin and myosin XIV is also localized in the PVM or have 
interaction with the PVM proteins. Besides these identified proteins, we also observed a large 
number of enzymes (twelve) including kinases, phosphatases, and proteases. These proteins 
are likely to have specialized functions in the parasitophorous vacuole, or on the PVM. 
Molestina and Sinai149 have shown recently that an unidentified parasite kinase is responsible 
for the phosphorylation of host IKBα localized at the PVM in infected cells. The most 
important funding is the identification of hypothetical proteins that would not have been 
found otherwise. Total five hypothetical proteins were identified in our study.  
All identified proteins were searched against toxodb.org, a total of 11 proteins contain 
trans-membrane domains (listed in Table 2.3.3) and are considered as membrane proteins. 
These proteins are very important for study of the composition of the PVM. Seven proteins 
(ROP2A, ROP2, toxofin, GRA1, GRA3, GRA5 and SAG3) out of eleven are secreted 
proteins from dense granule and rhoptry. Proteins, membrane anchor for myosin XIV 
precursor and cyst matrix protein, which already discussed above, also contain trans-
membrane domain. The remaining two identified membrane proteins are hypothetical 
proteins, which have not been reported before.  The localization of many identified proteins 
in our experiment needs to be further confirmed by immunoflueresence assay (IFA).  In 
addition,  the functions of these proteins needs to be studied by generating mutant parasites 
that are lacking of the relevant gene, by identifing the proteins with which they interact, and 
by characterizing their substrates if they are found to be enzymes. The successful 
construction of the PVM sub-proteome in our study provides many important targets for such 
analyses and establishes the foundation of the thorough study of the important organelle of T. 
gondii, the PVM. 
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Conclusion  
The Parasitophorous vacuole membrane (PVM) is an extracellular organelle of T. 
gondii, which is critical for the parasite’s survival. In this chapter, we presented a novel 
methodology which combined immunoprecipitation with TSGE-2D-LC-MS/MS.  By using 
this methodology, we successfully profiled T. gondii PVM proteome. 59 proteins were 
identified from the PVM enriched sample.  Result showed that 17 (29%) identified proteins 
were from secretory organelles Rhoptry and Dense Granule, where only 4% proteins belong 
to those organelles in whole parasite cell lysate. Furthermore, many proteins identified in our 
study were previously reported to be localized in the PVM or intemite related to the PVM. 
Therefore, the novel PVM purification method based on immunoprecipitation successfully 
enriched secretory proteins. The combination of immunoprecipitation with TSGE-2D-LC-
MS/MS can successfully analyze challenging organelle like the PVM.  
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Table 2.3. 3:  Identified membrane proteins 
 
database 
protein name(Toxdb/NCBInr) 
NCBInr Toxodb 
ID #(Toxdb/NCBInr) mass Mowse Score protein description 
transmembrane 
domain 
/54-kda antigen or ROP2 x  /gi|235333  61167 66 PVM 1 
dense granule protein 5 precursor,putative 
(GRA5) x x 76.m00004 12831 62 PVM 2 
dense granule protein 3/dense granule protein 
(GRA3) x x 42.m00013/gi|22652337 23861 480 PVM 2 
rhoptry antigen, putative (ROP2A)  x 33.m01398 66706 63 PVM 1 
/surface antigen( SAG3 protein) x  /gi 13447088 41747 42 PVM 1 
/Dense granule protein 1 precursor (Protein 
GRA 1) (Major antigen p24) x  /gi|129322 20137 102 PVM 1 
hypothetical protein  x 80.m02161 47892 91 hypothetical protein 1 
acid phophatase, putative/membrane anchor 
for myosin XIV precursor x  38.m01061/gi 46948064 46577 40 Structural Proteins 2 
cyst matrix protein, putative/65-kilodalton 
antigen that is expressed in the tissue cyst 
matrix and the cyst wall 
x x 59.m00006/gi|520474 49150 510 Cyst Proteins 1 
hypothetical protein  x 46.m02915 72948 35 hypothetical protein 1 
toxofilin x x 33.m02185 /gi|27763993 75026 36 PVM 1 
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Chapter 2.4 
Conclusion  
As an interface between the parasite and host cell, parasitophorous vacuole membrane 
(PVM) plays critical roles on various respects of the parasite’s life. It is understudied due to 
its unique structural features.  In this part of the dissertation, we developed a novel proteomic 
methodology for qualitative analysis of the sub-proteome, T. gondii PVM.  A new method, 
the “Three-layer Sandwich Gel Electrophoresis” (TSGE), was first developed based on the 
need for cleanup of the challenging PVM sample from biological preparation for subsequent 
bottom-up proteomic analysis. The TSGE is used for concentrating and cleaning up protein 
samples which are in uncharacteristically large volumes, contain high salt or other 
contaminants, and/or extremely dilute. Several parameters for three-layer gel formation were 
explored and their values were optimized to obtain the most effective methodology. The 
optimized TSGE method was compared with other available protein concentration and clean-
up methods. Results showed the TSGE methods can not only efficiently removed solvents 
and contaminants but also produced had the highest protein recoveries compared to other 
methods.  Furthermore, the TSGE method in combination with 2D-LC-MS/MS was applied 
to analyze T. gondii whole cell lysate. The results proved its reliability and usefulness of 
analyzing complex protein samples. 
The developed TSGE-2D-LC-MS/MS methodology then was applied in the analysis 
of enriched PVM protein samples which was achieved by using a novel PVM enriching 
method based on immunoprecipitation developed by Sinai and coworkers. The construction 
of the PVM proteome indicated the immunoprecipitation methodology successfully enriched 
the proteins in the PVM and immunoprecipitation coupled with TSGE-2D-LC-MS/MS can 
be applied to analysis of challenging organelles.  
In this part, we focused on proteomic method development on qualitative analysis of 
complex biological samples. In next part, we are going to devote to method development on 
quantitative proteomics.  
Copyright © Ting Liu 2008 
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DEVELOPMENT OF NOVEL ISOCYANATE PEPTIDE N-TERMINAL LABELING 
REAGENT FOR QUANTITATIVE PROTEOMIC APPLICATION USING LC-ESI-
MS/MS  
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Chapter 3.1 
Introduction 
A major goal of proteomics is to qualitatively and quantitatively analyze all the 
proteins expressed in a biological system like an organism, a tissue, an organelle, or a body 
fluid, under a specific condition150.  Various global quantitative approaches, which have the 
ability to accurately measure differential protein expression and directly detect global 
changes in health and disease, have been developed for analyzing complex biosystems.  
These approaches are being employed in a varity of biological studies such as the discovery 
of biomarkers of disease, the detection of new therapeutic targets and the studies of basic 
biological processes and mechanisms of cell function and signaling151, 152.  For this purpose, 
the protein patterns of two protein samples after perturbations like drug treatment and 
metabolic stress are compared.  Most of these quantitative methods are based on two 
strategies employed in bottom-up proteomics: Two-dimensional Gel Electrophoresis (2D-
SDS-PAGE) coupled with MS and 2D chromatography coupled with MS.  Efficient 
quatitative proteomic methods should have automated, robust and highly sensitive feature to 
meet the requirement of high through-put protein analysis.  Innovations in both gel-based and 
gel-free strategies make it possible to expand quantitative proteomics to new areas of 
biological research.    
This part of dissertation focuses on the systematic study of mass spectrometric 
properties of N-terminal labeled peptides with isocyanates using LC-ESI-MS/MS and the 
development of the appropriate isocyanate labeling reagent for quantitative proteomics 
application. 
Quantitative Proteomics Background 
Traditional quatitative proteomics is conducted using two dimensional gel 
electrophorisis, which was described in chapter 1.1. However, since the quantitative analysis 
results directly rely on the performance of both 2D gel and staining techniques, several issues 
have to be considered when using 2D-SDS-PAGE as separation and detection means for 
quantitative protein analysis. The first issue is the relatively low reproducibility of 2D-SDS-
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PAGE analysis due to the difficulty of making the exact same two gels. Another problem is 
that 2D-SDS-PAGE has limited capability in the analysis of membrane proteins.  Many large 
and hydrophobic proteins cannot be resolved and separated using 2D-SDS-PAGE.  Also 2D-
SDS-PAGE has relatively low sensitivity and a small dynamic range, which causes low 
abundant proteins which below limitation of detection of selected staining technique can not 
be detected.  More significantly, this method is sequential, labor intensive and difficult to 
automate and can’t be on-line coupled to mass spectrometry153. All these issues limit the 
application of 2D-SDS-PAGE on quantitative proteomics.  
Stable Isotope Labeling  
Instead of using gel involved technology, gel-free methods such as LC-MS- based 
stable isotope labeling strategy have become popular for the quantitative analysis of proteins 
in complex biological samples recently154, 155.  Based on the different strategy, stable isotope 
labeling is classified as enzymatic labeling156, AQUA157 and chemical labeling.   
Enzymatic labeling refers to protein digestion with a particular enzyme in the 
presence of either H216O or H218O, which is used for relative quantification.  Under this 
process, the enzymatically digested peptides are correspondingly labeled with 16O and 18O at 
their C-termini through the enzyme catalyzed incorporation of oxygen. Then both samples 
are combined and analyzed by LC-MS. The pairs of 18O-labeled and unlabeled peptides are 
detected due to the same retention time and a 4 Da mass difference. The relative quantitation 
is determined by the ratio of peptide pairs. For the identification of proteins, the fragment ion 
spectra are automatically collected in the MS/MS mode and database searches are performed 
using one of the computer-searching algorithms. While enzymatic labeling with H218O is a 
straightforward method for introducing stable isotopes into a peptide sample, however, since 
the resulting peptide pairs have only a 4 Da mass difference, it is difficult to distinguish 
between labeled and unlabeled peptide pairs for multiply charged species when using low-
resolution mass spectrometers. 
AQUA as an absolute quantification strategy was developed recently. In this strategy, 
special peptides are designed and synthesized with incorporated stable isotopes as ideal 
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internal standards to mimic native peptides produced from protein digestion.  After 
proteolysis of protein of interest, the isotope labeled AQUA peptide is introduced, and 
sample analyzed using LC-MS.  Even though AQUA can be used for absolute quantification, 
the preparation of the isotope labeled AQUA peptide is expensive and time-consuming. 
Furthermore, the AQUA peptide is not universal, a suitable peptide candidate has to be 
investigated and chosen for each different protein of interest.  
The most widely employed LC-MS-based stable isotope labeling strategy is chemical 
labeling, which involves labeling the control and the test sample with distinct labeling 
reagents via chemical reaction.  The labeling process can be performed either before or after 
enzymatic digestion depending on labeling reagents and targeted functional group in the 
protein.  Then the two enzymatically digested samples are mixed and subjected to LC-
MS/MS in a data-dependant mode.   In this manner, pairs of the isotopic labeled peptides are 
differing only in mass from their counterparts, therefore are chemically identical and act as 
mutual internal standards for accurate quantification158.  Theoretically, an isotopically labeled 
pair of peptides has identical physical chemical properties, thus they should behave the same 
during chromatographic separation and ionization procedure. In another words, all pairs of 
isotopic labeled peptides should be co-eluted from the chromatographic column and have 
same ionization efficiency during ESI process. Therefore, the relative quantity of individual 
peptide can be determined by calculation of the isotope ratios obtained from full mass scan.  
At the same time, peptide sequence information can be obtained by the subsequent tandem 
spectrum.  However, when deuterium isotope is used in heavy labeling reagents, an isotopic 
effect will take place during chromatographic separation159, which means modified peptides 
with differential isotopic labeling can be partially or even completely resolved during 
reversed-phase chromatography (RPC). This causes the isotope ratio to vary during the 
course of elution from RPC columns. Thus quantification can only be achieved by comparing 
their chromatographic peak areas using MS data. This means the relative quantity of the 
peptide of interest only can be determined after the corresponding analyte peak completely 
eluted from the LC-MS system160. The degree of chromatographic isotope effects depends on 
several factors including (1) the number of deuterium atoms (2) the structure of the labeling 
reagent, (3) peptides sequence and (4) peptide size 159. Currently, 13C is used in most isotopic 
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labeling reagents to eliminate the isotopic effect161.  Compared to traditional two-dimensional 
gel electrophoresis methods, the major advantage of stable isotope-coding strategies is that 
identification and quantification of proteins can be obtained simultaneously using MS and 
MS/MS analysis.  In addition, since these strategies can directly be coupled to LC-MS, it has 
the potential for automated large-scale quantification analysis.   
Among chemical labeling strategies, two different stable isotope labeling schemes 
have been applied to quantitative analysis of proteomes. One scheme is targeted labeling162, 
which means labeling specific amino acid residues in proteins.  The most famous example is 
Isotope Coded Affinity Tag (ICAT) labeling coupled with tandem mass-spectrometry 
(MS/MS), which has been relatively widely applied to identification and quantitative analysis 
differentially expressed proteins 11, 154, 163. In this method, Cys-containing proteins in two 
samples are labeled separately with isotopically labeled light and heavy ICAT reagents which 
have specificity toward thiol groups (cysteines). The labeled protein mixtures are combined 
and proteolyzed to peptides. Then the ICAT-labeled cys-containing peptides are isolated 
using affinity chromatography and then analyzed by LC-MS/MS. Since all non-cys 
containing peptides are removed prior to MS analysis, it significantly reduces the complexity 
of the sample, thereby facilitating the detection of less abundant peptides. Even though ICAT 
is a promising approach, it also has some limitations. For example, the ICAT method is not 
suitable to the analysis of non-Cys containing proteins, which probably constitute about 14% 
of all proteins164. Also, this method can’t be used to analyze protein modifications and post-
translational modifications if the peptides containing modifications do not have cysteine 
residues. In addition, the recovery from the avidin column is rather poor because of 
irreversible binding, which may cause reduction of  the number of cys-containing peptides 
identified by the ICAT method165.  
Another scheme, which is called global coding, labels N-terminus or C-terminus of 
peptides instead of labeling specific amino acid in protein. So it allows any peptide, from any 
place in a protein, to be used for quantitative analysis. As shown in Figure 3.1.1, in the 
Global Coding Strategy, first two protein mixtures representing two different cell states are 
proteolyzed to generate peptides. Then the two samples are labeled with light or heavy 
labeling reagents respectively. Finally, the two samples are combined and analyzed by LC-
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ESI-MS/MS. Then they are ionized during ESI process and introduced to the mass 
spectrometer for MS and MS/MS analysis. The relative quantity of the pair of peptides is 
determined by the ratio of extracted chromatographic peak areas in MS mode. Proteins are 
identified by sequence information obtained from MS/MS spectra. The advantage of this 
strategy is that it allows any peptide, from any place in a protein, to be used for quantitative 
analysis. In this part of dissertation, we introduce a novel methodology for selecting 
appropriate labeling reagent for global coding strategy based quantitative proteomics. 
Peptide Fragmentation Mechanism 
Peptides generate a series of fragment ions under low-energy CID.  The most widely 
accepted theory to describe how protonated peptides dissociate under low-energy CID is the 
‘mobile proton model’166, 167.  In brief, peptides can be protonated at various proteonation 
sites such as N-terminal, peptide bond backbone and side chain groups (arginine, lysine, and 
histidine), leading to various isomers. Based on the energetics of the protonated isomers, they 
are classified as two classes. The characteristic of class one is that large energy is needed to 
mobilize the proton to energetically less favored sites, for example, peptide containing 
arginine. For the second group, many of the protonation sites are accessible in a narrow 
energy range.  Investigation of a large number of peptides showed that backbone dissociation 
of protonated peptides under low-energy CID is a charge-directed process. In the gas phase, 
protons from the initial protonation sites migrate to amide nitrogen along the peptide 
backbone and trigger the cleavage of amide bonds in peptides to generate b ions and y ions. 
The energy required for proton ‘mobilization’ from protonation sites depends on the amino 
acid composition. For instance, proton on arginine need more energy to migrate compared to 
the proton on lysine. Proton on both arginine and lysine need more energy to move compared 
to that on N-terminal and non-basic peptide.  Arginine is easier to protonate than lysine and 
the N-terminal due to its high basicity. Since the probability of protonation depends on the 
basicity of the protonation sites during electrospray ionization, large populations of singly-
charged peptides are protonated on the C-terminal basic residues, which need high energy to 
dissociate. Large population of doubly-charged peptides is protonated on both N-terminal 
and C-terminal basic residues, which need less energy to dissociate compared to former. 
Therefore, doubly-charged precursors need less energy to fragment and fragment in the way
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Figure 3.1. 1: A schematic of global coding scheme. First two protein mixtures 
representing two different cell states are trypsin digested to generate peptides. Then the two 
samples are labeled with light or heavy labeling reagents respectivly. Finally, the two 
samples are combined and analyzed by LC-ESI-MS/MS. The relative quantity of the pair of 
peptides is determined by the ratio of extracted chromatographic peak areas in MS mode. 
Proteins are identified by sequence information obtained from MS/MS spectra.  
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 such that most of the peptide bonds break with comparable frequency, such that one is more 
likely to derive a complete sequence. Furthermore, since most fragment ions generated from 
doubly charged precursor ion are singly charged, the generated spectra become the easiest to 
interpret. In a nutshell, doubly charged peptides produce more product ions than singly 
charged forms of the same peptide.  
Study Rational 
Protein identification using MS/MS database search is based on matching acquired 
tandem spectrum to theoretical fragments from database. So peptide fragmentation is directly 
related to protein identification. The more sequence useful fragments obtained, the more 
probability the protein is identified during database search. Since doubly-charged precursors 
also fragment such that most of the peptide bonds break with comparable frequency, such 
that one is more likely to derive a complete sequence, obtaining high intensive doubly 
charged ions during ESI process for further fragmentation is very important for protein 
analysis. 
When subjecting the modified peptides into mass spectrometer, which operated in a 
data-dependent mode, the peptides are full scanned. Then the mass spectrometer 
automatically chooses the most intensive peak from the previous full mass scan for further 
CID fragmentation. If the N-terminal modification causes generating relatively more singly 
charged ions compared to doubly-charged ions, mass spectrometer may automatically choose 
singly-charged ion for further fragmentation, thus affecting protein identification. Therefore, 
beside the factors such as the completeness and the specificity of the labeling reaction, the 
influence of the modification on forming doubly charged ions during the electrospray 
ionization process need to be investigated when choosing N-terminal labeling reagent for 
quantitative proteomics.  More importantly, because fragmentation of modified peptides is 
directly related to identification of proteins, the effect of the modification on the 
fragmentation during low-energy CID must also be evaluated.  
Mason et al168 used phenyl isocyanate (PIC) as an N-terminal labeling reagent to 
study relative quantification of several styrene oxide adducts of human hemoglobin. 
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Isocyanate can react with N-terminal amino groups of peptide to form urea bonds. The 
reaction is shown in Figure 3.1.2. However, when we investigated the mass spectrometric 
properties of PIC modified peptides, we found several issues that may affect protein 
identifications. First, PIC N-terminal modification seriously affects the formation of doubly 
charged ion during ESI process. Figure 3.1.3 shows a full scan MS spectrum for peptide with 
m/z 1042, +1, singly charged ion dominates the spectrum, while the doubly charged ion is 
not detected. In data-dependant mode, the singly charged ion m/z 1042, +1 is selected for 
further fragmentation. Figure 3.1.4 shows the subsequent ms/ms spectrum at m/z 1042, +1. 
The two most intensive peaks m/z 922, +1 and m/z 948, +1 are formed by cleavages of two 
urea C-N single bonds. When the parent ion cleaves at position 1 (labeled in Figure 3.1.4), it 
produces the native form of product ion (m/z 922, +1) and at the same time loses a neutral 
PIC molecule. While the parent ion cleaves at position 2, it forms the isocyanate peptide 
form product ion (m/z 948, +1) and at the same time loses a neutral aniline molecule. A 
series of b ions and y ions are also formed. However, compared to the two dominant product 
ions, these b and y ions are in relatively low intensity. So the N-terminal labeling with PIC 
apparently affects the fragmentation of the modified peptide.  Based on these observations, 
phenyl isocyanate is not likely an ideal N-terminal labeling reagent for quantitative 
proteomics.  Therefore, one of our study goals is to find an isocyanate reagent that is more 
appropriate for quantitative proteomics application than phenyl isocyanate.   
Study Hypothesis 
Our hypothesis is alteration of isocyanate structure will change fragmentation pattern 
and ESI property of isocyanate modified peptides. Novel isocyanate reagent, which can be 
applied to quatitative proteomics, will be discovered by systematically studying mass 
spectrometric properties of isocyanate modified peptides.   
Study Goals 
We aim to systematically investigate the ESI property and the collision-induced 
dissociation of peptides labeled with a variety of aromatic isocyanates. Based on the results 
obtained from this investigation, we design a new isocyanate reagent and evaluate the new 
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agent labeled peptides.  Eventually, we seek to find an appropriate isocyanate reagent for 
future quantitative proteomics applications.
 102
 
 
 
Figure 3.1. 2:  Reaction of phenyl isocyanate with N-terminal of peptides. Isocyanate 
reacts with N-terminal of peptides to form a urea bond. 
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Figure 3.1. 3:  Full MS scan of phenyl isocyanate (PIC) N-terminal labeled peptide with 
sequence AEFVEVTK (m/z1042, +1). Only singly charged peak was observed. Doubly 
charged peak was not detected. 
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Figure 3.1. 4:  Tandem MS spectrum of peptide PIC-EFVEVTK with m/z 1042, +1. The 
two most intensive peaks m/z 922, +1 and m/z 948, +1 are formed by cleavages of two urea 
C-N single bonds. When the parent ion cleaves at position 1 (labeled in Figure 3.1.4), it 
produces the native form of product ion (m/z 922, +1) and at the same time loses a neutral 
PIC molecule. While the parent ion cleaves at position 2, it forms the isocyanate peptide 
form product ion (m/z 948, +1) and at the same time loses a neutral aniline molecule. A 
series of b ions and y ions are also formed. 
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Chapter 3.2 
Fragmentation of N-terminal Labeled Tryptic Peptides with Various Isocyanates by 
using low-energy collision-induced dissociation CID 
Introduction 
Various labeling reagents targeting specific amino acid residues in proteins or 
peptides have been explored169-171.  For example, the ICAT reagent specifically targets 
cysteines169 and NBS labeling reagent specifically reacts with tryptophan residues172.  
Labeling methods can involve enrichment of labeled peptides using affinity chromatography, 
which significantly reduces the complexity of the sample, thereby facilitating the detection of 
less abundant peptides.  However, these methods are not suitable for analyzing proteins not 
containing targeted amino acid residues.  Also, these methods have difficulty in the analysis 
of protein post-translational modifications if the peptides containing modifications do not 
have targeted amino acids165. 
Instead of targeting specific amino acid residues, an alternative labeling reagent, 
which reacts with N-terminal amino group of peptides, had also been studied159.  The 
advantage of this kind of reagent is that it allows any peptide, from any location in a protein, 
to be used for analysis.  A number of reagents for N-terminal modifications have been 
studied for quantitative analysis, such as phenyl isocyanate168, 4-sulfophenyl isothiocyanate 
(SPITC)173 and S-methylthioacetimidate174.  Some N-terminal labeling reagents with fixed-
charge are also employed to explore peptide fragmentation pathways (PFPs)175.  For 
example, tris (2,4,6-trimethoxyphenyl) phosphonium has been used as blocking reagent for 
obstructing the protonation site on N-terminus to investigate low-energy charge-remote PFPs 
in Asp-containing peptides176.  Another application of the N-terminal labeling reagents is de 
novo sequencing of peptides.  Noga et al.177 applied a 1:1 mixture of acetic anhydride and 
deuterated acetic anhydride to the peptide N-terminus and found it allows single and 
unambiguous identification of ions fitting in either y ion or b ion series, significantly 
simplifying peptide sequencing.  Munchbach et al.178 investigated the effect of N-terminal 
labeling of peptides with 1-(nicotinoyloxy) succinimide (Nic-NHS) esters and discovered 
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that the modification by highly basic nicotinyl group greatly increases the relative yield of 
the b-ions compared to the native peptide, therefore the modification facilitates de novo 
sequencing of full-length peptides. 
In this part, we focused on systematic studies of the fragmentation behavior of 
isocyanate modified peptides.  N-terminal modification of peptides with isocyanate, a highly 
reactive functional group, caught our attention for potential application with quantitative 
proteomics.  Isocyanates can react with various hydrogen donors such as amino179, 
sulfhydryl180, carboxyl179, and hydroxyl181 groups depending on the pH of solution.  Under 
neutral and basic condition, isocyanates can selectively react with amino and sulfhydryl 
groups.  Because of these unique chemical properties, it is possible to obtain quantitative 
reactions by optimizing reaction conditions. Thus isocyanates were evaluated as promising 
reagents for use in quantitative proteomics.  Mason et al.168 has proved the potential 
application value of isocyanates, they used phenyl isocyanate as a labeling reagent to modify 
N-terminal amino group of all peptides in proteolytic digests to study relative quantification 
of several styrene oxide adducts of human hemoglobin and reported 10000-fold linear 
dynamic range of quantification.  However, there have been no systematic studies of the 
fragmentation behavior of various isocyanate modified peptides.  The primary objective of 
our study is to investigate the low-energy collisionally induced dissociation of peptides 
labeled with a variety of isocyanates.  An understanding of fragmentation mechanisms will 
facilitate selection of appropriate isocyanate reagents to enhance quantitative proteomics 
applications.  
Experimental 
Materials 
Pyridine-3-isocyanate was obtained from Oakwood Products, Inc. (West Columbia, 
SC).  Phenyl isocyanate, phenethyl isocyanate and ammonium bicarbonate were acquired 
from Sigma-Aldrich Co. (St. Louis, MO).  Proteins including serum albumin (bovine), 
cytochrome c (horse), myoglobin, actin (bovine) and carbonic anhydrase were obtained from 
Sigma.  Sequencing grade modified trypsin was supplied from Promega (Madison, WI).  
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HPLC grade acetonitrile (ACN), HPLC grade water and formic acid were obtained from 
Fisher Scientific International Inc (Chicago, IL). 
N-terminal Labeling of Tryptic Peptides 
Proteins were digested with trypsin at a trypsin/protein ratio of 1:20(w/w) at 37°C 
overnight.  Separate N-terminal modification reactions were performed by mixing tryptic 
digests with 100 mM of the various isocyanates in ACN at a peptide/isocyanate molar ratio 
of 1:150 and incubating at 37°C for 1hour.  Reactions were terminated by adding 1µL of 
88% formic acid.  
LC-ESI-MS/MS Peptide Sequence 
A Finnigan LCQ ion trap mass spectrometer coupled with a Hewlett Packard HPLC 
system (1100 series) was used for LC-ESI-MS/MS analysis.  Unmodified tryptic peptides or 
N-terminal modified tryptic peptides obtained from protein mixture were injected into a 350 
um (I.D.) x15 cm laboratory fabricated fused silica capillary C18 column for 
chromatographic separation and analyzed by Finnigan LCQ.  The column was first 
equilibrated with 95% solvent A (0.1% formic acid in HPLC grade H2O) and 5% solvent B 
(0.1% formic acid in ACN) at a flow rate of 4µL/min.  After injection, the mobile phase 
composition was held at 95% solvent A, for 5 min, then was linearly changed from 95% to 
90% over 10 min.  For the next 90 min, a linear increase of solvent B was carried out to reach 
the composition of 55%.  Then solvent B was rapidly increased to 90% in 10 min and 
maintained at that concentration for additional 10 min.  In the following 10 min, the solvent 
A was changed back to 95% and held at 95% during the last 5 min. 
The mass spectrometer was operated in a data-dependent mode in which a full scan 
mass spectrum was followed by a tandem mass spectrum.  During the full MS acquisition, 
masses were scanned from 400 to 2000 m/z.  The most intense precursor ion was selected 
from the previous full MS scan to undergo CID with parameters of an activation Q of 0.250, 
activation time of 30 ms, and 35% normalized collision energy (NCE).  Once sampled, the 
precursor mass was placed in an exclusion list and no CID was performed on this mass for 
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the following 0.5 min. Both full scan and tandem MS spectra were collected by averaging 
five microscans.  
Unmodified tryptic peptide sequences were identified by using MASCOT server, 
which searched tandem mass spectra of unmodified peptides against the NCBInr protein 
sequence database. 
Results and Discussion 
Our study was based on the assumption that alterations in the isocyanate structure 
will change the fragmentation pattern of isocyanate modified peptides.  Systematic study of 
fragmentation of various isocyanates modified peptides will help explain the effect of 
isocyanate structure on CID fragmentation of modified peptides and will eventually lead to 
an appropriate isocyanate reagent for quantitative proteomics applications.  The study was 
carried out by choosing three isocyanates that have distinct structural characteristics.  Phenyl 
isocyanate (PIC) was previously reported for quantitative proteomics by Mason et al.168.  
They used PIC as an N-terminal labeling reagent to study relative quantification of several 
styrene oxide adducts.  Note that one distinct structural characteristic of PIC is the 
conjugation of an aromatic ring and isocyanate moiety, which may influence aspects of 
fragmentation.  In order to determine effects of conjugation, phenethyl isocyanate (PEIC) 
was also selected for study.  PEIC has an ethylene group between phenyl and isocyanate 
moiety in its structure, which serves as a spacer to break any conjugation between the two 
groups.  Finally, pyridine-3-isocyanate (PyIC) was selected since it has a similar structure to 
PIC in terms of electronic conjugation.  But unlike PIC and PEIC which are neutral species, 
PyIC is a basic isocyanate, which will enable us to determine the effect of basic groups on 
fragmentation behavior.   
Charge State Distribution Shifts 
During preliminary data collection of full scan mass spectra of PIC N-terminal 
modified peptides, we observed that for small peptides such as peptide AEFVEVTK, only 
singly charged ions appeared in full scan mass spectra.  For many peptides, doubly charged 
ions were observed in very low abundance or were not detected at all.  As a result, the data 
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dependent algorithm automatically selected singly charged ions as precursor ions for CID 
fragmentation, and no tandem spectra for doubly charged ions from those peptides were 
obtained. Based on the above observations, we conducted a thorough investigation of the 
electrospray ionization characteristics of the N-terminal modified peptides.  In this 
experiment, the charge state distribution of unmodified tryptic peptides and modified 
peptides with the model isocyanates were compared.  The charge state distribution of each 
peptide was evaluated based on average charge state (ACS), which was calculated as follows: 
∑
∑
=
=
∗
= N
i
i
N
i
ii
I
Iq
ACS
1
1                                                                           Eqn.3.2.1 
Where qi represents the ith charge state present in the mass range from 400 to 2000, Ii is the 
corresponding relative intensity and N is the number of observed charge states in the mass 
spectrum. Fourteen tryptic peptides from standard proteins including BSA, cytochrome c., 
myoglobin, actin and carbonic anhydrase were selected for this study and their sequences 
were listed in Table 3.2.1.  Based on the consideration of the maximum observed charge state 
of peptides obtained by ESI intimately correlated to the number of basic sites of peptide, 
peptides were classified as having two basic sites, one basic side chain and the N-terminal 
amino group, and peptides with three basic sites, caused by either one miss cleavage during 
trypsin digestion or histidine present in the peptides.  Each peptide was N-terminal labeled 
with PIC, PEIC and PyIC, respectively.  Full scan mass spectra of both unmodified and 
various modified peptides were obtained using LC-MS analysis.  Considering that various 
factors, such as elecrtrospray instrumental parameters182-184, solution pH values185, 186, and 
solvent composition187, have influences on the observed charged state distribution of analyte, 
all experiments were carried out with the same instrumental parameters and at the same pH.  
A possible issue that may affect some of the experimental results is solvent composition at 
the point of elution.  For most of the peptides, a slight change in hydrophobicity after PyIC 
modification resulted in the observed coelution of PyIC modified and unmodified peptides 
(listed in Table 3.2.1) by HPLC, therefore these pairs of peptides were ionized under 
identical electrospray conditions.  Conversely, modification of peptides with PIC or PEIC 
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significantly increased hydrophobicity of the peptides, thus PIC and PEIC modified peptides 
were observed to elute at higher concentrations of acetonitrile compared to corresponding 
unmodified peptides, which further leads to the increase of the observed ACSs for PIC and 
PEIC modified peptides187.     
Figure 3.2.1 shows a comparison of average charge states of unmodified and 
corresponding modified peptides with PyIC, PIC, and PEIC.  Not surprisingly, we found that 
N-terminal modifications with different isocyanates dramatically affected the charge state 
distribution of peptides when peptides with two basic sites were examined (Figure 3.2.1A).  
For N-terminal PyIC modification, peptide protonation was greatly enhanced compared to 
unmodified peptides.  Doubly charged modified peptides were observed to dominate the full 
scan MS spectra in almost every case.  Figure 3.2.1A shows that all PyIC modified peptides 
had ACS values of greater than 1.5; while most of ACSs from corresponding unmodified 
counterparts were less than 1.5.  In contrast, N-terminal PIC and PEIC modifications of the 
peptides significantly decreased average charge state values compared to unmodified 
counterparts.  ACS values for all PIC and PEIC modified peptides were close to 1.  As shown 
in Figure 3.2.1A, four peptides, VATVSLPR, YLYEIAR, VLDALDSIK and 
VGDANPALQK, with native peptide m/z 842, 927, 973 and 1012 respectively displayed 
significant decreases of protonation compared to corresponding unmodified peptides.  Singly 
charged ions were mainly produced in the full scan mass spectra of these peptides.  For the 
case of peptides MIFAGIK (m/z 779, +1) and LVTDLTK (m/z 789, +1), similar average 
charge state (ACS) values were obtained for unmodified, PIC and PEIC modified peptides.  
The reason for this observation is that doubly charged unmodified peptides were below low-
mass cutoff in full MS scan, consequently, the calculation of average charge states for 
unmodified peptides was only based on singly charged ions and produced ACS values of 1.  
It appears that modifications assisted by shifting masses of doubly charged ions to higher 
values and made it possible to detect doubly charged peptides with low m/z. 
For peptides with three basic sites (Figure 3.2.1B), doubly charged ions were 
observed to dominant in MS spectra and triply charged ions had relatively low contribution 
to charge state distribution.  Furthermore, it was found that N-terminal modification typically 
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Figure 3.2. 1:  Comparison of average charge states of unmodified tryptic peptides and 
modified peptides with PyIC, PIC and PEIC, respectively. The mass spectra for each 
unmodified and modified peptides were obtained by averaging five microscans during the 
full MS scan experiments.  
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Table 3.2. 1:  Sequences of selected peptides used for charge state distribution investigation 
Peptides with two basic sites Peptides with three basic sites 
Unmodified 
m/z, +1 sequence 
Unmodified 
m/z, +2 sequence 
779 MIFAGIK  454 MIFAGIKK 
789 LVTDLTK 584 TGPNLHGLFGR 
842 VATVSLPR 602 VLDALDSIKTK  
922 AEFVEVTK 681 ALELFRNDIAAK  
927 YLYEIAR 690 HGTVVLTALGGILK 
973 VLDALDSIK 803 VEADIAGHGQEVLIR 
1012 VGDANPALQK 847 AEFVEVTKLVTDLTK 
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affected triply charged ions of the modified peptides in full mass spectra.  Therefore, 
modifications with different isocyanates had relatively less effect on the charge state 
distribution of the modified peptides compared to peptides with two basic sides.  N-terminal 
modification with PIC and PEIC was observed to slightly decrease average charge state 
values.  For small peptides like peptide MIFAGIKK (m/z 454, +2) shown in Figure 3.2.1B, 
triply charged ions of both unmodified and modified were below the detection mass range.  
Average charge states were calculated only based on singly and doubly charged ions.  As a 
result, no significant difference between unmodified and various modified peptides was 
observed.  For other peptides such as peptide TGPNLHGLFGR (m/z 584, +2), the triply 
charged ion of unmodified peptide was not observed in mass spectrum due to its low mass.  
Not surprisingly, the average charge state value of unmodified peptide was the lowest 
compared to all corresponding modified peptides. 
In short, PyIC maintained and in some cases even increased the protonation of 
modified peptides compared to unmodified peptides.  Doubly charged ions dominated in full 
scan spectra.  In contrast, PEIC and PIC shifted the peptide charge state distributions to lower 
values. A possible explanation is that during the ESI process, peptides can be protonated at 
various sites including N-terminal amino group, side chain groups and amides188.  Of all 
those protonation sites, basic side chains, such as arginine, lysine, and histidine, and the N-
terminal amino group are more easily protonated. Modification of peptides N-terminus by 
neutral reagents like PIC or PEIC removed one protonation site of the peptides and directly 
led to a significant decrease of maximum charged state values. The replacement of PIC with 
PyIC increased the basicity of the N-terminus of modified peptide, which compensated for 
the lost of one basic site caused by turning N-terminal amino group into a urea bond.  In 
addition, the charge delocalization on the pyridine aromatic ring stabilized the protonated N-
terminus to some extent, therefore increased the protonation of PyIC labeled peptides 
compared to unmodified peptides especially for peptides with two basic sites.  The charge 
state for PIC or PEIC modified peptides primarily depended on the sequence of the peptides.  
Singly charged ion had the highest intensity in full scan MS spectrum for peptides with two 
basic sites, while doubly charged ion dominated for peptides with three basic sites.  When 
comparing PEIC with PIC modified peptides, similar charge state distributions for all cases 
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were found, which was consistent with the discussion motioned above.  Since multiply 
charged peptides fragment in more facile manor and give higher yields of product ions than  
singly charged forms of the same peptides189, and given that N-terminal modified peptides 
fragment in a similar way as unmodified pepetides, then theoretically, PyIC should be a 
better N-terminal modification reagent than PEIC and PIC.  
Fragmentation Characteristics of N-terminal Labeled Tryptic Peptides with Various 
Isocyanates using LC-ESI-MS/MS 
As discussed in Chapter 3.1, isocyanates react with the N-terminal amino group of a 
peptide to form a urea derivative.  To investigate the low-energy collision-induced 
dissociation characteristics of the modified peptides, all tryptic peptides from standard 
proteins were N-terminal modified with PIC, PEIC and PyIC, respectively.  A total of 72 
tandem mass spectra from singly charged peptides and 81 tandem spectra from doubly 
charged peptides were collected and compared.  We found that one striking characteristic of 
the fragmentation of N-terminal isocyanate modified peptide was the dominance of two 
product ions in the tandem spectrum.  A scheme of fragmentation of N-terminal isocyanate 
modified peptides is shown in Figure 3.2.2B.  One of the two main product ions resulted 
from the cleavage at site 1 (labeled in Figure 3.2.2B) and the loss of the intact isocyanate 
returning the native form of the peptide [M+H]+ or [M+2H]2+ (Figure 3.2.2B).  The other 
major product ion resulted from the cleavage at site 2 (labeled in Figure 3.2.2B) and the loss 
of the aryl portion of the isocyanate returning a peptide isocyanate [M+26+H]+ or 
[M+26+2H]2+, depending on the charge of the precursor ion.  When singly charged modified 
peptides were subjected to CID, two singly charged product ions were observed that 
dominated the spectrum. In the same manner, peaks corresponding to doubly charged form of 
both product ions were most intense in MS/MS spectra from doubly charged modified 
peptides.  Given that both dominant product ions resulted from cleavage of the urea bond in 
the labeled peptide, the urea bonds are thought to be more fragile than the peptide amide 
bonds such that only low abundance b and y ions were observed.  In order to inspect the 
characteristics of the fragmentation of modified peptide with various isocyanates in more 
detail, two concepts, Net Fragmentation Efficiency (NFE) and the ratio of two major 
products ion intensities (RN/I), were defined as 
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Figure 3.2. 2: (A) Structures of isocyanates employed in the study. (B). Scheme of 
fragmentation characteristic of N-terminal modified peptide by various isocyanates. 
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Where ΣII represented the total fragment ion intensity, IM* was native peptide ion intensity 
and IM** was isocyanate-form ion intensity.  Figure 3.2.2 shows the scheme of fragmentation 
Characteristic of N-terminal modified peptide by isocyanates as well as the structures of M* 
and M**.  Since the formation of native and isocyanate-form fragments directly suppressed 
the production of other sequencing useful fragments, NFE was used to measure the ion yield 
of fragments that were useful for obtaining sequence information of peptide.  The higher the 
value of NFE obtained, the more number or the higher relative intensities of useful fragments 
for peptide sequencing was acquired in tandem spectra.  The other concept, RN/I, was 
designed to monitor the cleavage preference between site 1 and site 2 (labeled in Figure 
3.2.2B), as N-terminal modified peptide with various isocyanates was subjected to CID 
fragmentation.  For instance, when a higher RN/I was obtained, the native peptide form of 
product ion dominated the tandem spectra, which implied that the modified peptide was more 
prone to cleaved at site 1 as labeled in Figure 3.2.2B. 
As can be seen from the previous experiment, singly charged ions were 
predominantly produced in mass spectra during ESI of peptides with two basic sites modified 
by PIC or PEIC, while doubly charged ions dominated the full scan mass spectra when 
peptides with three basic sites were electrospray ionized.  Understanding the fragmentation 
of both types of peptides by low-energy CID is critical for the quantification application in 
proteomics.  A total of 38 peptides were chosen for this study and they were classified into 2 
categories: peptides with two basic sites and peptides with three basic sites as described in 
‘charge state distribution’ experiments.  All 38 peptides were used to react with all three 
isocyanates, respectively.  Twenty peptides with two basic sites out of 38 peptides were 
chosen for investigation of fragmentation of singly charged precursor ions.  Tandem 
spectrum of each singly charged peptide was acquired for comparison between unmodified, 
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PIC, PEIC and PyIC modified peptides additionally, the remaining eighteen peptides with 
three basic sites were selected to investigate fragmentation of doubly charged peptides 
modified by PIC, PEIC and PyIC, correspondingly.  The sequences of those peptides were 
listed in table 3.2.2.  NFE values and RN/I data of all modified peptides were calculated, and 
the consequent results were displayed in Figure 3.2.3.  In order to easily present RN/I data, 
mass to charge ratios of the unmodified peptides were shown on the abscissa and the natural 
logarithm of RN/I values were given on the ordinate in Figure 3.2.3B.  Since RN/I was defined 
as the ratio of native peptide ion intensity to isocyanate-form ion intensity, Ln(RN/I) indicated 
the probability of the cleavages on site 1 and site 2 labeled in Figure 3.2.2B.  Value zero of 
Ln(RN/I) showed that the modified peptide statistically cleaved at both site 1 and site 2.  
Positive value represented that cleavage was more prone to occur at site 1, while negative 
value displayed the preference of cleavage at site 2.   
The Impact of the Structure of Isocyanates on Fragmentation of N-terminal Modified 
Peptides 
A significant effect of the isocyanate structure on the fragmentation pattern of 
modified peptides is shown in Figure 3.2.3.  Among the three isocyanate modified peptides, 
PIC modified peptides were observed to have relatively high net fragmentation efficiencies: 
74 percent of PIC modified peptides obtained the highest NFE values in contrast with 
corresponding PEIC and PyIC modified peptides.  Thus PIC modified peptides produced 
more sequence fragments and were more appropriate for quantitative proteomics than PyIC 
and PEIC.  In Figure 3.2.3B, the Ln(RN/I) values achieved from PIC modified peptides 
constantly lie in the middle compared to the corresponding values obtained from the other 
two isocyanate modified peptides.  This indicated that the two C-N bonds in urea of PIC 
modified peptides seemed to have relatively similar bond strengths and could be cleaved at 
both sites to form both native peptide and isocyanate-form fragments. 
A structural characteristic unique to PEIC is insertion of the aliphatic spacer between 
the aromatic ring and isocyanate moiety, which breaks the conjugation between the two 
groups.  The effect of PEIC structure on the fragmentation of modified peptides is also  
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Table 3.2. 2:  The sequences of peptides used for the study of fragmentation of modified 
peptides. 
 
Unmodified 
m/z, +1 Peptide sequence 
Unmodified 
m/z, +2 Peptide sequence 
644 GILTLK 437 HGLDNYR 
660 TPVSEK 454 MIFAGIKK 
678 YIPGTK 584 TGPNLHGLFGR 
779 MIFAGIK 602 VLDALDSIKTK 
789 LVTDLTK 636 LFTGHPETLEK 
842 VATVSLPR 653 HLVDEPQNLIK 
922 AEFVEVTK 676 TEREDLIAYLK 
927 YLYEIAR 681 ALELFRNDIAAK 
973 VLDALDSIK 690 HGTVVLTALGGILK 
980 DGPLTGTYR 720 RHPEYAVSVLLR 
909 DLTDYLMK 752 HPGNFGADAQGAMTK 
1003 QSPVNIDTK 791 YAAELHLVHWNTK 
1012 VGDANPALQK 803 VEADIAGHGQEVLIR 
1019 DFPIANGER 813 EETLMEYLENPKK 
1045 GTDVQAWIR 820 KVPQVSTPTLVEVSR 
1130 GYSFVTTAER 847 AEFVEVTKLVTDLTK 
1147 EPISVSSQQMLK 978 VAPEEHPTLLTEAPLNPK 
1429 FESNFNTQATNR 1100 AVVQDPALKPLALVYGEATSR 
1471 TGQAPGFTYTDANK   
1495 EETLMEYLENPK     
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shown in Figure 3.2.3.  Compared to PIC modified peptides, 90% of PEIC modified peptides 
had lower NFE values regardless of charge of the precursor ion.  However, when compared 
to PyIC modified peptides,  the result for singly charged peptides was different from that for 
doubly charged.  For singly charged peptides, PyIC modified peptides were inclined to 
generate more sequence fragments than corresponding PEIC modified peptides.  Conversely, 
in doubly charged cases, PEIC modified peptides were more likely to have higher NFE 
values than PyIC.  Figure 3.2.3B revealed that PEIC modified peptides had the lowest 
Ln(RN/I) among the three isocyanates, which implied PEIC modified peptides were prone to 
generate isocyanate-form peptide fragments by cleaving at site 2 (labeled in Figure 3.2.2). 
PyIC, which has similar structure as PIC except introduction of nitrogen on aromatic 
ring, was expected to have a similar effect on the fragmentation pattern of modified peptides 
as PIC.  And since PyIC modified peptides can easily form multiply charged ions during ESI, 
multiply charged PyIC modified peptides were expected to have even better fragmentation 
than PIC and PEIC.  Surprisingly, the net fragmentation efficiencies of PyIC modified 
peptides were low comparied to PIC and PEIC modified peptides, which meant that fewer 
sequence fragments were obtained when PyIC modified peptides were subjected to CID 
fragmentation.  In all cases, the most intensive peak in tandem spectra was observed to be the 
native peptide product ion, leading to the highest Ln(RN/I) values obtained in comparison to 
the corresponding PIC and PEIC modified peptides (Figure 3.2.3B). As mentioned before, 
the native peptide product ion was formed by cleaving at site 1 on the urea bond.  Therefore, 
PyIC modified peptides were prone to cleave at site 1 instead of site 2 (Figure 3.2.2B).     
A possible explanation for this fragmentation behavior of various isocyanate modified 
peptides is that for PIC modified peptides, conjugation of the aromatic ring with urea bonds 
may stabilize both of the two urea bonds, which led to relatively high NFEs compared to 
PEIC and PyIC modified peptides.  For PyIC modified peptides, due to the basicity of 
pyridine ring, the infused nitrogen could be protonated during the ESI process. The 
population of protonated and unprotonated pyridine on N-terminus of the modified peptides 
depends on the gas-phase basicities of the different protonation sites of the peptides. 
However, even for PyIC modified peptides with unprotonated N-terminus, due to the strong 
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π electron-withdrawing effect of the infused nitrogen in pyridine190 and the conjugation of 
pyridine ring with urea bonds, pyridine weakened both urea bonds, especially urea bond on 
site 1. Furthermore, the electron-withdrawing effect of the pyridine group increased when the 
pyridine nitrogen was protonated during the ESI process, causing more pronounced 
weakening of the two urea bonds. Therefore, PyIC modified peptides had relatively low 
NFEs compared to PIC and PEIC modified peptides during CID and the dominance of the 
native peptide fragment in spectrum.  While considering the feature of PEIC structure, the 
lack of conjugation between aromatic ring and two urea bonds caused the two urea bonds 
more unstable compared to PIC.  Consequently, PEIC modified peptides had relatively low 
NFEs compared to PIC and had the preference of producing isocyanate-form fragments to 
native peptide fragment. 
The Influence of Peptide Sequence on Fragmentation of N-terminal Isocyanate 
Modified Peptides 
In addition to the isocyanate structure, Figure 3.2.3 clearly shows the amino acid 
composition of peptide was intimately related to both net fragmentation efficiency and the 
preference of cleavage site of urea bonds.  In Figure 3.2.3A, it was observed that fragments 
derived from the cleavage of peptide bonds were suppressed to some extent regardless of 
isocyanate modified peptide charge state.  Among 114 NFE values presented in Figure 3.2.3, 
the highest NFE was 88% and the lowest was only 5% which yielded an average NFE value 
of 40.83%.  The low NFE values indicated that isocyanate modified peptides produced 
relatively few useful fragments compared with unmodified peptides.  As a result, labeling 
peptides with isocyanates can limit identification of peptides and corresponding proteins. The 
basicity of basic sites that peptides contained in their sequences seemed to play an important 
role on NFE values.  Eleven investigated peptides have arginine and but no lysine, and 
relatively low NFEs were obtained from those peptides (Table 3.2.2).  Among all arginine 
containing isocyanate modified peptides, 72% had NFEs lower than the average NFE value.  
Conversely, Lys-containing modified peptides were more likely to obtain high NFE values 
compared to Arg-containing peptides, where 56% of lysine containing modified peptides had 
NFE values higher than the average.  This observation could be explained in terms of the 
“mobile proton” model166, 167.  In brief, a proton migrates from the original  
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Figure 3.2. 3:  Net fragmentation efficiency values (A) and Ln(RN/I) (B) of singly charged 
(shown in  the left) and doubly charged (shown in the right of the figure) modified peptides 
by PyIC, PIC and PEIC. The tandem mass spectra for each modified peptides were obtained 
by averaging five microscans during the MS/MS experiments. 
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protonated site to the amide nitrogen, triggering the cleavage of amide bonds and generating 
a series of bn and yn ions. The energy needed for proton migration relied on the amino acid 
composition of the peptide.  For instance, arginine-containing peptides need the highest 
energy to migrate a proton; peptides without basic amino acid require the least; and lysine-
containing peptides sit about in the middle. Based on the “mobile proton” model, we can 
rationalize that the urea bonds of isocyanate modified peptides are so weak that cleavage of 
the urea bond could be achieved via charge-remote fragmentation at much lower energy than 
that is required for charge-directed fragmentation by migrating a proton from lysine or 
arginine.  Consequently, two product ions (native form and peptide isocyanate) dominate the 
MS/MS spectrum.  Relatively high NFE values were observed in lysine-containing peptides, 
because less energy is needed than arginine-containing peptides. 
Similar to net fragmentation efficiency, the peptide sequence also significantly 
influenced the preference of cleavage of the two urea bonds and the relative intensities of 
resultant native form and peptide isocyanate product ions.  In Figure 3.2.3B, Ln(RN/I) values 
for peptides modified by PyIC, PIC and PEIC were observed to vary from 6.31 to 0.06, from 
1.98 to -1.45 and from 0.62 to -3.25, respectively.  A five-hundred-fold difference was 
observed between the maximal and the minimal RN/I value in PyIC modified peptides, which 
indicated the strong effect of peptide sequences on bond strength of the two urea bonds. 
Potential Application on De Novo Peptide Sequencing  
Since fragmentation patterns of singly charged precursor ions and those of doubly 
charged precursor ions are quiet different, the effect of charge on fragmentation of those 
precursor ions will be discussed individually. 
Figure 3.2.4 gave four examples of the comparison of tandem spectra obtained from 
singly charged precursor ions of unmodified peptide (a) and modified peptide by PIC (b), 
PyIC (c) and PEIC (d).  All singly charged precursor ions of the peptides of interest were 
selected to perform CID fragmentation.  It was observed that in addition to the two 
characteristic product ions (native peptide ion and isocyanate-form ion), the cleavage patterns 
of unmodified peptides were strikingly different from those of isocyanates modified peptides.  
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The isocyanate modified peptides were observed to produce a limited number of fragment 
ions by low-energy CID compared to unmodified peptides. In some cases, the b-ion series 
can be easily identified and provide complete sequence coverage of the peptides.  For 
example, a peptide EDLIAYLK was modified with all isocyanates.  The tandem spectrum of 
the unmodified peptide is shown in Figure 3.2.4A (a).  It was observed that b ions were 
absent or of low abundance which was in good agreement with the characteristic 
fragmentation of peptides with an N-terminal glutamic acid189.  However, Figure 3.2.4A (b to 
d) showed that the modified peptides with various isocyanates were able to form both yn and 
bn ions.  In addition, the relative intensities of entire generated b-ion series were significantly 
enhanced in all spectra of modified peptide compared to unmodified peptides.  The complete 
sequence of this peptide can be easily and rapidly extracted using the modification of 
isocyanates.  Interestingly, it was found in Figure 3.2.4D that tandem spectra of different 
isocyanates modified peptide (AEFVEVTK) exhibited tremendous differences.  
Fragmentation of PIC modified peptide was shown in Figure 3.2.4D (b), where b-ion series 
were observed dominating the MS/MS spectrum.  Due to the limited mass range of the ion 
trap, b1 and b2 ions were absent in the spectrum.  In contrast, both y and b ion series were to a 
certain extent suppressed for PEIC and PyIC modified peptides (Figure 3.2.4D (c), (d)).  
Consequently, we believed that PIC is a better N-terminal labeling reagent for application in 
de novo peptide sequencing than PyIC and PEIC.  One problem we discovered was that some 
modified peptides produced very low intensities of either yn or bn ion series no matter which 
isocyanates were used.  For example, Figure 4C shows tandem spectra of peptide 
DLTDYLMK, entire b-ion and y-ion series were in very low intensities. 
Figure 3.2.5 showed six examples of comparing tandem spectra obtained from doubly 
charged precursor ions of unmodified peptide (a) and modified peptide by PIC (b), PyIC (c) 
and PEIC (d).  The most distinguishing feature is the detection of b1 ions in almost every case 
when N-terminal PIC and PEIC modified peptides were subjected to CID.  Those b1 ions 
were labeled with bold characters in Figure 3.2.5.  The limited MS/MS mass range of the ion 
trap usually precluded the collection of an entire fragment series, especially low mass 
fragments.  Adding the isocyanate on the N-terminal shifts the entire b-ion series to higher 
mass range, making the detection of low mass fragments feasible.  The combined use of 
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unmodified and N-terminal PIC or PEIC modified peptide should prove useful in de novo 
sequencing of peptides.  The other feature observed from Figure 3.2.5 was that PyIC 
modified peptides produced less fragments with very low relative intensities compared to 
PIC and PEIC modified peptides.  Furthermore, PyIC modified peptides were more likely to 
produce b-T ions (b ions which lost the N-terminal isocyanate derivative tag) compared to 
PIC and PEIC modified peptides.  That may be because the urea bonds in PyIC modified 
peptides are unstable during CID.  Fragments assigned to b-T ions were observed in 4 
peptides in Figure 3.2.5.  Similar to singly charge modified peptides, another important factor 
that also affected the fragmentation pattern of modified peptides was the basic site in 
peptides.  For example, Figure 3.2.5 shows three peptides (Figure 3.2.5A, C, D), which had 
either two lysines or one lysine and one histidine in their sequences, and peptide 
TGPNLHGLFGR (Figure 3.2.5B), which had one arginine and one histidine in its sequence.  
It could be seen from these tandem spectra that modified peptide with arginine in the 
sequence had less fragments compared to peptides with lysine in the sequences.  Figure 
3.2.5E and Figure 3.2.5F showed tandem spectra of doubly charged modified peptides with 
one basic amino acid in the sequences.  These peptides could easily acquire one positive 
charge via protonation of the basic residue.  However, the second charge for doubly charged 
modified peptides had to be obtained by protonating a non-basic site of the peptide because 
of the block of N-terminal amino group.  It can be easily seen from Figure 3.2.5E and Figure 
3.2.5F that when modified by PIC or PEIC, these peptides produced spectacularly low 
relative-intensities of native peptide and isocyanate-form fragments.  In Figure 3.2.5E (b) and 
(d), the two fragments did not even appear in the spectrum. Meanwhile, fragments derived 
from the cleavages of amide bonds dominated the spectra.  The unusually high net 
fragmentation efficiency results from the highly active proton obtained during protonation of 
peptide. Less energy was required to mobilize the active proton along the backbone of the 
peptide and perform charge-directed fragmentation than that is required to activate the 
cleavage of the urea bonds in modified peptides.  Moreover, PIC and PEIC modification also 
produced new b ions or y ions that were not apparent in unmodified peptide tandem spectra 
(labeled with bold characters), which may facilitate de novo peptide sequencing. 
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The Effect of N-terminal Modification on Peptide Identification 
The above discussion indicated that PIC modified peptides produced the best 
fragmentation, while PyIC modified peptides formed the fewest fragments useful for peptide 
sequencing during CID.  Based on these results, PIC and PyIC were chosen to study the 
effect of N-terminal modification on peptide identification.  Myoglobin tryptic peptides were 
N-terminal labeled with PIC and PyIC as described in the experimental section.  Both 
unmodified and various isocyanate modified peptides were mixed at a ratio of 1 and 
subjected to CID. 
The resulting MS/MS data were used to search against NCBInr database using the 
Mascot algorithm, in which PIC and PyIC N-terminal modification was added to the 
modification list by putting masses of those reagents into the Unimod database.  Similar 
protein sequence coverage was obtained for unmodified and PIC modified protein digest 
when “PIC N-term” was chosen as variable modification in Mascot parameter.  The PyIC 
modification had much lower sequence coverage when obtained MS/MS data were analyzed 
using Mascot with parameter variable modifications set as “PyIC N-term”.  For example, 
protein sequence coverage of myoglobin reached 73% for PIC modification but only 62% for 
PyIC modification.  Moreover, identified peptides from both modifications did not 
completely overlap.  Several peptides identified for PIC modification were small peptides 
with molecular weight less than 800.  Because of the small size of those peptides, which were 
less than 7 amino acids, the number of fragments generated from CID was not enough to 
prevent false positive peptide identification191.  Probably because of the poor quality of the 
tandem mass spectra, those peptides were not in the sequenced peptide list for PyIC 
modification.  It seemed that PIC modification had difficulty in identification of large 
peptides with few basic sites.  Therefore, PIC may not be suitable for quantitative application 
of hydrophobic proteins, such as membrane proteins, which contain a few basic amino acids 
and produce large peptides by tryptic digestion.  Large peptides such as peptide m/z 1175 
(+3) were found sequenced when PyIC was used as labeling reagent. 
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Figure 3.2. 4:  Typical ESI ion trap MS/MS spectra of singly charged precursor ions of 
unmodified peptide (a), and N-terminal modified by PIC (b), PyIC (c) and PEIC (d).  Four 
peptides (A-D) with sequence labeled were shown in this Figure.  In each spectrum, bn and 
yn ions are labeled and bn ions are highlighted.  b-T ion represents b ion which lost the N-
terminal isocyanate derivative tag.  M* refers to the native form of the product ion and M** 
means Isocyanate peptide product ion. M0 represents the native form of the product ion that 
lost a water molecule. 
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Figure 3.2. 5 : Typical ESI ion trap MS/MS spectra of doubly charged precursor ions of 
unmodified peptide (a), and N-terminal modified by PIC (b), PyIC (c) and PEIC (d).  Four 
peptides (A-D) with sequence labeled were shown in this Figure.  In each spectrum, bn and 
yn ions are labeled. New b ions or y ions that were not apparent in unmodified peptide 
tandem spectra are highlighted.  b-T ion represents b ion which lost the N-terminal 
isocyanate derivative tag.  M* refers to the native form of the product ion and M** means 
Isocyanate peptide product ion. M0 represents the native form of the product ion that lost a 
water molecule. 
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Conclusion 
In this study, we systematically studied both ESI characteristics and the fragmentation 
pattern of N-terminal modified peptides with three typical isocyanates: PIC, PEIC and PyIC, 
which represented aromatic neutral, aliphatic neutral and aromatic basic isocyanate, 
respectively.  We observed that isocyanate modification had effects on charge state 
distribution of the peptides during ESI process.  PIC and PEIC modification was found to 
severely decrease the protonation of modified peptides, while PyIC modification maintained 
and in some cases increased the protonation compared to unmodified counterparts.  A 
fragmentation study of each reagent modified peptides was carried out by comparison of 
NFE and Ln(RN/I) values.  In our experiments, PIC modified peptides produced the most 
sequence product ions and had tendency to cleave at both urea bonds.  Conversely, PyIC 
modified peptides produced relatively fewer sequence product ions and were prone to cleave 
at site 1 of the urea bonds.  Compared to PyIC, PIC modification was better for protein 
identification.  One positive feature of the N-terminal modification by isocyanates was 
shifting bn series ions to higher mass ranges and making b1 ion detectable in tandem MS.  
Therefore N-terminal isocyanate modification has potential for enhancing de novo peptide 
sequencing.  Future efforts will be focused on designing new isocyanate reagent to 
overcome, or at least minimize limitation of both PIC and PyIC.  That is, modified peptides 
by this reagent should have higher charge state distribution during ESI and produce more 
abundant sequence product ions by CID fragmentation. 
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Chapter 3.3 
Fragmentation of N-terminal Modified Tryptic Peptides by 3-(Isocyanatomethyl) 
Pyridine using Low-energy Collision-Induced Dissociation CID 
Introduction 
Our previous works showed that the adjustment of isocyanate structure changes both 
ESI characteristic and the fragmentation pattern of isocyanate modified peptides.  Phenyl 
isocyanate (PIC), phenethyl isocyanate (PEIC) and pyridine-3-isocyanate (PyIC) were 
chosen to carry out the investigation.  PIC and PEIC modifications were found to severely 
decrease the protonation of modified peptides during the ESI process, even though PIC 
modified peptides produced the most sequence product ions by CID. On the other hand, PyIC 
modification maintained and in some cases increased the protonation compared to 
unmodified counterparts.  However, PyIC modified peptides produced the fewest sequence 
product ions among the three isocyanate modified peptides when subjected to CID.  We 
rationalized that the decrease of protonation of PIC and PEIC modified peptides results from 
the neutral property of the both reagents.  In addition, the structural characteristics of PyIC, 
which were depicted as both electron-withdrawing feature of protonated PyIC and the 
conjugation of pyridine ring with urea bonds once reacted with amino group, causes the 
significant reduction of fragments when PyIC modified peptides were subject to CID. 
To expand upon these prior studies, we designed a new isocyanate reagent called 3-
(isocyanatomethyl) pyridine (PyMIC) (Scheme 3.3.1), which had the same compound 
structure as PyIC except a methyl group was introduced between the pyridine ring and the 
isoyanate group. The methyl group was expected to act as a spacer to eliminate or at least 
weaken the effect of electron-withdrawing feature of protonated pyridine ring on the two 
urea bonds when reacted with amino group. In this study, we investigated the effect of the 
PyMIC structure on peptide protonation and fragmentation pattern by comparing PyMIC 
modified peptides with PIC and PyIC modified peptides.  The results revealed that PyMIC is 
a more appropriate reagent for quantitative proteomics applications compared to PIC and 
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PyIC. In addition, to further characterize the fragmentation behavior of PyMIC modified 
peptides, we have compared the tandem mass spectra for PyMIC modified and unmodified 
tryptic peptides originating from standard proteins. Based on the results we obtained, the 
application of PyMIC modification on de novo peptide sequencing is also discussed.  
Experimental 
Materials 
Pyridine-3-isocyanate was obtained from Oakwood Products, Inc. (West Columbia, 
SC).  Phenyl isocyanate was acquired from Sigma-Aldrich Co. (St. Louis, MO).  Proteins 
including serum albumin (bovine), cytochrome c (horse), myoglobin, actin (bovine) and 
carbonic anhydrase came from Sigma.  Ammonium bicarbonate, Diphenylphosphoryl azide, 
1,8-Diaminonaphthalene and 2-(pyridin-3-yl) acetic acid hydrochloride were purchaseed 
from Sigma.   Sequencing grade modified trypsin was supplied from Promega (Madison, 
WI).  Tetrahydrofuran (THF), triethylamine, HPLC grade acetonitrile (ACN), HPLC grade 
water and formic acid were obtained from Fisher Scientific International Inc. (Chicago, IL).  
The Synthesis of 2-(Pyridin-3-yl) Acetyl Azide (by Rong Hua Lu) 
To a suspension of 2-(pyridin-3-yl) acetic acid hydrochloride (160 mg, 0.92 mmol) in 
10 mL dry THF was added diphenylphosphoryl azide (DPPA) (0.22 mL, 1.0 mmol) on ice.  
Triethylamine (0.2 mL, 1.42 mmol) was then added. After 2 h, the mixture was concentrated 
under reduced pressure and the product was purified by flash chromatography (mobile phase: 
50% ethyl acetate in 50% petro ether).  Removal of the solvent under reduced pressure gave 
60 mg (40% yields) of 2-(pyridin-3-yl) acetyl azide as colorless oil.  
The Synthesis of 3-(Isocyanatomethyl) Pyridine (PyMIC) (by Rong Hua Lu) 
2-(pyridin-3-yl) acetyl azide (20.0 mg) was dissolved in 0.5 mL benzene and heated 
to 60°C for 3 hours.  Before the heating and after the heating, the 1H NMR were taken. The 
spectra showed the reaction went very well.  All the starting materials were changed to the 
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product, no other byproducts formed.  The synthesis of 3-(isocyanatomethyl) pyridine 
(PyMIC) was shown in scheme 1. 
N-terminal Labeling of Tryptic Peptides 
Proteins including BSA, cytochrome c, myoglobin, actin and carbonic anhydrase 
were digested with trypsin at a trypsin/protein ratio of 1:20(w/w) at 37°C overnight.  The 
resultant tryptic digest was diluted with the same volume of ACN.  N-terminal modification 
reactions were performed by mixing tryptic digests with 100 mM of 3-(isocyanatomethyl) 
pyridine (PyMIC) in benzene at a peptide/isocyanate molar ratio of 1:150 and incubating at 
37°C for 1hour.  Solvent was removed by speedvac.  PyMIC modified peptides were 
dissolved in 0.1% formic acid for following analysis.  PIC and PyIC modification was 
performed as previously described. Tryptic digests were mixed with 100 mM of PIC or PyIC 
in ACN at a peptide/isocyanate molar ratio of 1:150 and were incubated at 37°C for 1hour.  
Reaction was terminated by adding 1µL of 88% formic acid.  
LC-ESI-MS/MS Peptide Sequence 
LC-ESI-MS/MS analysis was performed using a Hewlett Packard HPLC system 
(1100 series) coupled with a Finnigan LCQ ion trap mass spectrometer.  The reversed-phase 
capillary HPLC column was laboratory fabricated by packing 5-µm C18 packing material 
(macrosphere particle size: 300Å, Alltech Inc., Deerfield, IL) into a 350 um (I.D.) fused 
silica capillary tubing and the final C18 column length was 15cm. The mobile phase 
consisted of solvent B (0.1% formic acid in ACN), and solvent A (0.1% formic acid in HPLC 
grade H2O).  The column was first equilibrated with 95% solvent A and 5% solvent B at a 
flow rate of 4µL/min.  Once the sample was loaded onto the column, the mobile phase 
composition was kept at 95% solvent A for 5 min, then was linearly changed from 95% to 
90% over 10 min.  Another linear gradient from 90%A to 45%A was performed in the next 
90 min.  Then solvent A was rapidly decreased to 10% in 10 min and kept the concentration 
for additional 10 min.  In the following 10 min, the solvent A was increased back to 95% and 
held at 95% during the last 5 min. 
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A data-dependent acquisition was employed for ms full scan and the selection of 
precursor ions for the following tandem mass scan.  The mass range of full MS acquisition 
was set from 400 to 2000 m/z.  The most intensive precursor ion was selected from the 
previous full MS scan to undergo collision induced dissociation (CID).  Once sampled, the 
precursor mass was put on exclusion list and no CID was performed on this mass for the 
following 0.5min.  In all experiments, the parameters of collision induced dissociation (CID) 
were set as follows: an activation Q of 0.250, activation time of 30 ms, and 35% normalized 
collision energy (NCE).   
Unmodified and isoyanate modified tryptic peptide sequences were identified by 
using the in-house licensed MASCOT server, which searched tandem mass spectra of 
unmodified or modified peptides against the NCBInr protein sequence database. 
Results and Discussion 
Fragmentation Characteristics of PyMIC Modified Peptides 
The effect of PyMIC modification on the fragmentation of tryptic peptides was 
investigated by LC-ESI-MS/MS.  As indicated in scheme3.3.1, isocyanates react with the N-
terminal amino group of a peptide to form a urea derivative.  Previous work showed that one 
striking characteristic of the fragmentation of N-terminal isocyanate modified peptide was 
the dominance of two product ions in the tandem spectrum.  One of the two product ions 
resulted from the cleavage at site 1 (labeled in scheme 3.3.1) and the loss of the intact 
isocyanate returning the native form of the peptide yn (scheme 3.3.1).  The other major 
product ion resulted from cleavage at site 2 (labeled in scheme 3.3.1) and the loss of the aryl 
portion of the isocyanate returning a peptide isocyanate M**.  The preference of cleavage at 
the two sites depended on the structure of isocyanate employed.  For example, phenylethanyl 
isocyanate modified peptides are prone to cleave at site 2 while 3-pyridyl isocyanate 
modified peptides incline to cleave at site 1.  In order to investigate the characteristics of 
fragmentation of PyMIC modified peptides, tryptic peptides from BSA, cytochrome C, actin 
and myoglobin were reacted with PyMIC as described in experimental section.  The resultant 
modified peptides were subjected to LCQ for MS/MS analysis. Figure 3.3.1 shows typical 
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tandem spectra of four doubly charged PyMIC modified peptides (a-d). We found that 
similar to 3-pyridyl isocyanate, PyMIC modified peptides were observed to primarily cleave 
at site 1 (labeled in bold line scheme 3.3.1) to produce yn fragment.    In Figure 3.3.1, these yn 
and M** ions are labeled with bold characters.  It was observed that all presented spectra 
showed relatively high intensities of yn ions.  While M** ions produced from cleavage at site 
2 were also present in tandem spectra, but the intensity of M** ions were tremendously low 
compared to yn ions. In some cases, M** ion was not able to be detected.  The predominant 
yn ion was either singly charged or doubly charged depending on investigated peptide 
sequence. Predominantly singly charged yn ions appeared in Figure 3.3.1a, b, and d whereas 
double charged yn were dominant in Figure 3.3.1c.  Another striking characteristic of 
fragmentation of PyMIC modified peptides is that a mass tag with m/z 135, derived from 
PyMIC portion during cleavage at the site 1 (scheme3.3.1), was observed in the tandem 
spectrum of PyMIC modified peptide.  In Figure 3.3.1, the mass tags present in all four 
spectra were labeled as “T” in bold.  Among all identified PyMIC modified peptides in the 
experiment, fifteen of PyMIC modified peptides had molecular weight lower than 980, all 
spectra of those peptides were observed m/z 135 mass tag.  While the mass tag was not 
detected in the tandem spectra for the remaining peptides with MW higher than 980 due to 
the limited mass range of quadruple ion trap.  The mass tag was below low mass cut-off 
when such large peptides were subjected to the mass spectrometer.  In addition, N-terminal 
PyMIC modification caused all b ions had a 135 mass unit shift, making it possible to detect 
low mass b ions in the tandem spectra.  For example, b1 ions appeared in all the four spectra 
in Figure 3.3.1. 
Charge State Distribution Shifts of PyMIC Modified Peptides 
Our previous work found that N-terminal modification of peptides with PIC 
significantly decreases peptide protonation compared to corresponding unmodified peptides 
during ESI process, while increases for peptide modified with PyIC.  In order to 
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Scheme 3.3. 1:  A schematic of the fragmentation of N-terminal 3-(isocyanatomethyl) 
pyridine (PyMIC) modified peptide. PyMIC modified peptides were observed to primarily 
cleave at site 1 (labeled in bold line) to produce yn fragment.     
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Figure 3.3. 1: Typical tandem spectra of four doubly charged PyMIC modified peptides 
(a-d). a: PyMIC-IETMR, b: PyMIC-ATEEQLK, c: PyMIC-SEIAHR, d: PyMIC-LVTDLTK. 
A mass tag with m/z 135 (labeled as “T” in bold), derived from PyMIC portion during 
cleavage at the site 1 (scheme3.3.1), was observed in the tandem spectrum of PyMIC 
modified peptide.   
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evaluate protonation property for PyMIC, tryptic peptides from standard proteins including 
BSA, cytochrome c., myoglobin, actin and carbonic anhydrase were chosen to react with PIC 
and PyMIC, respectively.  Then mass spectra of both PIC and PyMIC modified and 
unmodified peptides were acquired as described in the experimental section. Considering that 
various factors, such as elecrtrospray instrumental parameters182-184, solution pH values185, 186, 
and solvent composition187, have influences on the observed charged state distribution of 
analyte, all experiments were carried out with the same instrumental parameters and at the 
same pH.  A possible issue that may affect some of the experimental results is solvent 
composition at the point of elution.  The peptide hydrophobicity was increased in the order of 
unmodified, PyMIC modified and PIC modified peptides.  Thus the unmodified peptides 
were eluted first from HPLC column, followed by the corresponding PyMIC modified 
peptides.  At last, the corresponding PIC modified peptides were eluted from HPLC.  Since 
high concentration of solvents with high volatility and high gas-phase basicity, such as 
acetonitrile, increases observed average charge state of the same analytes187,  the difference 
of hydrophobicity among the three species may further lead to the increase of the observed 
ACSs for PyMIC and PIC modified peptides.     
A total of twelve pairs of PIC and PyMIC modified peptides were compared. The 
sequences of investigated peptides are listed in Table 3.3.1.  The charge state distribution of 
each peptide was evaluated based on average charge state (ACS), which was previously 
described in chapter 3.2: 
∑
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1                                                                           Eqn. 3.2.1 
Where qi represents the ith charge state present in the mass range from 400 to 2000, Ii 
is the corresponding relative intensity and N is the number of observed charge states in mass 
spectrum. Figure 3.3.2A shows a comparison of average charge states of PIC modified and 
corresponding PyMIC modified peptides. It shows that all PyMIC modified peptides had 
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Table 3.3. 1:  The peptide sequences used for the study of charge state distribution shift 
 
MW peptide sequence MW peptide sequence 
665 IETMR 1045 GTDVQAWIR 
712 SEIAHR 1164 LVNELTEFAK 
779 MIFAGIK  1482 LGEYGFQNALIVR 
789 LVTDLTK 1568 DAFLGSFLYEYSR 
818 ATEEQLK 1168* TGPNLHGLFGR 
922 AEFVEVTK 1496 EETLMEYLENPK 
927 YLYEIAR 1248 FESNFNTQATNR 
974 DLGEEHFK 1272* LFTGHPETLEK 
998 DLTDYLMK 1640* KVPQVSTPTLVEVSR 
1015 QTALVELLK 1582* YAAELHLVHWNTK 
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modified peptides had higher average charge states than corresponding PIC modified 
peptides.  
Multiply charged ions dominate the full MS spectra for PyMIC modified peptides, 
while singly charged ions were observed to be dominant for PIC modified peptides, 
especially in the case of small peptides. In Figure 3.3.2A, small peptides with MW 779, 789, 
922 and 927 were observed to have very low ACS values when modified with PIC, while 
protonations of those peptides were significantly improved by PyMIC modification. The 
ACS values from PyMIC modified peptides were at least half unit higher that from 
corresponding PIC modified peptides. 
 The protonation of PyMIC modified peptides was also evaluated by comparison of 
The ACS values of PyMIC modified peptides with corresponding unmodified peptides 
(Figure 3.3.2B). A total of 19 pairs of peptides were employed and their sequences are listed 
in Table 3.3.1.  ACS values of all modified peptides were higher than corresponding 
unmodified peptides except peptides with MW 974, MW 1496 and MW 1582, which 
unmodified forms had slightly higher ACS values than modified counterpart (Figure 3.3.2B).  
Furthermore, N-terminal modification assisted the observed peptide m/z shifting to higher 
values and made it possible to detect multiply charged peptides with low MW in the limited 
mass range of ion trap.  For example, Figure 3.3.2B shows four peptides with native peptide 
MW 665, 712, 779 and 789.  Since native form molecular weights of the four peptides were 
less than 800, doubly charged ions could not be detected when the mass range of the mass 
spectrometer was set from 400 to 2000.  Thus ACSs of the four peptides for unmodified 
forms were calculated only based on singly charged ion and produced values of 1.  N-
terminal PyMIC modification made the doubly charged ion of the modified peptide 67 mass 
units higher relative to that of the unmodified ion.  Doubly charged ions were able to be 
detected under the same instrument condition and ACSs of the modified peptides were 
calculated based on both singly and doubly charged ions.  The largest ACS differences 
between unmodified and modified forms were observed for the four peptides compared to 
others showed in Figure 3.3.2B.  The enhancement of protonation upon N-terminal PyMIC 
modification may be explained by considering the following evidence.  As we know, one of 
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the most distinguishing characteristics of electrospray ionization is the tendency to form 
multiply charged species.  During the ESI process, peptides can be protonated at various sites 
including N-terminal amino group, side chain groups and amides188.  Of all those protonation 
sites, basic side chains, such as arginine, lysine, and histidine, and the N-terminal amino 
group are more easily protonated during the ESI process. The replacement of N-terminus 
with neutral species like PIC reduced the possible protonation sites, while when substitute 
with basic group like PyMIC maintained the possible protonation sites in peptide.  In 
addition, considered the structural characteristic of PyMIC, the charge delocalization on the 
pyridine aromatic ring stabilized the protonated N-terminus to some extent. Therefore N-
terminal modification of peptide with PyMIC increased the protonation during ESI process.   
The CID Comparison of the Most Intensive Precursor Ions of N-terminal PyMIC 
Modified Peptides with PIC and PyIC Modified Peptides Generated during the ESI 
Process  
As a result of the protonation enhancement for peptide modified by PyIC or PyMIC, 
ion yield of multiply charged peptides was significantly increased. Multiply charged ions of 
PyMIC and PyIC modified peptides were dominate in full MS spectra. In data-dependent 
mode, mass spectrometer automatically selected the most intensive ion in full scan spectrum 
to perform CID fragmentation.  Therefore, multiply charged precursor ions from the two 
isocyanates modified peptides had more chance to be subjected to CID fragmentation.  
Figure 3.3.3 shows the comparison of full MS spectra and the following tandem spectra of 
peptides modified with PIC (a), PyIC (b) and PyMIC (c) respectively. Three peptides, 
YLYEIAR (Figure 3.3.3A), LVTDLTK (Figure 3.3.3B) and KVPQVSTPTLVEVSR (Figure 
3.3.3C), were chosen to perform the study.  As shown in Figure 3.3.3, for PIC N-terminal 
modification, doubly charged ions for small peptides YLYEIAR (Figure 3.3.3A-a) and 
LVTDLTK (Figure 3.3.3B-a), which had one basic residue in the sequences (labeled in 
bold), were not detected in full MS scan, only singly charged ion were observed dominant in 
the spectra for both peptides. Therefore, no tandem mass spectra from doubly charged ions 
were obtained for both peptides. 
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Figure 3.3. 2: Comparison of average charge states of 3-(isocyanatomethyl) pyridine 
(PyMIC) modified peptides with phenyl isocyanate (PIC) modified peptides(A), and 
unmodified peptides(B), respectively. The mass spectra for each unmodified and modified 
peptides were obtained by averaging five microscans during the full MS scan experiments. *: 
peptide with two basic amino acid residues.  
A
B 
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 Even though the tandem mass spectra from singly charged ions were easily obtained in data-
dependent mode, fragments useful for peptide sequencing were observed in very low intense 
in the spectra.  On the other hand, doubly charged ions for both PyIC and PyMIC modified 
YLYEIAR and LVTDLTK dominated the full scan spectra. Tandem spectra for both doubly 
charged ions were achieved (Figure 3.3.3).  However, PyIC modified peptides generated very 
few sequencing useful fragments.  Tandem spectra of PyIC-YLYEIAR and PyIC- 
LVTDLTK were shown in Figure 3.3.3A-b and Figure 3.3.3B-b, it can be seen that only y5 
and y6 were detected for YLYEIAR, and b4, y5 and y6 found for LVTDLTK.  While a series 
of high intensive fragments were observed in the spectra when PyMIC-YLYEIAR (Figure 
3A-c) and PyMIC-LVTDLTK were subjected to CID (Figure 3.3.3B-c).  Peptide 
KVPQVSTPTLVEVSR, which had two basic residues in the sequence, was also employed 
for this study. The spectra were shown in Figure 3.3.3C. It was observed that both doubly 
charged and singly charged ions for PIC-KVPQVSTPTLVEVSR were present in the full 
scan spectrum, but singly charged ion still dominate the spectrum compared to doubly 
charged. For PyIC and PyMIC modification, triply charged ions were detected, and doubly 
charged ions dominated the spectra.  Tandem mass spectra of doubly charged precursor ions 
were obtained for all three modifications.  It was found that PIC-KVPQVSTPTLVEVSR and 
PyMIC-KVPQVSTPTLVEVSR generated similar fragment ions, while PyIC-
KVPQVSTPTLVEVSR had much less fragments than PIC and PyMIC modification.  Only 
four y ions were detected and had very low relative intensities (Figure 3.3.3C-(b)).  
Based on the above observations, we conducted a thorough investigation of the effect 
of isocayanate structure on fragmentation of modified peptides.  As described in our previous 
work, Net Fragmentation Efficiency (NFE), which was used to measure the ion yield of 
fragments that were useful for obtaining sequence information of peptide, was previously 
defined as 
                                                                                                                  Eqn. 3.2.2 
%100*
)( ***
∑
∑ −−
=
I
MMI
I
III
NFE
 145
 146
 
Figure 3.3. 3: The comparison of full MS spectra and the following tandem spectra of 
peptides modified with PIC (a), PyIC (b) and PyMIC (c) respectively. A: peptide YLYEIAR, 
B: peptide LVTDLTK, C: peptide KVPQVSTPTLVEVSR. 
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Where ΣII represented the total fragment ion intensity, IM* was native peptide ion intensity 
and IM** was isocyanate-form ion intensity.  A total of 19 tryptic peptides from standard 
proteins were N-terminal modified with PIC, PyIC and PyMIC, respectively.  Among the 19 
peptides, six peptides contained one basic residue in their sequences. The singly charged 
precursors ions of all three isocyanate modified peptides were selected to perform CID for 
this study.   The remaining 13 peptides, which were labeled by asterisks in Figure 3.3.4, 
contained two or more than two basic residues in their sequences. Tandem mass spectra from 
doubly charged ions of the three-isocynate modified peptides were collected for NFE 
comparison.   The result is shown in Figure 3.3.4.  It was observed that PyMIC modified 
peptides had NFEs equivalent to PIC when peptides contained two basic residues in the 
sequences, more than half of PyMIC modified peptides obtained the highest NFE values in 
contrast with corresponding PIC and PyIC modified peptides.  While for peptides with one 
basic residue, PyMIC modified peptides were observed to have highest net fragmentation 
efficiencies in most of the cases except peptide with MW 922.  Thus PyMIC modified 
peptides produced more sequence fragments and were more appropriate for quantitative 
proteomics than PIC and PyIC.   A possible explanation for high NFE values of PyMIC 
modification compared to PIC and PyIC involved the structural differences of the 
isocyanates.  For PyIC modified peptide, the protonation of the pyridine nitrogen greatly 
increases the electron-withdrawing character of this group.  In addition, due to the 
conjugation of pyridine ring with urea bonds, protonated pyridine weaken both urea bonds, 
especially urea bond on site 1 (scheme 3.3.1), which caused the relatively low NFEs 
compared to PIC and PyMIC modified peptides during CID and the predominance of the 
native peptide fragment in spectrum.  While considering the feature of PyMIC structure, the 
exist of methylene group between pyridine ring and two urea bonds broke the conjugation of 
the two groups, thus the electron-withdrawing character of protonated pyridine ring was not 
able to dramatically influence bond strengths of the two urea bonds. In consequence, PyMIC 
modified peptides had higher NFEs compared to corresponding PyIC modified peptides. For 
PIC modification, conjugation of the aromatic ring with urea bonds may stabilize both of the 
two urea bonds, which led to produce relatively high NFEs compared to PyIC modified 
peptides  
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Figure 3.3. 4:  The comparison of Net Fragmentation Efficiency (NFE) peptides modified 
with PyMIC, PIC and PyIC respectively. The tandem mass spectra for each modified 
peptides were obtained by averaging five microscans during the MS/MS experiments. *:  
investigated peptides contain two or more than two basic residues in their sequences. 
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 during CID.  PIC modified peptides have relatively high NFEs, however, the modification of 
N-terminal amino group significantly decreased the protonation of peptide, especially for 
peptide with one basic residue. PyIC modification can increase protonation of peptide, thus 
making doubly charged ion dominant, however, the modified peptides have relatively low 
NFEs. PyMIC overcome the drawbacks of both PIC and PyIC. On one hand, PyMIC 
modified peptides produced multiply charged ions during ESI process, making it possible to 
perform CID fragmentation for doubly charged precursor ions. On the other hand, the 
fragmentation of PyMIC modified peptides generated enough fragments, so that peptide 
sequence can be identified by either manually sequencing or searching against database using 
searching algorithm like the MASCOT.  Therefore, PyMIC is a more appropriate reagent for 
quantitative proteomics applications compare to PIC and PyIC. 
Comparison of Low energy CID Dissociation of Unmodified Peptides and PyMIC N-
terminal Modified Peptides  
To compare the fragmentation pattern of PyMIC modified peptides with their 
corresponding unmodified peptides. Tryptic peptides from standard proteins were reacted 
with PyMIC using the protocol depicted in experimental section.  Then unmodified and 
modified peptides were subjected to LC-ESI-MS.  Tandem mass spectra of both unmodified 
and modified peptides were collected.  Figure 3.3.5 gave six examples of tandem spectra 
obtained from doubly charged precursor ions of unmodified peptide (a) and PyMIC modified 
peptide (b).  Figure 3.3.5A-E shows five small peptides with native MW lower than 1020 Da 
and Figure 5F shows one large peptide with native MW 1640 Da.  Peptide sequences are 
shown in the Figure 3.3.5.  One of the most striking character of the N-terminal PyMIC 
modification is the detection of complimentary product ions b1 and yn-1 for small peptides, 
which caused by the enhanced cleavage of the N-terminal peptide bond.  Those b1 and yn-1 
ions were labeled with bold characters in Figure 3.3.5A-E.  It can be seen that all small 
peptides modified with PyMIC were observed y1 ions with relative high abundance.  While 
these y ions were either absent (Figure 3.3.5A, C, D, E) or in very low abundance (Figure 
3.3.5B) for unmodified counterpart.  Since ion trap mass spectrometers have limited MS/MS 
mass range, low mass fragments like b1 ion usually were not detected in the tandem spectra 
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even for small peptides.  Adding the isocyanate on the N-terminal shifts the entire b-ion 
series to higher mass range, making the detection of low mass fragments feasible.  In Figure 
3.3.5A-E, b1 ions were detected for every small peptides modified with PyMIC, while in 
unmodified case, no b1 ions were observed in the corresponding tandem mass spectra.  Figure 
3.3.5F shows a MS/MS comparison of unmodified and PyMIC modified peptide with 
sequence KVPQVSTPTLVEVSR to elucidate the fragmentation characteristic of PyMIC 
modification for large peptides.  Instead of cleavage enhancement of the N-terminal peptide 
bond for PyMIC-KVPQVSTPTLVEVSR, PyMIC modification was observed to improve the 
cleavage between Val and Pro, which caused the formation of complimentary product ions b2 
and yn-2.  For peptide KVPQVSTPTLVEVSR, since it had high molecular weight, even 
considered the mass shift, the b1 ion was still below the mass range of the ion trap.  The b2 
ion was successfully detected for the PyMIC modified peptide, but not for corresponding 
unmodified case. The yn-2 ion from PyMIC-KVPQVSTPTLVEVSR was also observed to 
significantly increase in intensity compared to the unmodified counterpart.   
In addition, when PyMIC modified peptides were subjected to CID, a greater number 
of product ions were obtained compared to corresponding unmodified especially for small 
peptides. At the same time, the relative intensities of product ions generated from PyMIC 
modified peptides significantly increased compared to unmodified counterpart.  Figure 
3.3.5(a) shows tandem spectra of unmodified and PyMIC modified AEFVEVTK, when the 
corresponding doubly charged precursor ions (m/z 462, +2 and m/z 529, +2) were subjected 
into CID. CID of unmodified AEFVEVTK resulted in selective cleavage between Glu and 
Phe. Consequently, complimentary product ions were observed to be dominant in the 
spectrum and limited number of other product ions was generated.  Product ions like y7+, b4+ 
and b1+ were not present in the tandem spectrum.  N-terminal PyMIC modification changed 
cleavage preference. As shown in Figure 3.3.5(a), besides the predominant ion yn, PyMIC- 
AEFVEVTK produced contiguous b and y ion series. All the product ions were in relatively 
high intensities.  Figure 3.3.5(b) shows the comparison of tandem spectrum of ATEEQLK 
(m/z 410,+2) and PyMIC-ATEEQLK (m/z 477,+2). The predominance of M0++ product ion 
in unmodified form indicated that unmodified ATEEQLK lost water in an easier manner than 
fragment at peptide bonds. Also, few y serial product ions were observed and only one b ion 
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was obtained. However, PyMIC modified ATEEQLK produced entire y+ and b+ ions and all 
product ions were in high intensities. Similar results were obtained from Figure 3.3.5(c) to 
Figure 3.3.5(e).  It was proved that this phenomenon is common for all of the kinds of 
peptides investigated. Figure 3.3.5(f) depicts the CID fragmentation of the unmodified and 
PyMIC modified peptide KVPQVSTPTLVEVSR, which have two basic residues in the 
sequence.  It is apparent that PyMIC modified peptide produced similar number of product 
ions as unmodified peptide even for large peptide like KVPQVSTPTLVEVSR.  The results 
can be explained that the bond strength of urea bonds in PyMIC modified peptides were 
weaker than that of peptide amide bond, which caused the cleavage preference at site 1 
(scheme 3.3.1) to form mass tag with m/z 135 or yn ion.  In addition, the existence of urea 
bonds decreased the differences of peptide amide bonds between various residues.  In 
consequence, the fragmentation patterns of modified peptides were changed and more 
product ions present in tandem spectrum. 
De novo Peptide Sequencing 
The fragmentation characteristics of PyMIC modified peptides showed great promise 
for de novo peptide sequencing.  First, PyMIC modification changed the preferred 
fragmentation pathway and caused the formation of complementary b1 and yn-1 fragment ion 
pairs in CID experiments, which enabled to identify N-terminal residues during de novo 
sequencing.  Second, PyMIC modified peptides were able to produce contiguous series of b 
ions and y ions under low energy CID, which helped to identify more residues in peptide 
during de novo sequencing. In addition, since entire b ions in spectra shifted 135 mass units 
once peptide modified with PyMIC, the comparison of tandem mass spectra of PyMIC 
modified peptide with that of unmodified peptide can easily distinguish y ion series from b 
ions, thus significantly simplifying the sequencing process.  For example, tandem mass 
spectra of the unmodified and PyMIC modified doubly charged ions of YLYEIAR were 
acquired and are displayed in Figure 3.3.5 (d). By matching isobaric peaks in both spectra, it 
is easily to assign m/z 246.3, 359.3, 488.3 and 651.4 in the spectra to y ion series. Also when 
compared the spectra of PyMIC modified peptide with the unmodified, two new intensive 
peaks with m/z 298.0 and 764.4 were found to appear in the spectra of PyMIC modified case. 
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Figure 3.3. 5:  A-F, examples of tandem spectra obtained from doubly charged precursor 
ions of unmodified peptide and PyMIC modified peptide. 
E 
F 
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 And the sum of their masses equals to molecular weight of the modified peptide. So the two 
peaks were easily recognized as b1 (m/z 298.0) and y6 (m/z764.4) ion.  Peak with m/z 927.4 
in PyMIC modified case was assigned as y7 since it is equal to the molecular weight of the 
unmodified peptides.  Therefore, the complete y ion series were identified except y1.  Once y-
ion series were conformed, b-ion series were also able to be identified by calculating and 
matching the two spectra. Consequently, the entire sequence of this peptide was identified.    
Conclusion 
We designed a new isocyanate reagent, 3-(isocyanatomethyl) pyridine (PyMIC), 
which had the same compound structure as PyIC except a methyl group was introduced 
between the pyridine ring and the isoyanate group. The fragmentation characteristics of 
PyMIC modified peptides was evaluated. First, we found that similar to 3-pyridyl isocyanate, 
PyMIC modified peptides were observed to primarily cleave at site 1 (labeled with a bold 
line scheme 3.3.1) to produce yn fragments.  Another characteristic of fragmentation of 
PyMIC modified peptides is that a mass tag with m/z 135, derived from PyMIC portion 
during cleavage at the site 1 (scheme 3.3.1), was observed in the tandem spectrum of PyMIC 
modified peptides.  In addition, we investigated the effect of the PyMIC structure on peptide 
protonation by comparing PyMIC modified peptides with PIC modified peptides and 
unmodified peptides.  This comparison shows that all PyMIC modified peptides had higher 
average charge states than corresponding PIC modified peptides and unmodified peptides. 
Multiply charged ions dominated the full MS spectra for PyMIC modified peptides. The 
comparison of mass spectrometric properties of PyMIC modified with phenyl and pyridine 
isocyanate modified peptides using LC-ESI-MS/MS was also performed. It was observed 
that PyMIC modified peptides produced considerabley more sequencing useful fragments 
compared to PIC and PyIC modified peptides, making it a more appropriate reagent for 
quantitative proteomics applications. In addition, to further characterize the fragmentation 
behavior of PyMIC modified peptides, we compared the tandem mass spectra for PyMIC 
modified and unmodified tryptic peptides originating from standard proteins.  PyMIC 
modification was surprisingly observed to improve the cleavage of the peptides. New product 
ions were observed when compared to unmodified peptides.  In a nutshell, PyMIC is a more 
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appropriate N-terminal labeling reagent for quantitative proteomic application compared 
other isocyanate reagents.   
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Chapter 3.4 
Conclusion 
Selection of appropariate labeling reagents is critical for quantitative proteomics 
based on isotope labeling strategies. It directly affects total performance of the application 
such as the identification of proteins and the accuracy of quantitative analysis. High-quality 
labeling reagents, such as ICAT, can be widely applied to various quantitative proteomic 
studies and extend the application of proteomics to new biological area 11, 154, 163.  However, 
currently there is no well-developed methodology for selecting ideal labeling reagents.  
Researchers still use empirical method to find reagents that might suitable for quantitative 
application. In this part of the dissertation, we developed a new methodology to choose an 
isocyanate compound as an appropriate N-terminal labeling reagent for global labeling 
strategy based quantitative proteomics.  
Initially, three typical isocyanates: PIC, PEIC and PyIC, which represented aromatic 
neutral, aliphatic neutral and aromatic basic isocyanates, respectively, were carefully chosen 
for systematic study to investigate the effects of N-terminal labeling on peptide 
fragmentation.  Based on the structural and cleaving characteristics of N-terminal modified 
peptides with various isocyanates, three concepts, average charge state (ACS), net 
fragmentation efficiency (NFE) and the ratio of two major products ion intensities (RN/I) 
were used to conduct the systematic study. The concept of average charge state was used for 
a thorough investigation of the electrospray ionization characteristics of the N-terminal 
modified peptides. Net fragmentation efficiency, which was originally used to study peptide 
fragmentation mechanisms, was utilized to measure the ion yield of sequence-useful 
fragments during CID.  We also introduced the concept of the ratio of two major product ion 
intensities (RN/I) to monitor the cleavage preference between two urea bonds formed during 
N-terminal modification, as N-terminal modified peptide with various isocyanates was 
subjected to CID fragmentation. Based on the average charge state invetigation, we 
rationaled that isocyanate modification shifted the charge state distributions of modified 
peptides during ESI process.  PIC and PEIC modification was found to severely decrease the 
protonation of modified peptides, while PyIC modification maintained and in some cases 
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increased the protonation compared to unmodified counterparts.  The decrease of protonation 
of PIC and PEIC modified peptides results from the neutral property of the both reagents.  
The modification also affects the fragmentation of modified peptides.  PIC modified peptides 
produced the most sequence product ions and had tendency to cleave at both urea bonds.  
Conversely, PyIC modified peptides produced relatively fewer sequence product ions and 
were prone to cleave at the urea bonds on peptide side.  PEIC modified peptides were prone 
to cleave at the urea bonds on isocyanate side.  Compared to PyIC and PEIC, PIC 
modification was better for protein identification.   
Based on those results, we rationalized that the structure of isocyanate is the main 
reason leading to fragmentation changes of the modified peptides. Since PIC reacts with the 
N-terminus of the peptide to form two urea bonds, the conjugation of a benzene ring on PIC 
with the two urea bonds can strengthen the two C-N bonds and make them have relatively 
similar bond strengths. Therefore the PIC modified peptides have the highest NFE values and 
could be cleaved at both sites to form both native peptide and isocyanate-form fragments. 
While the structural characteristics of PyIC, which were depicted as both electron-
withdrawing feature of PyIC and the conjugation of pyridine ring with urea bonds once 
reacted with amino group, causes the significant reduction of fragments when PyIC modified 
peptides were subject to CID.  PEIC has an ethylene group between phenyl and isocyanate 
moiety in its structure, which serves as a spacer to break any conjugation between the two 
groups. Therefore, the two urea bonds are not as strong as that in PIC, and cause the decrease 
of NFE values. 
Combining the structural characteristics of the all three isocyanates of studied,  we 
designed a new isocyanate reagent, PyMIC, which has the same compound structure as PyIC 
except a methyl group is introduced between the pyridine ring and the isoyanate group. The 
methyl group was expected to act as a spacer to eliminate or at least weaken the effect of 
electron-withdrawing feature of protonated pyridine ring on the two urea bonds when reacted 
with amino group. When applying the new methodology we developed for monitoring the 
mass spectrometric properties of modified peptides, we found that PyMIC modification 
significantly increases protonation of peptides. Doubly charged peaks dominate the full scan 
MS spectra. Furthermore, PyMIC modified peptides produce more sequence useful 
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fragments compared to other investigated ioscyanate modified and unmodified peptides. 
Therefore, we successfully found an isocyanate labeling reagent which is appropriate for 
global coding strategy based quantitative proteomics applications. 
Copyright © Ting Liu 2008 
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CHAPTER FOUR 
CONCLUSIONS 
Since Marc Wilkins first used the term ‘proteome’ to represent the entire complement 
of proteins expressed by the genome, proteomics has become the fastest-growing area of 
biological research. By targeting systems and monitoring protein pattern changes rather than 
single proteins, proteomics has allowed us to identify, characterize, and quantify proteins on 
a massive scale and resulted in a fundamental change in biological and chemical approaches 
to understanding proteins. To date, proteomics has been widely applied to immunology, 
biology, biomedicine, almost every field related to proteins.  The rapid progress of 
proteomics in the last decade is based on the developments and innovations in four main 
aspects: the completion of genome projects for humans or other species of interest; the 
improvement of protein separation techniques; the development of mass spectrometry and 
the establishment of bioinformatics.  By developing and integrating new technologies, new 
reagents, and new strategies into proteomics, it is possible that proteomics can be applied to 
deeper and broader study areas.      
The development of proteomics is bringing a revolution to its application areas such 
as biomarker discovery, disease diagnosis and treatment.  Currently, majority of biomarkers 
are discovered by traditional linear, single event–based methods, in which research is driven 
by previous knowledge.  Early, accurate disease diagnosis, which offers the best chance to 
treat and cure diseases, is still challenging for a varity of diseases. The odds of death caused 
by lethal diseases like cencers remain adversely high, especially for those detected at an 
advanced stage. Disease treatments are still basically "one size fits all", which means that the 
same treatment is given based on the type of disease regardless of the individual biological 
heterogeneity.  With the potential of identifying protein pattern changes in a biosystem, one 
can envision that proteomics could be applied to evaluation of the heterogeneity of cancer 
patients, examination of alterations in disease progress research, identification of multiple 
targets for new drug development. And one day in the future, individualized health care in 
most of the medical areas will be realized.  
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Parasitic diseases are the most common disease with world-wide distribution. 
According to the World Health Organization, 3.5 billion people suffer parasitic diseases. The 
symptoms of parasitic diseases can vary enormously from acute to chronic, from no 
significant symptoms to death.  So far, some medicines that treat parasitic infections are 
available, but no vaccines for parasitic diseases are available yet. Therefore, the discovery of 
effective vaccines is imperative to cure world-wide infected  population and prevent futher 
transmission.  As one of the disease-causative parasite, T. gondii draws wide attentions due 
to its ability to infect virtually all warm-blooded animals. After many years’ study and effort, 
scientist cannot yet thoroughly elucidate state of the art of the parasite’s host-cell infection. 
Because of its unique structure and localization, the Parasitophorous Vacuole Membrane 
(PVM) has received a lot of attention for study of the mechanism of worldwide distributing 
parasite’s survival.  As such, it is an attractive target for discovery of novel vaccines and 
drugs.  
The first part of this dissertation described the development of LC-MS-based 
methodologies for the qualitative analysis of the PVM proteome, which were enriched by 
newly developed immunoprecipitation protocol by Sinai et. al. The goal of this project is to 
identify as much as possible proteins in a proteome, especially low abundance proteins from 
the challenging organelle.  This was achieved through the development of novel protein 
concentration and clean-up methods, followed by the integration of biological sample 
preparation, protein concentration and 2D-LC-MS/MS steps.  The invention of “Three-layer 
Sandwich Gel Electrophoresis” (TSGE) protein concentration and clean-up protocol based on 
the art of gel electrophoresis (which has been implanted in proteomics for years) makes 
TSGE readily incorporate into the protein processing workflows. The example of analyzing a 
whole cell extract of Toxoplasma gondii by the TSGE in combination with 2D-LC-MS/MS 
demonstrates TSGE is suitable for high-throughput proteomic analysis of complex protein 
mixtures. With significant high protein recovery and efficient concentration and salt removal 
ability for challenging samples, one can envision that the TSGE method will easily adapt to a 
wide range of diverse studies and have broad applications.   
The application of the developed sample concentration method (TSGE) coupled with 
2D-LC-MS/MS methodology to characterization of the T. gondii Parasitophorous Vacuole 
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Membrane (PVM) proteins clearly demonstrates the power of LC-MS-based proteomics in 
subproteome research.  One can envision this methodology will have extensive application to 
similar subproteome studies in the future. The proteins from the established PVM proteome 
will be considered as attractive targets for discovering novel vaccines and drugs against the 
parasite, dramatically narrowing down the investigation range from thousands of proteins 
present in T. gondi. Therefore, it will dramatically accelerate the drug discovery process.  Of 
course, further biological techniques like immunoflourescence assays for each identified 
protein will be needed to offer more direct information on those proteins’ localization.  The 
studies of protein-protein interaction for interested protein in PVM proteome using similarly 
designed immunoprecipitation-TSGE-LC-MS methods can provide a clearer understanding 
of the functions of those proteins in the PVM. Targeted gene disruption technique such as 
gene knockouts or transgenic models for interested proteins can also be used for 
determination the importance of a gene implicated in a particular pathway or phenotype.  In a 
nutshell, the establishment of the PVM proteome by using developed qualitative proteomic 
methodology provides a solid foundation for elucidation of protein functions in the PVM and 
parasite activities associated with the PVM, which will pave the way to entirely 
understanding the mechanism of T. gondii’s host-cell infection and discovering novel drugs 
and vaccine.  
One major goal of proteomics is to systematically identify and quantify proteins in a 
given biosystem. The PVM proteome characterization example discussed above 
demonstrates the power and importance of method development on proteomics for 
qualitative application. Indeed, an ideal proteomic method is expected to be capable of 
identifying low abundant proteins in a complex sample and obtaining high proteome 
coverage for challenging biosystems. Beyond that, proteomic technologies also are expected 
to be reliable, sensitive and accurate for the need of quantification application to ensure 
minute quantity of proteins and slight changes between samples in a verity of biosystems can 
be detected. However, by using traditional proteomic approach like 2D-SDS-PAGE, it is 
very difficult to sufficiently capture the entire proteome for a given biological system due to 
its limited ability to handle proteins with the vast diversity of properties such as molecular 
sizes, charge state, hydrophobicity, protein conformational states and post-translational 
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modifications.  The development of new reagents for gel-free based strategies that have the 
ability of analyzing broader range of proteins and more complex samples is critical for the 
extension of the quatification applications in a verity of biological research. A well-known 
example is the introduction of the LC-MS-based ICAT reagent. It has been widely applied to 
various research areas.   
Stable isotope labeling utilized in LC-MS-based quantitative methods holds greater 
promise for accurate and large-scale quantitative analyses due to its ability to simultaneously 
identify and quantify proteins.  For developing novel stable-isotope-labeling reagents, 
evaluation of the electrospray ionization property and fragmentation of the reagent-labeled 
peptides is nessessary and important, since these features directly influence on protein 
identification. As with the PVM study in Part 1, careful method design and reagent candidate 
choice proved to be highly beneficial in achieving the desired goals.  In this part, we 
carefully selected three typical isocyanates, phenyl isocyanate (PIC), phenethyl isocyanate 
(PEIC) and pyridine-3-isocyanate (PyIC) to carry out the investigation.  The systematic study 
revealed that basicity of labeling reagent severely impacts ESI efficiencies, while the 
electronic effect of labeling reagents directly affects the net fragmentation efficiencies and 
the sequencing-useful fragments during CID process.  A thorough understanding of the effect 
of isocyanate structure on mass spectrometric properties of labeled peptides is helpful in 
directing the design of a new isocyanate, with which labeled peptides are expected to have 
better ESI and CID properties. The novel isocyanate (PyMIC) labeled peptides proved to 
have high ESI efficiency and better fragmentation compared to other isocyanates and even 
natural tryptic peptides. Therefore, PyMIC has valuable potential to be exploited as a 
labeling reagent for both quantitative proteomics applications and peptide de novo 
sequencing.  
The systematic study of the three isocyanate reagents presented here offered a 
foundation for understanding the structure impact of isocyanate on mass spectrometric 
properties of N-terminal labeled peptide, the alternative examination on bond strength using 
quantum calculation will surely provide a deeper appreciation of the underlying mechanisms 
for this phenomenon. Also, in this study we provided a promising labeling reagent for 
quantitative proteomics, futher preparation of 13C labeled PyMIC will be definitely necessary 
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for application.  A thorough examination of the completeness and the specificity of the 
modification reaction between PyMIC and various peptides will make it closer to the actual 
quantitative applications. 
Method development in both qualitative and quantitative proteomics along with 
application of developed methodology on establishment of the PVM proteome described in 
this dissertation clearly demonstrates the power of innovations in the proteomic technology.  
A well thought-out integration of modifications and innovations in each component of 
proteomics shows its capability to extend new research areas. Further improvement in this 
fast-growing field will continue to revolutionize many fields, such as drug discovery, clinical 
diagnostics, disease prevention, basic biological research, and biotechnology. With the 
potential that proteomics carries, it will not be too far in the future that proteomic 
technologies will play key role in those areas. Proteomics has proved and will continue to 
demonstrate its potential to improve quality of life. Our work described in this dissertation is 
only one individual contrbution to the progress of proteomic technology and it is high-speed 
evolving everyday.  
 
Copyright © Ting Liu 2008 
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Appendix 
Table1: Proteins in T. Gondii identified based on multiple peptides 
 
protein description Accession No. database source 
MW 
(Da) score 
sequence 
coverage 
(%) 
No. of 
peptides 
1 
elongation factor 1-alpha, putative/ 
elongation factor 1-alpha, 
putative 
76.m00016/ 
83.m00013 http://toxodb.org/download/release-3.3/Genome/pep 
48974/ 
48974 
1048/ 
1048 41/41 15/15 
2 heat shock protein 70, putative 583.m00009 http://toxodb.org/download/release-3.3/Genome/pep 73208 688 30 14 
3 protein disulfide isomerase, putative 27.m00003 http://toxodb.org/download/release-3.3/Genome/pep 52769 614 38 15 
4 lactate dehydrogenase 44.m00006 http://toxodb.org/download/release-3.3/Genome/pep 35525 537 38 9 
5 heat shock protein 70, putative 59.m00003 http://toxodb.org/download/release-3.3/Genome/pep 72834 518 26 14 
6 enolase, putative/ enolase, 
putative 
59.m03410/ 
59.m03411 http://toxodb.org/download/release-3.3/Genome/pep 
52080/ 
48311 453/ 348 20/4 6/2 
7 heat shock protein 90 80.m00001 http://toxodb.org/download/release-3.3/Genome/pep 81882 448 18 11 
8 elongation factor 2, putative 20.m03912 http://toxodb.org/download/release-3.3/Genome/pep 106504 401 14 15 
9 
bi-functional aminoacyl-tRNA 
synthetase, putative / prolyl-tRNA 
synthetase,putative 
38.m00021 http://toxodb.org/download/release-3.3/Genome/pep 80380 337 12 6 
10 ATP synthase beta chain, putative 55.m00168 http://toxodb.org/download/release-3.3/Genome/pep 59879 304 21 8 
11 actin 25.m00007 http://toxodb.org/download/release-3.3/Genome/pep 41881 293 25 9 
12 hypothetical protein 80.m02161 http://toxodb.org/download/release-3.3/Genome/pep 47892 292 16 5 
13 ribosomal protein L23a, putative 49.m00008 http://toxodb.org/download/release-3.3/Genome/pep 36412 290 5 2 
14 myosin A, putative 46.m00001 http://toxodb.org/download/release-3.3/Genome/pep 93260 286 12 7 
15 hypothetical protein 42.m00026 http://toxodb.org/download/release-3.3/Genome/pep 220725 284 2 5 
16 phosphoglycerate kinase, putative 641.m00193 http://toxodb.org/download/release-3.3/Genome/pep 44647 258 26 8 
17 pyruvate kinase, putative 55.m00007 http://toxodb.org/download/release-3.3/Genome/pep 57493 257 18 8 
18 nucleoside-triphosphatase I/ nucleoside-triphosphatase II 
65.m00001/ 
65.m01111 http://toxodb.org/download/release-3.3/Genome/pep 
69112/ 
82332 253/ 34 7/1 3/1 
19 p36 protein 49.m00048 http://toxodb.org/download/release-3.3/Genome/pep 37644 251 18 5 
20 fructose-1,6-bisphosphate aldolase 46.m00002 http://toxodb.org/download/release-3.3/Genome/pep 46930 244 30 12 
21 glyceraldehyde-3-phosphate dehydrogenase 80.m00003 
http://toxodb.org/download/release-3.3/Genome/pep 36605 238 27 6 
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22 tubulin alpha chain 583.m00022 http://toxodb.org/download/release-3.3/Genome/pep 50081 233 16 5 
23 heat shock protein 90, putative 49.m00060 http://toxodb.org/download/release-3.3/Genome/pep 96763 231 11 5 
24 acid phosphatase, putative 38.m01061 http://toxodb.org/download/release-3.3/Genome/pep 46577 224 9 4 
25 
tubulin beta chain, putative/ tubulin 
beta chain / tubulin beta chain, 
putative 
41.m00036/ 
57.m00003/ 
28.m00301 
http://toxodb.org/download/release-3.3/Genome/pep 50005/ 
50041/ 
50020 
209/ 209/ 
104 13/ 13/ 6 5/ 5/ 2 
26 proteasome PCI domain-containing protein 37.m00775 http://toxodb.org/download/release-3.3/Genome/pep 66008 206 5 2 
27 40S ribosomal protein S7, putative 49.m00013 http://toxodb.org/download/release-3.3/Genome/pep 22573 189 33 4 
28 profilin-related 83.m00017 http://toxodb.org/download/release-3.3/Genome/pep 17544 184 20 2 
29 toxofilin 33.m02185 http://toxodb.org/download/release-3.3/Genome/pep 26772 182 21 4 
30 
rhoptry protein, putative / protein 
kinase domain-containing protein 
20.m03896 
http://toxodb.org/download/release-3.3/Genome/pep 
62626 175 
11 4 
31 adenosylhomocysteinase, putative 42.m00008 http://toxodb.org/download/release-3.3/Genome/pep 51777 171 13 3 
32 14-3-3 protein, putative 55.m00015 http://toxodb.org/download/release-3.3/Genome/pep 37150 171 32 7 
33 major surface antigen p30 44.m00009 http://toxodb.org/download/release-3.3/Genome/pep 34709 169 25 6 
34 glyceraldehyde-3-phosphate dehydrogenase 59.m00091 http://toxodb.org/download/release-3.3/Genome/pep 53495 163 10 3 
35 40s ribosomal protein S14, putative 55.m00221 http://toxodb.org/download/release-3.3/Genome/pep 16292 162 22 3 
36 glutaminyl-tRNA synthetase, putative 37.m00743 http://toxodb.org/download/release-3.3/Genome/pep 95468 162 7 4 
37 
tudor domain-containing protein / 
staphylococcal nuclease homologue 
domain-containing protein 
49.m00009 http://toxodb.org/download/release-3.3/Genome/pep 103977 159 3 2 
38 60S ribosomal protein L8, putative 20.m00388 http://toxodb.org/download/release-3.3/Genome/pep 28237 157 17 3 
39 
2,3-bisphosphoglycerate-dependent 
phosphoglycerate mutase, 
(phosphoglycerate mutase), putative 
113.m00016 http://toxodb.org/download/release-3.3/Genome/pep 30027 157 22 4 
40 60S ribosomal protein L7a, putative 55.m00280 http://toxodb.org/download/release-3.3/Genome/pep 31012 153 12 5 
41 heat shock protein 60 50.m00006 http://toxodb.org/download/release-3.3/Genome/pep 60875 152 14 7 
42 ADP/ATP carrier, putative 50.m00009 http://toxodb.org/download/release-3.3/Genome/pep 35233 151 16 4 
43 rhoptry antigen, putative 83.m02145 http://toxodb.org/download/release-3.3/Genome/pep 103803 149 4 4 
44 eukaryotic translation initiation factor 3 subunit 3, putative 50.m03396 http://toxodb.org/download/release-3.3/Genome/pep 65672 146 6 2 
45 40s ribosomal protein S6, putative 27.m00119 http://toxodb.org/download/release-3.3/Genome/pep 28938 143 20 3 
46 
hydroxymethyldihydropterin 
pyrophosphokinase-dihydropteroate 
synthase 
55.m00011 http://toxodb.org/download/release-3.3/Genome/pep 82633 143 6 3 
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47 TCP-1/cpn60 family chaperonin, putative 20.m03910 http://toxodb.org/download/release-3.3/Genome/pep 60575 141 9 2 
48 importin beta-3 subunit, putative 44.m02525 http://toxodb.org/download/release-3.3/Genome/pep 133597 139 3 2 
49 ribosomal protein L5, putative 641.m00186 http://toxodb.org/download/release-3.3/Genome/pep 35320 136 7 2 
50 60S ribosomal protein L18a, putative 55.m05004 http://toxodb.org/download/release-3.3/Genome/pep 21317 135 26 4 
51 elongation factor 1-beta, putative 42.m00069 http://toxodb.org/download/release-3.3/Genome/pep 36026 131 10 2 
52 myosin light chain (TgMLC1) 55.m00021 http://toxodb.org/download/release-3.3/Genome/pep 24108 131 13 2 
53 malate dehydrogenase, putative 641.m00168 http://toxodb.org/download/release-3.3/Genome/pep 50335 130 7 2 
54 TCP-1/cpn60 family chaperonin, putative 77.m00088 http://toxodb.org/download/release-3.3/Genome/pep 59295 128 10 4 
55 60s ribosomal protein L13a, putative 80.m00062 http://toxodb.org/download/release-3.3/Genome/pep 32728 127 14 3 
56 asparaginyl-tRNA synthetase, putative 59.m03518 http://toxodb.org/download/release-3.3/Genome/pep 74957 125 8 6 
57 serine-threonine phosophatase 2C 44.m00037 http://toxodb.org/download/release-3.3/Genome/pep 36767 124 11 3 
58 hypothetical protein 583.m00019 http://toxodb.org/download/release-3.3/Genome/pep 286259 124 1 4 
59 RNA recognition motif domain-containing protein 645.m00319 http://toxodb.org/download/release-3.3/Genome/pep 49454 122 5 2 
60 small heat shock protein, putative / 
bradyzoite-specific protein, putative 44.m02755 http://toxodb.org/download/release-3.3/Genome/pep 20253 117 11 2 
61 phosphate carrier protein, putative 65.m00005 http://toxodb.org/download/release-3.3/Genome/pep 53058 117 7 2 
62 ATP synthase alpha chain, putative 20.m00382 http://toxodb.org/download/release-3.3/Genome/pep 61073 116 6 3 
63 eukaryotic translation initiation factor 4A 50.m05680 http://toxodb.org/download/release-3.3/Genome/pep 46644 115 11 4 
64 dense granule protein 5 precursor, putative 76.m00004 http://toxodb.org/download/release-3.3/Genome/pep 12831 115 17 2 
65 rhoptry antigen, putative 551.m00238 http://toxodb.org/download/release-3.3/Genome/pep 60933 115 20 6 
66 porin, putative 55.m08198 http://toxodb.org/download/release-3.3/Genome/pep 31332 114 22 2 
67 nucleolar phosphoprotein (nucleolin), putative 80.m02340 http://toxodb.org/download/release-3.3/Genome/pep 73075 113 3 2 
68 hypothetical protein 42.m08072 http://toxodb.org/download/release-3.3/Genome/pep 27317 112 9 2 
69 60S acidic ribosomal protein P2, putative 583.m00610 http://toxodb.org/download/release-3.3/Genome/pep 11761 112 27 2 
70 elongation factor 1-gamma, putative 145.m00003 http://toxodb.org/download/release-3.3/Genome/pep 44011 110 6 2 
71 hypothetical protein 42.m03584 http://toxodb.org/download/release-3.3/Genome/pep 57998 107 6 2 
72 DEAD/DEAH box helicase, putative 46.m00027 http://toxodb.org/download/release-3.3/Genome/pep 59930 106 11 4 
73 threonyl-tRNA synthetase, putative 145.m00604 http://toxodb.org/download/release-3.3/Genome/pep 95838 105 4 3 
74 peroxidoxin 2 583.m00002 http://toxodb.org/download/release-3.3/Genome/pep 24446 105 20 4 
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75 phosphoenolpyruvate carboxykinase, putative 80.m00002 http://toxodb.org/download/release-3.3/Genome/pep 75294 104 3 2 
76 glycyl-tRNA synthetase, putative 55.m04665 http://toxodb.org/download/release-3.3/Genome/pep 86319 103 5 3 
77 NAD-specific glutamate dehydrogenase, putative 50.m00072 http://toxodb.org/download/release-3.3/Genome/pep 125469 101 3 2 
78 KH domain-containing protein 35.m00901 http://toxodb.org/download/release-3.3/Genome/pep 100033 100 4 2 
79 phosphofructokinase, putative 42.m00123 http://toxodb.org/download/release-3.3/Genome/pep 131279 96 2 3 
80 eukaryotic translation initiation factor 2 gamma subunit, putative 46.m00024 http://toxodb.org/download/release-3.3/Genome/pep 50476 95 8 2 
81 cell division protein 48, putative 59.m03661 http://toxodb.org/download/release-3.3/Genome/pep 88267 94 8 4 
82 cytosol aminopeptidase 80.m00088 http://toxodb.org/download/release-3.3/Genome/pep 59804 94 5 3 
83 SAG1-related sequence 2 44.m00010 http://toxodb.org/download/release-3.3/Genome/pep 39094 93 6 2 
84 60S ribosomal protein L13, putative 55.m00189 http://toxodb.org/download/release-3.3/Genome/pep 35678 93 3 2 
85 actin depolymerizing factor 39.m00001 http://toxodb.org/download/release-3.3/Genome/pep 12914 91 10 3 
86 nascent polypeptide-associated complex alpha chain, putative 20.m03918 http://toxodb.org/download/release-3.3/Genome/pep 650452 91 0 2 
87 peroxiredoxin 37.m00001 http://toxodb.org/download/release-3.3/Genome/pep 21708 85 16 2 
88 60S ribosomal protein L14, putative 57.m01833 http://toxodb.org/download/release-3.3/Genome/pep 15452 85 18 2 
89 purine nucleoside phosphorylase, 
putative 583.m00630 http://toxodb.org/download/release-3.3/Genome/pep 33022 83 9 2 
90 hypothetical protein 25.m02949 http://toxodb.org/download/release-3.3/Genome/pep 50170 81 7 3 
91 
ubiquitin / ribosomal protein CEP52 
fusion protein, putative/ 
polyubiquitin, putative 
 
80.m02240/ 
38.m01076 http://toxodb.org/download/release-3.3/Genome/pep 
14676/ 
34429 79/ 79 27/ 11 5/ 5 
92 ROP8, putative 80.m02343 http://toxodb.org/download/release-3.3/Genome/pep 57575 79 5 2 
93 gbp1p protein (RNA bindiong protein), putative 55.m00241 http://toxodb.org/download/release-3.3/Genome/pep 31740 78 5 2 
94 eukaryotic translation initiation factor 3, putative 83.m01278 http://toxodb.org/download/release-3.3/Genome/pep 49703 77 10 2 
95 rhoptry antigen, putative 33.m01398 http://toxodb.org/download/release-3.3/Genome/pep 66706 76 3 2 
96 54-kDa antigen, partial 63.m00146 http://toxodb.org/download/release-3.3/Genome/pep 42334 75 11 3 
97 malate:quinone oxidoreductase, putative 80.m00006 http://toxodb.org/download/release-3.3/Genome/pep 60342 73 5 2 
98 40S ribosomal protein S13, putative 59.m03516 http://toxodb.org/download/release-3.3/Genome/pep 17166 71 29 4 
99 tryptophanyl-tRNA synthetase, putative 80.m00063 
http://toxodb.org/download/release-3.3/Genome/pep 52781 69 4 2 
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100 aconitate hydratase, putative 42.m03524 http://toxodb.org/download/release-3.3/Genome/pep 114813 68 4 2 
101 40S ribosomal protein S3a, putative 44.m02744 http://toxodb.org/download/release-3.3/Genome/pep 29352 67 8 3 
102 apical membrane antigen 1, putative 55.m00005 http://toxodb.org/download/release-3.3/Genome/pep 62980 66 2 2 
103 hypothetical protein 80.m00049 http://toxodb.org/download/release-3.3/Genome/pep 48042 65 10 2 
104 60S ribosomal protein L9, putative 76.m00009 http://toxodb.org/download/release-3.3/Genome/pep 21410 63 10 2 
105 40S ribosomal protein S16, putative 55.m05028 http://toxodb.org/download/release-3.3/Genome/pep 25289 63 8 2 
106 thioredoxin, putative 42.m03331 http://toxodb.org/download/release-3.3/Genome/pep 68905 63 4 2 
107 60s ribosomal protein L19, putative 80.m02220 http://toxodb.org/download/release-3.3/Genome/pep 22146 61 11 3 
108 60s ribosomal protein L4, putative 583.m00619 http://toxodb.org/download/release-3.3/Genome/pep 45720 60 13 4 
109 40S ribosomal protein S8, putative 50.m00067 http://toxodb.org/download/release-3.3/Genome/pep 23547 58 12 2 
110 60S ribosomal protein L3, putative 42.m00084 http://toxodb.org/download/release-3.3/Genome/pep 44028 54 10 5 
111 cAMP-dependent protein kinase regulatory subunit, putative 49.m00003 http://toxodb.org/download/release-3.3/Genome/pep 34988 52 9 3 
112 60S acidic ribosomal protein P0 38.m00002 http://toxodb.org/download/release-3.3/Genome/pep 34136 52 7 2 
113 60S ribosomal protein L22, putative 49.m05661 http://toxodb.org/download/release-3.3/Genome/pep 15064 51 18 3 
114 multisynthetase complex auxiliary component p43, putative 41.m00027 http://toxodb.org/download/release-3.3/Genome/pep 73990 50 2 2 
115 ribosomal protein L27, putative 55.m05006 http://toxodb.org/download/release-3.3/Genome/pep 16791 49 13 2 
116 hypothetical protein 50.m03261 http://toxodb.org/download/release-3.3/Genome/pep 54249 47 6 2 
117 glycine hydroxymethyltransferase, putative 46.m01590 http://toxodb.org/download/release-3.3/Genome/pep 54518 45 4 2 
118 alanyl-tRNA synthetase, putative 38.m01067 http://toxodb.org/download/release-3.3/Genome/pep 113338 43 2 2 
119 asparagine synthase, putative 52.m00010 http://toxodb.org/download/release-3.3/Genome/pep 65826 42 4 2 
120 26S proteasome subunit 4, putative 57.m03106 http://toxodb.org/download/release-3.3/Genome/pep 49090 41 4 2 
121 60S ribosomal protein L10a, putative 33.m01368 http://toxodb.org/download/release-3.3/Genome/pep 24587 41 13 3 
122 chaperone protein dnaK, putative / heat shock protein 70, putative 50.m00085 http://toxodb.org/download/release-3.3/Genome/pep 78202 41 6 3 
123 ribosomal protein L22, putative 583.m00016 http://toxodb.org/download/release-3.3/Genome/pep 16334 38 14 2 
124 histone H3.3 variant/ histone H3 38.m00006/ 55.m00013 http://toxodb.org/download/release-3.3/Genome/pep 
15404/ 
15393 36/ 36 13/ 13 3/ 3 
125 WD-40 repeat-containing protein 583.m05430 http://toxodb.org/download/release-3.3/Genome/pep 142765 36 1 2 
126 18 kDa cyclophilin 41.m00001 http://toxodb.org/download/release-3.3/Genome/pep 19592 35 11 2 
127 myosin D, putative 55.m00020 http://toxodb.org/download/release-3.3/Genome/pep 102104 35 2 2 
128 succinyl-CoA ligase, putative 583.m00592 http://toxodb.org/download/release-3.3/Genome/pep 53355 35 6 2 
129 60S ribosomal protein L10, putative 80.m00017 http://toxodb.org/download/release-3.3/Genome/pep 24785 34 16 3 
130 hypothetical protein 20.m07752 http://toxodb.org/download/release-3.3/Genome/pep 56874 33 3 2 
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131 40S ribosomal protein S11, putative 42.m00125 http://toxodb.org/download/release-3.3/Genome/pep 18665 30 14 2 
132 histone H2B variant 1 25.m00008 http://toxodb.org/download/release-3.3/Genome/pep 13723 29 15 2 
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Table 2: Protein identified based on single peptide  
 protein description Accession 
No. 
database source MW 
(Da) 
protein 
score 
sequence 
coverage 
(%) 
No. of 
peptides 
peptide sequence precursor 
m/z, 
charge 
mass error 
observed 
(Da) 
highest 
peptide 
score 
muitiple 
observations 
1 N-glycosylase/DNA lyase-
related 
83.m01295 http://www.toxodb.org 143536 573 2 1 LSVVVDDALGTVD 
AINALATHVVGAVK 
1324.32, 
2+ 
0.17 79 14 
2 conserved hypothetical 
protein 
69.m00139 http://www.toxodb.org 34746 211 5 1 LGDDDMFSTDLTEE 
ELSR 
1037.19, 
2+ 
0.48 102 3 
3 hypothetical protein 41.m00022 http://www.toxodb.org 41634 115 6 1 TLTPLLVDITTMG 
DKLPGVAAWNK 
1277.59, 
2+ 
-0.21 92 2 
4 thioredoxin, putative 50.m00069 http://www.toxodb.org 46946 114 6 1 GDFSQESINTFLT 
QLLAGKAPISELPK 
1453.10, 
2+ 
0.67 114 1 
5 fructose-1,6-
bisphosphatase, putative 
50.m00005 http://www.toxodb.org 42370 110 4 1 LLYEANPMAF 
LAEQAGGK 
1922.47, 
1+ 
-0.5 72 2 
6 cleft lip and palate 
transmembrane protein 
1-related 
129.m00256 http://www.toxodb.org 71224 102 3 1 SVSSPSASEA 
SVSETGNSR 
920.19, 2+ 0.53 102 1 
7 mitochondrial processing 
peptidase beta subunit, 
putative 
46.m01692 http://www.toxodb.org 58618 101 3 1 TQLLGHLDST 
TAVAEDIGR 
999.27, 2+ 0.51 101 1 
8 nucleolar RNA helicase, 
putative 
583.m05295 http://www.toxodb.org 91836 100 2 1 SEEASEETDTP 
ETVEAQSAK 
1069.64, 
2+ 
0.35 100 1 
9 ribosomal protein S23, 
putative 
44.m02556 http://www.toxodb.org 15792 96 13 1 DGSLNYIDEND 
EVLVAGFGR 
1091.83, 
2+ 
-0.37 92 2 
10 RNA binding motif-
containing protein 
80.m02342 http://www.toxodb.org 84218 96 1 1 AAAAAAAAVSAR 500.79, 2+ 0.03 66 3 
11 lysophospholipase, 
putative 
76.m01665 http://www.toxodb.org 107177 95 2 1 GLTPQTMYTQIAH 
GIDSAMDDAR 
1246.73, 
2+ 
0.31 95 1 
12 40S ribosomal protein 
S18, putative 
42.m00037 http://www.toxodb.org 17712 94 7 1 AGELTADEISK 567.35, 2+ 0.12 57 3 
13 40S ribosomal protein 
S12, putative 
20.m03903 http://www.toxodb.org 15389 92 19 1 KVVGASCVCVTDFG 
EESEALTFLQNHIK 
1008.98, 
3+ 
0.45 68 2 
14 ubiquitin carboxyl-
terminal hydrolase, 
putative 
83.m01263 http://www.toxodb.org 64018 92 2 1 TPAPSPSAAAV 
SAPQTK 
791.08, 2+ 0.32 92 1 
15 conserved hypothetical 
protein 
583.m00625 http://www.toxodb.org 64938 91 2 1 TGQPAPAAAAPG 
YQTQR 
843.19, 2+ 0.53 67 3 
16 ribosomal protein L35, 
putative 
50.m03373 http://www.toxodb.org 20056 85 2 1 FALIA 534.22, 1+ -0.11 32 6 
17 seryl-tRNA synthetase, 
putative 
50.m00020 http://www.toxodb.org 54082 82 3 1 SVPVSNDEV 
NNQVVR 
828.70, 2+ 0.56 82 1 
18 inhibitor-1 of protein 
phosphatase type 2A 
59.m03592 http://www.toxodb.org 31912 81 6 1 TLELTDNHISG 
GLEALVK 
955.79, 2+ 0.55 81 1 
19 translation initiation 
factor eIF-2B epsilon 
59.m03731 http://www.toxodb.org 88756 81 1 1 DQGDDSAFASEIR 706.15, 2+ 0.69 81 1 
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subunit-related 
20 hypothetical protein 44.m06355 http://www.toxodb.org 104123 81 2 1 SLYGGIANTLETP 
FADSEAVAK 
1127.67, 
2+ 
0.22 81 1 
21 translationally-controlled 
tumor protein, putative 
50.m03408 http://www.toxodb.org 19160 80 19 1 GAEDYGIADNSEED 
GGGVDSTSETVVD 
VVDAFR 
1688.51, 
2+ 
0.56 80 1 
22 MA3 domain protein 76.m00019 http://www.toxodb.org 58932 79 4 1 LVGDVDDYSLDNP 
DVYYLLAK 
1194.17, 
2+ 
0.18 62 2 
23 DNA-binding protein 
HU, putative 
42.m00103 http://www.toxodb.org 25173 73 8 1 TGEQLTVPATTFP 
TFSFSK 
1030.16, 
2+ 
0.28 73 1 
24 facilitative glucose 
transporter, putative 
33.m00002 http://www.toxodb.org 61648 72 2 1 GVSDDLTKGTEVV 1319.50, 
1+ 
-0.17 47 3 
25 28 kDa antigen 42.m00015 http://www.toxodb.org 19792 72 5 1 AAHVPVPDFSQ 584.56, 2+ 0.54 59 2 
26 receptor for activated C 
kinase, RACK protein, 
putative 
35.m00002 http://www.toxodb.org 35125 71 5 1 IWDLENKNVLSEI 
TPEK 
1014.86, 
2+ 
0.66 71 1 
27 UV excision repair 
protein rhp23, putative 
86.m00361 http://www.toxodb.org 39715 71 7 1 AAAESALFTGPQL 
EETLTHLVAMGFPR 
1429.59, 
2+ 
0.72 71 1 
28 hypothetical protein 49.m00035 http://www.toxodb.org 48493 70 3 1 AAANALGSDAVDE 
YAK 
1565.58, 
1+ 
-0.16 70 1 
29 proteasome subunit 
alpha type 4, subunit 
49.m03152 http://www.toxodb.org 27919 69 4 1 KAQELQAEEQAP 671.48, 2+ 0.3 47 2 
30 NAC domain containing 
protein 
55.m11049 http://www.toxodb.org 20303 69 10 1 GAGAGGMNFDTS 
LITPEMLR 
1019.75, 
2+ 
0.52 69 1 
31 TCP-1/cpn60 family 
chaperonin, putative 
49.m00030 http://www.toxodb.org 72191 69 3 1 NVLLEKEYGPPMI 
VNDGVTIAR 
1214.69, 
2+ 
0.08 69 1 
32 serine/threonine protein 
phosphatase, putative 
583.m05469 http://www.toxodb.org 61497 68 3 1 AEGEGVSGEAATS 
QDTR 
832.90, 2+ 0.05 68 1 
33 biotin requiring domain-
containing protein / 2-oxo 
acid dehydrogenases 
acyltransferase catalytic 
do 
20.m00373 http://www.toxodb.org 97179 68 3 1 GLSLISASSSPAADS 
TPAVTDLLMPSLSP 
SLK 
1557.59, 
2+ 
0.54 68 1 
34 peroxisomal catalase 44.m00005 http://www.toxodb.org 57262 68 2 1 FSTVAGESGSADTR 693.07, 2+ 0.5 68 1 
35 protein kinase 3 57.m00024 http://www.toxodb.org 44440 67 7 1 LPSGGPLPELFTFSQ 
LELQNMSPAAQVK 
1500.55, 
2+ 
0.55 67 1 
36 60S ribosomal protein 
L17, putative 
129.m00402 http://www.toxodb.org 22255 67 9 1 NLDVDNLVIEHIQV 
NRAPK 
1093.91, 
2+ 
-0.38 67 1 
37 pyridine nucleotide-
disulphide 
oxidoreductase domain-
containing protein 
25.m00219 http://www.toxodb.org 71114 66 1 1 FLADQSEFALAR 684.57, 2+ 0.44 66 1 
38 hypothetical protein 49.m03169 http://www.toxodb.org 44683 66 4 1 EIPTVAGFVQKYV 
LAAQLSR 
1095.93, 
2+ 
0.62 66 1 
39 DNA-directed RNA 
polymerase II subunit 
55.m04747 http://www.toxodb.org 140861 65 0 1 DSAGVYAQTR 534.39, 2+ 0.27 65 1 
40 40S ribosomal protein S2, 541.m00133 http://www.toxodb.org 29317 64 4 1 SPYQEWSDYLAR 758.19, 2+ 0.68 59 2 
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putative 
41 nucleolar protein NOP5, 
putative 
20.m00365 http://www.toxodb.org 54315 62 3 1 NVELSPLLPDEIAA 
EVK 
1837.70, 
1+ 
0.7 47 2 
42 hypothetical protein 38.m01037 http://www.toxodb.org 132202 62 1 1 SVEEAADAAAASAK 1290.46, 
1+ 
-0.16 48 2 
43 hypothetical protein 645.m00330 http://www.toxodb.org 40637 61 5 1 RNFVQGEENEENVE 
QTFGVR 
1191.33, 
2+ 
0.55 61 1 
44 hypothetical protein 583.m00626 http://www.toxodb.org 24692 61 8 1 LFQYIAPGGLDEEKA 
EEL 
1011.72, 
2+ 
0.43 61 1 
45 hypothetical protein 41.m01274 http://www.toxodb.org 35433 56 4 1 LVELDTGVASPVFAR 787.48, 2+ 0.1 56 1 
46 dense-granule antigen 
DG32, putative 
113.m00802 http://www.toxodb.org 24138 56 10 1 GVGEHIGGTPVDLVL 
NDLYPLIVK 
1259.70, 
2+ 
0.01 56 1 
47 signal peptide peptidase 
domain-containing 
protein 
46.m00022 http://www.toxodb.org 46231 56 2 1 QNEVDEVTGEK 624.49, 2+ 0.41 56 1 
48 40S ribosomal protein 
S28, putative 
25.m02955 http://www.toxodb.org 7583 55 19 1 VTFMADETDLAGR 1425.62, 
1+ 
-0.05 55 1 
49 RNA-binding protein, 
putative 
20.m05985 http://www.toxodb.org 59027 55 1 1 TAGDLIQEAR 537.52, 2+ 0.48 55 1 
50 conserved hypothetical 
protein 
35.m00899 http://www.toxodb.org 45089 55 4 1 SVELTRPQAVLGAV 
GMGK 
907.40, 2+ 0.79 55 1 
51 hypothetical protein 28.m00590 http://www.toxodb.org 28880 53 6 1 TGSSENNEVLPSFQD 
AEK 
976.81, 2+ 0.73 53 1 
52 hypothetical protein 41.m02358 http://www.toxodb.org 61478 52 2 1 VALSSLTTQPAEISK 1544.57, 
1+ 
-0.28 52 1 
53 ribosomal protein L32, 
putative 
57.m00005 http://www.toxodb.org 15607 52 7 1 SARLDTAEDE 1107.28, 
1+ 
0.78 52 1 
54 40S ribosomal protein 
S17, putative 
25.m00216 http://www.toxodb.org 15219 52 9 1 ISEEVAVIPSKR 664.55, 2+ 0.34 52 1 
55 peptidyl-prolyl 
isomerase, putative 
76.m00007 http://www.toxodb.org 55554 52 2 1 LGEFSEAIEQTTK 1452.64, 
1+ 
-0.08 52 1 
56 GTPase-related 20.m00340 http://www.toxodb.org 72779 51 3 1 SATSPARTEPPAAS 
AGAASGEVSR 
1114.74, 
2+ 
0.38 51 1 
57 importin-alpha re-
exporter, putative 
52.m01606 http://www.toxodb.org 120810 51 1 1 IAETDLPLDWPTLLP 
ELSQK 
1140.47, 
2+ 
0.71 51 1 
58 conserved hypothetical 
protein 
59.m00041 http://www.toxodb.org 55768 51 2 1 VAALAGPSPVAK 1080.59, 
1+ 
-0.05 51 1 
59 TCP-1/cpn60 family 
chaperonin, putative 
20.m00349 http://www.toxodb.org 58580 50 5 1 VVGGGGSAELAA 
AIAVENEADKIPGV 
EQYAVR 
1570.81, 
2+ 
0 50 1 
60 eukaryotic translation 
initiation factor 3 subunit 
6 interacting protein, 
putative 
59.m00055 http://www.toxodb.org 75026 50 2 1 FINPATPSFEDPQA 
LER 
966.64, 2+ 0.33 50 1 
61 40S ribosomal protein S4, 
putative 
25.m00221 http://www.toxodb.org 30152 49 4 1 GVPALITHDGR 568.26, 2+ -0.11 49 1 
62 hypothetical protein 27.m00846 http://www.toxodb.org 59296 49 2 1 VAALRPNVVYGQ 
AR 
757.25, 2+ -0.37 49 1 
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63 hypothetical protein 583.m05652 http://www.toxodb.org 89288 49 3 1 GAASSPASSSVFFA 
TSPLSEAEKEELSV 
LPR 
1576.69, 
2+ 
0.79 49 1 
64 eukaryotic translation 
initiation factor 3 subunit 
9, putative 
41.m00006 http://www.toxodb.org 88336 49 1 1 AALLDDFDEIVGR 1433.64, 
1+ 
-0.09 49 1 
65 formate/nitrite 
transporter-related 
25.m02951 http://www.toxodb.org 44261 49 7 1 GNPGTNPPSKSPE 
SSATGGTGAAASP 
TATS 
1329.27, 
2+ 
0.31 49 1 
66 hypothetical protein 44.m02716 http://www.toxodb.org 33936 48 3 1 YLGPESSVPHR 1241.66, 
1+ 
0.03 48 1 
67 histone H2A, putative 55.m04926 http://www.toxodb.org 13621 47 7 1 AGLQFPVGR 472.80, 2+ 0.06 47 3 
68 eukaryotic translation 
initiation factor 3 subunit 
10, putative 
20.m03667 http://www.toxodb.org 119053 47 2 1 SADAPVLPGQGL 
GDLDSVADSPED 
LLLSTLQIEVR 
1796.19, 
2+ 
0.53 47 1 
69 proteasome A-type and 
B-type domain-
containing protein 
72.m00688 http://www.toxodb.org 30247 46 4 1 TAHQYAALLSR 1230.84, 
1+ 
0.18 46 1 
70 hypothetical protein 583.m05696 http://www.toxodb.org 15961 46 6 1 AAGSVVLVRPK 548.84, 2+ 0 46 1 
71 60s ribosomal protein 
L33-A, putative 
50.m03286 http://www.toxodb.org 12839 45 7 1 VFLYPSNI 952.57, 1+ 0.06 43 4 
72 2-oxoglutarate 
dehydrogenase, putative 
49.m03397 http://www.toxodb.org 124186 45 2 1 GHEIAAVNPLSLP 
QETPFVSGSR 
1203.81, 
2+ 
0.38 45 1 
73 ran-specific GTPase-
activating protein, 
putative 
83.m01206 http://www.toxodb.org 24277 45 5 1 KFEEAAALNAK 1191.76, 
1+ 
0.12 45 1 
74 hypothetical protein 583.m00642 http://www.toxodb.org 44110 44 4 1 YSVTPDALSPQQL 
EALAK 
966.18, 2+ 0.35 44 1 
75 oxygen-regulated 
protein-related / heat 
shock protein-related 
42.m03533 http://www.toxodb.org 108385 44 1 1 VQQELGALMGAK 1244.72, 
1+ 
0.05 44 1 
76 lipoamide acyltransferase 
component of branched-
chain alpha-keto 
dehyrogenase complex, 
putative 
641.m00177 http://www.toxodb.org 54998 43 2 1 LADIGEGIAQVELLK 1568.71, 
1+ 
-0.18 43 1 
77 hypothetical protein 52.m02675 http://www.toxodb.org 83790 43 3 1 KAEEGDDALSALRPS 
SLLPSSLLLK 
1305.91, 
2+ 
0.39 43 1 
78 ATP-dependent RNA 
helicase, putative 
35.m00026 http://www.toxodb.org 49083 43 2 1 DVQNIFMATPK 1263.56, 
1+ 
-0.08 43 1 
79 40s ribosomal protein 
S20, putative 
41.m01387 http://www.toxodb.org 25883 42 5 1 LIDLHSPSDVVK 1322.72, 
1+ 
-0.01 42 1 
80 Sec61beta family protein 27.m01477 http://www.toxodb.org 10097 41 20 1 VGTNAPSAQASSA 
QHVGGAR 
933.53, 2+ 0.14 41 1 
81 ubiquinol-cytochrome c 
reductase, putative / 
Rieske iron-sulfur 
641.m00178 http://www.toxodb.org 54758 40 3 1 TSVWHDPNEPAIVS 
VSR 
947.69, 2+ 0.44 40 1 
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protein, putative 
82 hypothetical protein 44.m02826 http://www.toxodb.org 345049 40 0 1 LICLLLR 843.49, 1+ -0.06 40 1 
83 ATP-dependent RNA 
helicase, putative 
42.m00117 http://www.toxodb.org 78544 39 3 1 GLDISNVTHVINFDLP 
TNIDDYVHR 
1434.46, 
2+ 
0.48 39 1 
84 conserved hypothetical 
protein 
55.m10286 http://www.toxodb.org 80093 39 1 1 ATDAFADAASK 1067.34, 
1+ 
-0.16 39 1 
85 TCP-1/cpn60 family 
chaperonin, putative 
59.m03655 http://www.toxodb.org 58607 39 2 1 LLAPIAVDAVMK 620.87, 2+ 0 39 1 
86 hypothetical protein 55.m00103 http://www.toxodb.org 61909 39 3 1 EVDEGEELLHFADVE 
YPTSISR 
1267.78, 
2+ 
-0.64 39 1 
87 hypothetical protein 27.m00081 http://www.toxodb.org 22201 39 8 1 IFSAYFPPKDPV 
TMLK 
927.81, 2+ 0.62 39 1 
88 thioredoxin, putative 50.m00058 http://www.toxodb.org 26927 39 4 1 LKAFAEGGWK 1106.62, 
1+ 
0.02 39 1 
89 DnaJ domain-containing 
protein 
583.m05418 http://www.toxodb.org 47419 38 3 1 VTLEQMYSGATKR 742.51, 2+ 0.26 38 1 
90 PAN domain-containing 
protein (same names) 
8.m00176/ 
8.m00177/ 
8.m00178/ 
8.m00179 
http://www.toxodb.org 38737/ 
38858/ 
38728/ 
39079 
38/ 38/ 
38/ 38 
3/ 3/ 3/ 3 1 TKYAGETVATFPK 1412.76, 
1+ 
0.02 38 1 
91 proteasome subunit 
alpha type 6, putative 
49.m03281 http://www.toxodb.org 28096 38 7 1 ILSEHEVEDHLTSI 
AERE 
703.20, 3+ 0.56 38 1 
92 leucine rich repeat 
protein, putative 
20.m05970 http://www.toxodb.org 196788 38 0 1 LEENNETK 976.29, 1+ -0.17 38 1 
93 succinyl-CoA ligase alpha 
subunit, putative 
80.m00087 http://www.toxodb.org 35068 37 3 1 MLEVMQAAGLH 1199.53, 
1+ 
-0.06 37 1 
94 duplicated carbonic 
anhydrase 
113.m00755 http://www.toxodb.org 58068 36 3 1 DHSSGSDPSLPSSHWR 1751.61, 
1+ 
-0.16 36 1 
95 ras-related protein 
RAB7, putative 
50.m05646 http://www.toxodb.org 23376 36 5 1 TSLMNQYVNKK 663.71, 2+ 0.73 36 1 
96 coatomer protein gamma 
2-subunit, putative 
59.m00090 http://www.toxodb.org 112224 36 2 1 EAGDDIGYEDEYPVEP 
VVVTIGNYIAPK 
1526.83, 
2+ 
0.18 36 1 
97 branched-chain alpha-
keto acid dehydrogenase, 
putative 
583.m00686 http://www.toxodb.org 45570 35 4 1 VTGYDTPFPLAFEP 
FYLPDER 
1237.91, 
2+ 
0.63 35 1 
98 cAMP-dependent protein 
kinase catalytic subunit, 
putative 
42.m00079 http://www.toxodb.org 39385 35 2 1 LLTPDLAQR 513.87, 2+ 0.15 35 1 
99 heat shock protein, 
putative 
38.m01113 http://www.toxodb.org 90085 35 1 1 SAVVAKLEELQA 
VGGK 
800.09, 2+ 0.27 35 1 
100 cysteinyl-tRNA 
synthetase, putative 
145.m00322 http://www.toxodb.org 77976 35 1 1 STEQGVDFLTLAR 719.13, 2+ 0.52 35 1 
101 40S ribosomal protein S3, 
putative 
44.m04669 http://www.toxodb.org 26060 35 5 1 FKDGYLISTGEPSK 1541.81, 
1+ 
0.03 35 1 
102 GTP-binding nuclear 
protein RAN/TC4, 
putative 
50.m00042 http://www.toxodb.org 24579 35 6 1 SNYNFEKPFLWLAR 893.36, 2+ 0.8 35 1 
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103 26S proteasome 
regulatory subunit, 
putative 
59.m03441 http://www.toxodb.org 38415 34 7 1 TAAAASGEPQLDSLSSF 
ASVAGLVASK 
1268.15, 
2+ 
0.01 34 1 
104 hypothetical protein 83.m02140 http://www.toxodb.org 32830 34 2 1 MLLTLSR 849.45, 1+ -0.04 34 1 
105 26S proteasome non-
ATPase regulatory 
subunit 4, putative 
42.m00027 http://www.toxodb.org 41352 34 2 1 DGDLVPSR 858.44, 1+ 0.01 34 1 
106 60S ribosomal protein 
L30, putative 
44.m00044 http://www.toxodb.org 11654 34 5 1 LQLVMK 731.46, 1+ 0.01 34 1 
107 GTP binding protein, 
putative 
33.m01280 http://www.toxodb.org 44519 33 2 1 MGLVGLPNVGK 1084.33, 
1+ 
-0.29 33 1 
108 D-3-phosphoglycerate 
dehydrogenase, putative 
49.m00027 http://www.toxodb.org 65153 33 2 1 VFATPQSLGLDAI 1331.52, 
1+ 
-0.2 33 3 
109 10 kDa heat shock 
protein, mitochondrial, 
putative 
55.m05067 http://www.toxodb.org 17123 33 7 1 SGLFLPDSAQK 1162.52, 
1+ 
-0.09 33 1 
110 aminopeptidase N, 
putative 
42.m03350 http://www.toxodb.org 156663 32 0 1 DILSPPTK 870.60, 1+ 0.11 32 1 
111 oxidoreductase, putative 37.m00770 http://www.toxodb.org 37159 32 3 1 VIPVDGGMLFGGN 1275.58, 
1+ 
-0.06 32 1 
112 TCP-1/cpn60 family 
chaperonin, putative 
49.m00047 http://www.toxodb.org 61434 32 1 1 SVWLDNPAAK 1100.51, 
1+ 
-0.06 32 1 
113 transaldolase, putative 44.m04690 http://www.toxodb.org 40243 32 4 1 LLSVVVADTGDFVA 
LKK 
888.19, 2+ 0.34 32 1 
114 CTP synthase, putative 129.m00261 http://www.toxodb.org 70953 32 1 1 SGAVYEEVESA 1140.39, 
1+ 
-0.12 32 1 
115 heat shock protein-
related 
76.m01677 http://www.toxodb.org 31074 31 6 1 QGPSPASPWDVM 
PFAWGGR 
1022.32, 
2+ 
0.68 31 1 
116 60s ribosomal protein l6, 
putative 
583.m05552 http://www.toxodb.org 21506 31 4 1 APTAAALAK 813.43, 1+ -0.05 31 1 
117 hypothetical protein 55.m08184 http://www.toxodb.org 30194 31 5 1 GSGEGAAELLESLNA 1417.56, 
1+ 
-0.12 31 1 
118 splicing factor u2af 
protein-related 
641.m01535 http://www.toxodb.org 56626 31 2 1 LEETSFAQYIAPLLQ 1722.50, 
1+ 
-0.39 31 1 
119 26S proteasome non-
ATPase regulatory 
subunit, putative 
80.m02359 http://www.toxodb.org 61401 31 3 1 ALQEEMARVEDEEL 
DDDDLDML 
1297.62, 
2+ 
0.13 31 1 
120 TCP-1/cpn60 family 
chaperonin, putative 
44.m02569 http://www.toxodb.org 59179 30 2 1 TANAAAVQS 
IANILR 
1512.74, 
1+ 
-0.11 30 1 
121 polypyrimidine track-
binding protein, putative 
80.m00057 http://www.toxodb.org 71059 30 2 1 SPTMYQALIQF 
QSPDQAR 
1041.32, 
2+ 
0.62 30 1 
122 hypothetical protein 55.m10321 http://www.toxodb.org 20073 29 7 1 FPSPALGRSKPGK 1341.53, 
1+ 
-0.23 29 1 
123 26S proteasome 
regulatory particle non-
ATPase subunit-related 
50.m03375 http://www.toxodb.org 52534 29 4 1 APGVTQAEFQREL 
QEAQAALAR 
1192.69, 
2+ 
0.14 29 1 
124 troponin c, isotype 
gamma., putative 
50.m00082 http://www.toxodb.org 17614 29 3 1 FVFLLK 766.41, 1+ -0.08 29 1 
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